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ABSTRACT 
  Chemotherapy and radiotherapy are widely accepted as common 
forms of treatment for cancers. The majority of cancer patients receive 
chemotherapy alone or in combination with radiotherapy. Most chemotherapeutic 
drugs cause DNA damage to the rapidly dividing cancer cells but normal cells are 
also damaged in the process. Therefore DNA repair levels in tumour and normal 
cells may determine the success of the treatment. 
  The aim of this work was to evaluate the use of DNA repair biomarkers for 
assessing responses to chemotherapeutic drugs. The novel technique of imaging 
flow cytometry was employed to analyse the induction and resolution of γ-H2AX 
and RAD51 DNA repair biomarkers in DNA repair normal cell lines MRC5-SV1 and 
NB1-HTERT, an ATM-deficient cell line AT5BIVA (derived from an Ataxia 
Telangiectasia patient) and an XPF-deficient cell line GM08437B. Two cell lines were 
also developed, MRC5-SV1R and NB1-HTERTR which had been made resistant to 
HN2. A range of chemotherapeutic drugs, Adriamycin, Cisplatin and Nitrogen 
Mustard which have different modes of action were examined in this work. 
 We have demonstrated distinct differences in γ-H2AX and RAD51 foci 
induction and resolution between the two DNA repair normal cell lines following 
exposure to different chemotherapeutic drugs.  Additionally, it was demonstrated 
that both the resistant and sensitive cell lines have elevated γ-H2AX and RAD51 
expression profiles in comparison to the parental cell lines over a 48 hour period 
post treatment with the cross-linking agent HN2. It is concluded that while both the 
γ-H2AX and Rad51 biomarkers may be useful for determining chemotherapeutic 
response, a larger cohort of cell lines and tumour samples is required for further 
analysis. 
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1.1 DNA Damage  
 Our genome is under continual assault from a vast array of exogenous and 
endogenous factors which result in the formation of DNA lesions such as 
 double and single strand breaks 
 formation of DNA adducts such as inter or intra strand cross links  
 base damage 
 formation of dimers as a result of ultraviolet (UV) exposure 
Accurate transfer of genetic information during cell division is a vital process and 
requires precise replication of DNA. It necessitates accurate DNA repair of 
spontaneous and induced DNA damage to minimise mutations being passed onto 
daughter cells. Unrepaired lesions have an effect on numerous cellular processes 
such as replication or transcription and may ultimately lead to the development of 
cancer due to accumulation of genetic modifications within the somatic cells and 
inherited genetic disorders if mutations occur in germ cells (Beckman and Loeb 
2005). Laboratory models and human carcinogenesis have shown that the 
accumulation of six or more genetic mutations lead to the development of 
tumourigenic cells (Hanahan and Weinberg 2000).  
 Causes of DNA damage can be broadly categorised into three groups 
(Hoeijmakers 2001). These are  
 Environmental agents e.g. ionising radiation, UV rays, tobacco smoke 
 By-products of normal cellular metabolism e.g. hydroxyl radicals 
 Spontaneous hydrolysis of chemical bonds in DNA 
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Errors in cellular processes such as DNA replication, recombination or repair can 
also lead to the fixation of DNA damage leading to mutations. Table 1.1 below 
shows an overview of the different types of DNA damage that can occur. 
 
Table 1.1: Overview of different types of DNA damage 
Type of damage Cause DNA repair pathways 
Single strand 
break, Abasic sites 
X-rays, alkylating 
agents, oxygen radicals 
Base Excision Repair 
Double strand 
break  
Gamma Radiation 
Non-homologous End Joining 
Homologous Recombination 
Cyclobutane 
pyrimidine dimer 
(CPD) Bulky 
adduct 
UV Light, polycyclic 
aromatic 
hydrocarbons 
Nucleotide Excision Repair 
Inter/Intra strand 
crosslink 
X-rays, anti-tumour 
drugs such as Cisplatin 
Nucleotide Excision Repair 
Homologous Recombination 
Mismatch of base 
pairs, insertion or 
deletion of bases 
Errors during 
replication 
Mismatch repair 
 
1.1.1 DNA double strand break  
 The DNA double strand break (DSB) is one of the most toxic lesions in living 
cells (Valerie and Povirk 2003). It can become cytotoxic if left unrepaired and may 
lead to cell death. If it is repaired incorrectly, it can lead to genetic instability 
through events such as loss of heterozygosity, chromosome rearrangements or loss 
of genetic information; all of which can have numerous consequences such as cell 
death or inheritable mutations being formed and may subsequently increase an 
individual’s chances of developing cancer and inherited genetic diseases (Scott and 
Pandita 2006). Subsequently this could cause inactivation of tumour suppressor 
genes or the activation of oncogenes which can instigate carcinogenesis in cells 
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(Jackson 2002). DSBs can be induced directly or indirectly by exogenous agents such 
as ionising radiation (IR) and chemotherapeutic agents. However there are events 
where DSBs are crucial in order to facilitate recombination between homologous 
chromosomes and subsequently are intentionally initiated such as during V(D)J 
recombination and immunoglobulin class-switch recombination as well as during 
meiosis.   
  
1.1.2 DNA adduct formation 
 DNA adducts are chemical modifications of the DNA, generally bulky lesions 
forming on the DNA. The formation of DNA adducts occurs following exposure to 
cross-linking agents such as the Nitrogen Mustards (i.e. Mechlorethamine), 
Platinum based drugs (i.e. Cisplatin (Pt)) and Mitomycin C  (Cole 1973; McHugh et 
al. 2001). DNA crosslinking can occur in one of three ways and can result in grossly 
distorted DNA (refer to Figure 1.1) 
 Intrastrand - crosslinking of DNA on the same strand 
 Interstrand - crosslinking (ICL) of DNA between two complementary strands 
 DNA-protein - crosslinking between DNA base and reactive groups on 
proteins 
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Figure 1.1 Different types of adducts formed by crosslinking agents (McHugh et al. 
2001) 
 
Unless repaired, these adducts can have deleterious effects such as blocking 
transcription or stalling of replication forks. Additionally the presence of DNA 
adducts increase the potential for mutagenesis to occur (Dipple 1995). These 
adducts are very cytotoxic and as such, form the basis of the mechanism of action 
of many chemotherapeutic agents. 
 
1.1.3 Free Radical Formation 
Free radical formation results from intrinsic factors such as the by-product 
of normal metabolic reactions such as respiration and lipid peroxidation and 
extrinsic factors such as IR and carcinogenic agents (Dizdaroglu et al. 2002). One of 
the most dangerous compounds formed is the highly reactive hydroxyl radical OH- 
which is capable of causing oxidative damage to DNA and has been associated with 
ageing, mutagenesis and carcinogenesis (Dizdaroglu et al. 2002). Spontaneous 
hydrolysis of nucleotide residues or deamination of bases can lead to the formation 
of abasic sites (Kow 2002).  
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1.1.4 UV damage  
 Exposure to ultraviolet B radiation (UVB) results in the formation of DNA 
damage such as CPDs and (6-4) photoproducts (Ichihashi et al. 2003). However it 
can also lead to other forms of damage such as protein-DNA crosslinks, single 
strand breaks (SSB) and oxidative base damage (de Gruijl et al. 2001).  
 
Figure 1.2: Formation of CPDs and 6-4 photoproducts (taken from (Ichihashi et al. 
2003) 
 
The above shows how adjacent pyrimidine dimmers on the same strand change following 
exposure to UVB, resulting in the formation of either CPDs (1.2 (a)) or (6-4) photoproducts (1.2(b)).  
 
If left unresolved, this damage can induce mutations in epidermal cells which can 
lead to the development of skin cancers such as basal cell carcinomas, squamous 
cell carcinomas and cutaneous melanomas (de Gruijl et al. 2001).  
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1.2 DNA Repair pathways 
 Due to the possible adverse consequences that may arise from unrepaired 
DNA damage such as cell death, accumulation of mutations and development of 
cancer, it is crucial for the cell to repair any lesions prior to cell division to prevent 
the mutation being passed onto daughter cells (Malumbres and Barbacid 2009) and 
maintain genomic integrity (Wang et al. 2000). DNA repair pathways are an integral 
part of the cell cycle and these are stringently regulated by a series of cell cycle 
checkpoints at every phase of the cell cycle (Hoeijmakers 2001). DNA repair 
pathways in humans include the following  
 Excision Repair Pathways 
o Nucleotide Excision Repair (NER) 
o Base Excision Repair (BER) 
o Mismatch Repair (MMR) 
  Strand break repair 
o Non Homologous End Joining (NHEJ) 
o Homologous Recombination Repair (HR) 
o Single strand annealing  
 Direct Reversal  
The following sections will review the DNA repair pathways primarily associated 
with the repair of DNA damage induced by chemotherapeutic agents.  
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1.2.1 The DNA Damage Response  
 Although the exact mechanisms for how the DNA repair pathways that 
become activated after DNA damage has occurred have yet to be elucidated, 
sufficient progress has been made to allow for a general organisation of the DNA 
damage response pathway. It has emerged as a regulatory pathway which has 
numerous targets but overall its goal is to sense and facilitate the repair of 
damaged DNA.  
 There are two central protein kinases at the heart of this pathway, Ataxia 
Telangiectasia Mutated (ATM) and Ataxia Telangiectasia and RAD3 related (ATR). 
They appear to work in similar pathways; a consensus which stems from findings 
that they both phosphorylate p53 on Ser15 (Shiloh 2001). The deleterious effects of 
a non-functional ATM gene is characterised by the disorder Ataxia Telangiectasia 
(A-T) which renders individuals sensitive to IR and susceptible to the development 
of cancers. There are no known diseases which present with impaired ATR function 
(Harper and Elledge 2007), making it difficult to fully characterise the functionality 
of this protein.  
 The MRE11/RAD50/NBS1 (MRN) complex sense the formation of DSBs and 
recruits ATM to the damaged DNA which results in its autophosphorylation on 
Serine 1981 (Harper and Elledge 2007). ATM plays a pivotal role in the response to 
damage induced by IR and controls phosphorylation of downstream targets such as 
p53, Mdm2, BRCA1 and Chk2 in response to DNA damage (Shiloh 2001).  
 ATR is thought to be recruited when a replication block such as a stalled 
replication fork is encountered (Harper and Elledge 2007). When DNA polymerases 
stall, the replication helicases pursue unwinding of DNA ahead of the replication 
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fork, producing single strand DNA (ssDNA). The ssDNA then binds to a single strand 
binding protein, replication protein A (RPA), forming the ssDNA-RPA complex. This 
complex then recruits ATR via a regulatory subunit known as ATRIP and enables co-
localization with the PCNA-related 911 complex. This initiates phosphorylation of 
the two proteins and down-stream signalling ensues (Harper and Elledge 2007).    
 
1.2.2 Base Excision Repair 
 BER protects the cellular genome against damage arising as a result of DNA 
interaction with reactive oxygen species (ROS) such as methylation, deamination 
and hydroxylation (Seeberg et al. 1995) which results in the formation of lesions 
such as 8-oxo-guanine (Refer to Figure 1.3).  It is also thought to be essential in 
protecting the cell against damage caused by exogenous agents such as IR (Seeberg 
et al. 1995). 
Figure 1.3: Oxidative conversion of Guanine into 8-Oxo-Guanine (Niles et al. 2006) 
 
 
The repair pathway is initiated by DNA glycosylases which cleave the N-glycosylic 
bond between the damaged base and the deoxyribose backbone at the 5’ end of 
the abasic site (Gary et al. 1999). This creates an apurinic or apyrimidine (AP) site 
which are cytotoxic and must be repaired (Krokan et al. 1997).  There are two 
routes that can be taken to process and correct the abasic site after this initial 
Guanine  8-Oxo-Guanine  
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excision is made. These are the short patch pathway which is the dominant 
pathway in mammalian cells and the long patch pathway which is dependent on 
Flap endonuclease/ 5’-3’ exonuclease (FEN-1) and Proliferating Cellular Nuclear 
Antigen (PCNA), a protein found in abundance in the nucleus (Klungland and 
Lindahl 1997).  The short patch pathway involves the removal of a single nucleotide; 
the gap is then filled by DNA Polymerase β and the strand is sealed by DNA 
Ligase/XRCC1 (X-ray Repair Cross Complementing protein 1) (Gary et al. 1999). The 
long patch pathway is thought to be activated for altered DNA bases which are not 
susceptible for removal by DNA Polymerase β (Gary et al. 1999). These are usually 
sites with altered bases or sugars which requires FEN-1 to remove the 5’ 
deoxyribose sugar along with at least one other nucleotide although this has been 
shown to be extended up to 8 nucleotides being removed in total by Klungland and 
Lindahl, (1997). An overview of the two distinct branches of this pathway is shown 
in Figure 1.4. 
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Figure 1.4: Overview of BER pathway (image taken from (Klungland and Lindahl 
1997)) 
 
The above figure depicts the two branches of the BER pathway. Figure 1.3A depicts the short 
patch pathway where a single nucleotide is replaced and this is the usual route of repair for AP 
site formation. Figure 1.3B indicates the long patch pathway where a stretch of nucleotides are 
replaced; usually seen during the repair of oxidised or reduced bases which cannot be repaired by 
the short patch pathway.  
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1.2.3 Homologous Recombination 
HR and NHEJ pathways are the main route taken in the repair of direct DNA 
DSBs in vertebrate cells (Takata et al. 1998). The point at which the cell is 
progressing through the cell cycle plays a role in determining the pathway that will 
become activated to repair the DSB (Lees-Miller and Meek 2003). It is generally 
agreed that in the G1/G0 phase of the cell cycle, DSBs are repaired by NHEJ while 
HR is more prominent during the late S/G2 phase (Valerie and Povirk 2003). HR is 
suppressed in G0/G1 and M phases of the cell cycle as supported by findings that 
Rad51 foci only appear in S and G2 phases (Graeser et al. 2010). Takata et al, (1998) 
demonstrated that HR and NHEJ are complementary in repairing the DSBs and 
concluded that both play a significant role in maintaining the integrity of 
chromosomes.  
 HR is essential in both mitosis and meiosis; promoting gene diversity in 
offspring through the combination of genetic information from both maternal and 
paternal alleles in the latter process (San Filippo et al. 2008). The presence of an 
intact sister chromatid is required for this repair pathway (Davies et al. 2001) which 
may serve as an explanation as to why this repair pathway is not the most common 
one used even though it results in the precise repair of the DNA lesion. An overview 
of this pathway is shown in Figure 1.5. 
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Figure 1.5: Homologous Recombination (diagram adapted from (San Filippo et al. 
2008)) 
 
 
HR can be split into three main stages (Li and Heyer 2008) 
 Presynapis – Processing of DNA ends 
 Synapsis – Strand invasion  
 Post synapsis  
DSB occurs in DNA, 
triggering DNA damage 
response.
DNA ends are  processed to form ssDNA
with 3’ OH ends.
3’
Mre11 Rad50 Nbs1 MRN complex  recruited to site 
of damage and is involved in the 
processing of the DNA ends
Strand invasion mediated by RAD51 once homologous strand 
has been located forming nascent D-loop structure
D-loop structure
Synthesis 
dependent stand 
annealing
3’
D-loop unwound and the ssDNA strand 
anneals with other ssDNA strand 
associated with DSB
Gap filling DNA synthesis and ligation
Holiday junctions
Double strand 
break repair
Second end captured to form 
second Holiday junction.These are 
resolved by endonucleases
Depending on how Holiday junctions are 
resolved, it can lead to formation of non-
crossover products (a) or crossover 
products (b)
A
B
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The repair pathway (refer to Figure 1.5) is initiated through the formation of a DSB. 
The MRN complex processes the two strands; producing a ssDNA tail with 3’ OH 
ends. RAD51 binds to ssDNA; a process mediated by BRCA2 (Davies et al. 2001), to 
form the presynaptic filament.  
 This filament searches for the homologous sequence by capturing a duplex 
DNA molecule and while the exact procedure that takes place has not yet been 
established in eukaryotes, the RAD51 homolog in E. coli has been shown to locate 
the homologous sequence through random collisions between the presynaptic 
filament and the duplex DNA (San Filippo et al. 2008).  
 Once the homologous sequence has been located, the processed 3’ end of 
the DNA molecule invades the duplex DNA, forming a nascent D-loop structure. 
DNA synthesis then takes place.  
 The second DNA DSB end is captured by annealing to the extended D-loop 
which forms Holliday junctions. The process is completed through the resolution of 
these Holliday junctions by the action of resolvases (Osborn et al. 2002). The end 
products will either be crossover or non-crossover. Cross-over products result from 
the exchange of an arm of the two participating chromosomes.    
 Both BRCA1 and BRCA2, which are tumour suppressor genes, play a role in 
HR. BRCA1 is a component of the BRCA1-associated genome-surveillance complex 
(BASC) which comprises tumour suppressors, DNA damage sensors and signal 
transductors (Wang et al. 2000).  It has been proposed that the BASC complex can 
influence the repair pathway taken based on the type of DNA lesion inflicted 
(Turner et al. 2005).  
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 In contrast to BRCA1, BRCA2 plays a major role in the progression of HR by 
regulating RAD51 strand invasion (Carreira et al. 2009). It has been demonstrated 
that BRCA2 promotes HR by directly associating with Rad51 through the 8 
conserved RAD51 binding regions (Davies et al. 2001). Jensen et al, (2010) showed 
that BRCA2 stabilises Rad51 bound to ssDNa through down regulation of its ATPase 
activity. 
 Following processing of the DNA strand break ends by the MRN complex, 
thought to be regulated by BRCA1 (Turner et al. 2005), BRCA2 relocates to the site 
of damage. BRCA2 works at the crossing point between the processed single strand 
to aid RAD51 mediated strand invasion by displacing RPA from the overhang 
(Turner et al. 2005).   
 
1.2.4 Non Homologous End Joining (NHEJ) 
 NHEJ is a quick albeit error-prone method of repairing DNA. It is the main 
pathway for the repair of induced DSBs as well as programmed DSBs that occur 
during V(D)J recombination.  The basic principle behind this mechanism is simple; 
detect the broken ends and rejoin them by breaking off incompatible bases. Initially 
the broken ends of the DNA molecule are detected by the Ku heterodimer which 
comprises Ku70 and Ku80 subunits. Walker et al, (2001) demonstrated that the Ku 
heterodimer is a symmetrical molecule with a preformed protein ring in the centre 
which can accommodate duplex DNA. The ring allows the two broken ends to be 
harnessed together. The Ku heterodimer restricts the DNA molecule movement 
along the helical structure and also forms a barrier to prevent binding of the broken 
DNA ends prior to repair taking place (Walker et al. 2001). 
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 DNA-PKcs, a member of the phosphatidylinositol-3 Kinase related protein 
kinase family (PIKKs) (Lees-Miller and Meek 2003) is then recruited by the Ku 70/80 
complex to the site of the break. Upon binding to the Ku-DNA complex, DNA-PKcs 
becomes autophosphorylated and the two ends are brought within close proximity 
of each other. This process is precise when rejoining compatible blunt ends of DNA 
but more often than not, end processing is required to produce ligatable ends 
(Weterings and Chen 2008). The DNA ends are then ligated by the XRCC4/DNA 
Ligase IV complex which is also thought to play a role in the end processing step 
(Lees-Miller and Meek 2003). Figure 1.6 represents a general overview of this 
pathway.  
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Figure 1.6: Schematic representation of the NHEJ pathway adapted from (Lees-
Miller and Meek 2003) and (Hefferin and Tomkinson 2005) 
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1.2.5 Nucleotide Excision Repair (NER) 
 NER is a complex repair pathway involving numerous proteins which is 
responsible for the removal of helix distorting DNA lesions such as UV-light induced 
lesions i.e. CPDs, DNA adducts formed by chemical agents such as AflatoxinB1 
(Fousteri and Mullenders 2008) and ICLs formed by exposure to chemotherapeutic 
agents such as Pt. NER-deficient individuals present with rare autosomal diseases 
such as Xeroderma Pigmentosum (XP), Cockayne Syndrome (CS) and 
Trichothiodystrophy (TTD) ; all of which are associated with a hypersensitivity to 
sunlight, effectively demonstrating the significant role that NER plays in maintaining 
genomic stability and integrity (Fousteri and Mullenders 2008).   
  Two sub pathways exist within this repair pathway; Global Genome NER 
(GG-NER) and Transcription Coupled NER (TC-NER). GG-NER repairs lesions in 
untranscribed strands of active genes throughout the entire genome; however the 
efficiency of its repair varies which is thought to be linked to chromatins 
surrounding the lesion as NER requires a sister strand to complete its repair 
(Fousteri and Mullenders 2008). Conversely TC-NER is activated in the repair of DNA 
lesions encountered in transcribed strands of active genes only (Furuta et al. 2002). 
The other fundamental difference between these two sub pathways lies in the 
detection of the DNA lesion.  UV-DDB and XPC-RAD23B activate the GG-NER 
pathway when a DNA lesion is sensed whereas TC-NER is activated through the 
stalling of RNA Polymerase II (RNAPII) complex during transcription. 
  When RNAPII stalls, two transcription-coupled repair specific factors CSA 
and CSB are recruited to the site of the damage.  CSA encodes 7 WD-40 motifs 
which are associated with diverse aspects of cellular metabolism and are generally 
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viewed as having regulatory functions (Henning et al. 1995). CSB is able to bind to 
DNA; thought to be mediated by binding to core histone proteins within the 
nucleosome (Henning et al. 1995). CSA and CSB colocalise with RNAPII to mediate 
formation of the repair machinery; each has its own role in this process. CSB is 
required for the recruitment of NER proteins to the stalled RNAPII and CSA in 
concert with CSB recruit nucleosomal binding proteins HMGN1, XAB2 and TFIIS. 
Mutations in CSA and CSB lead to the development of CS; which is discussed 
elsewhere. TC-NER has been implicated as the main repair pathway for the repair of 
ICLs induced by Cisplatin (Furuta et al. 2002).  Using cells that were deficient in XP-
A, XP-D, CSA AND CSB, Furuta et al, (2002) were able to demonstrate 
hypersensitivity to Pt, despite the fact that these cells still had a functional GG-NER 
pathway. Their findings were further validated by demonstrating normal resistance 
in an XP-C cell line which has functional TC-NER but limited GG-NER capacity.  
 The two sub-pathways share a requirement for activation of the same 
factors once the lesions has been sensed in order to repair the damage. In both 
instances, specific factors and NER proteins are recruited to the site of damage. 
Components of Transcription repair factor IIH (TFIIH), which are coded by XPB and 
XPD genes, unwind the DNA double helix around the section of the lesion, creating 
a stretch of ssDNA. The DNA strand is cut at 3’ and 5’ ends by XPG and ERCC1-XPF 
respectively.  DNA repair then takes place, using the sister strand as a template.  
 ERCC1-XPF is a structure specific endonuclease involved in the excision 
process in NER. Deficiencies in ERCC1-XPF lead to increased sensitivity to UV light, 
characterised in patients suffering from Xeroderma Pigmentosum 
(Complementation Group F). It incises the damaged strand at the 5’ position, 
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enabling the 3’ end to be used as a template to replaced damaged nucleotides by 
the DNA repair machinery. However there have been findings to suggest that the 
functions of this nuclease may not be limited to NER alone (Al-Minawi et al. 2009). 
Al-Minawi et al, (2009) indicated that ERCC1-XPF plays a role in the repair of ICLs via 
the HR pathway which is in line with findings by Niedernhofer et al, (2004) who 
demonstrated that ERCC1-XPF is not required to form DSBs after ICL damage but 
are crucial in resolving this damage.  
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Figure 1.7: Overview of the two branches of the NER pathway (taken from 
(Fousteri and Mullenders 2008)) 
 
The above shows an overview of the two distinct branches of the NER pathway. Figure 1.7 (A) 
shows the different mechanisms of damage recognition and Figure 1.7 (B) shows where the two 
branches overlap to complete repair 
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1.3 DNA Repair defective disorders 
 The significance of having fully-functional DNA repair pathways is 
highlighted in diseases where DNA repair is impaired.  The importance of the DNA 
damage response can be seen in the deleterious consequences experienced by 
patients with Ataxia Telangiectasia (A-T), Nijmegen breakage syndrome (NBS),  
Blooms syndrome and Fanconi Anaemia (FA) (Scott and Pandita 2006). These have 
all been classed as chromosomal instability disorders where patients have a 
predisposition to the development of cancer and a decline in the efficacy of their 
immune system (Digweed 2003).  There is another group of disorders which are 
deficient in the NER pathway which render individuals sensitive to UV rays such as 
XP, CS and TTD. An overview of some of the different disorders affected by 
defective DNA damage and repair responses is shown in Table 1.2. The clinical 
manifestations of these disorders emphasize the colossal roles the various DNA 
repair pathways play in protecting our genome and the importance of recognising 
and dealing with DNA damage efficiently.  
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Table 1.2: Overview of disorders affected by defective DNA damage and repair 
responses (adapted from (Lehmann 2003)) 
Disorder Defect Consequences 
Xeroderma 
Pigmentosum (XP) 
XP complementation 
genes (XP A-G & XP-
V) 
Hyper sensitive to UV light 
Cockayne Syndrome 
(CS) 
CS A or CSB  
Unable to resume RNA 
synthesis post UV exposure 
Trichothiodystrophy 
(TTD) 
XPB or XPD helicases 
or TTDA 
Dysfuctional transcription 
Ataxia Telangiectasia     
(A-T) 
ATM gene Radiosensitivity 
Ataxia Telangiectasia 
Like Disorder (ATLD) 
MRE11 gene Impaired DSB repair 
Nijmegen Breakage 
Syndrome (NBS) 
NBS1 gene Impaired DSB repair 
Fanconi Anaemia (FA) 
Fanconi Anaemia 
genes 
Defective repair of interstrand 
crosslinks 
Bloom’s Syndrome BLM gene 
Increased sister chromatid 
exchange 
Werner’s Syndrome WRN gene Impaired DNA repair 
Rothmund-Thompson 
Syndrome 
RECQL4 gene Impaired DNA repair 
Severe Combined 
immunodeficiency 
(SCID) 
SCIDX1 gene Defective immune system 
Seckel Syndrome ATR gene 
Impaired DNA damage 
response 
LIG4 Syndrome DNA Ligase IV gene Defective V(D)J recombination 
Li-Fraumeni Syndrome p53 gene 
Unable to effectively induce cell 
cycle arrest 
DNA PKCS deficiency DNA PKcs  Impaired DSB repair 
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1.3.1 Ataxia Telangiectasia 
 A-T is a neurodegenerative condition which usually presents in early 
childhood (McKinnon 2004). The underlying cause of this syndrome is a mutated 
ATM gene which usually renders the patient susceptible to the development of 
cancers such as lymphoma and leukaemia in addition to presenting with 
immunodeficiencies (McKinnon 2004). The ATM gene is at the core of the signalling 
cascade that responds to DSBs by coordination of the cellular response to this 
lesion (Friesner et al. 2005). As it is also involved in the response to DSBs caused 
during V(D)J recombination and meiosis, A-T patients are also known to suffer from 
sterility due to the defective meiosis recombination that arises as a result of the 
mutated ATM gene.  
 Friesner et al, (2005) showed that ATM is required for the formation of γ-
H2AX foci which is thought to be one of the first cellular responses to DSBs that 
arise from exposure to ionising radiation which may provide some explanation for 
the radiosensitivity of these patients. This line of evidence was further backed by 
Bourton et al, (2011) who demonstrated that the AT5BIVA cell line, derived from a 
patient with classical A-T showed an increased sensitivity to IR in comparison to the 
normal patients.  
 
1.3.2 Nijmegen Breakage Syndrome  
 NBS is a rare autosomal disease with a defect in the NBS1 gene where 
patients are susceptible to the development of B cell lymphomas. Patients present 
with numerous symptoms such as growth retardation, receding foreheads and 
mental retardation which worsens with age.  
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 The NBS1 protein plays a pivotal role in the damage response pathway. It 
directly binds to H2AX and recruits MRE11 and RAD50 to the site of damage. NBS1 
associates with MRE11 and RAD50 in response to form the MRN complex. The MRN 
complex then mediates the repair of DSBs, primarily through HR (Komatsu et al. 
2007). Their findings led to the conclusion that NBS1 is a key regulator of HR.  
 
1.3.3 Blooms Syndrome 
 Bloom’s syndrome is caused by a loss of function in the BLM gene which 
leads to patients experiencing striking increases in chromosome aberrations, sister 
chromatid exchange and mutations ((Wang and Heddle 2004)). The BLM gene 
encodes a RecQ helicase which is involved in unwinding of DNA; a necessary step 
during cellular processes such as replication and repair.   
 Patients exhibit facial erythema which is sensitive to sunlight and they are 
also immunocompromised. As with the other chromosomal instability diseases, 
they show an increased susceptibility to the development of cancers such as 
leukaemia and lymphoma.  
 
1.3.4 UV-Sensitive Disorders 
 There are three distinct disorders, CS, XP and TTD which are all associated 
with hypersensitivity to the effects of UV rays due to defects in various components 
of the NER pathway but present with differing physical characteristics. 
  CS patients usually present with physical manifestations such as growth 
retardation, skeletal and retinal abnormalities, neurological defects, increased 
sensitivity to sunlight and mental retardation. CS patients have defects in either the 
CSA gene or CSB gene which form part of the RNAPII complex to recruit various NER 
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proteins to the site of damage. These defects lead to the inability for CS patients to 
resume RNA synthesis post exposure to UV light and there is a deficiency in TC-NER 
brought about by a deficiency in either CSA or CSB (Lehmann 2003). 
 XP patients suffer from hyper-pigmentation post exposure to sunlight, very 
dry scaly skin, loss of elasticity, skin lesions and an increased vulnerability (>1000 
fold increase) to the development of various skin cancers (Lehmann 2003). XP 
patients can be categorised into 8 different complementation groups; XP A-G, 
which are known as classical XP and XP-V, also known as XP-variant. XPC and XPE 
patients present with defects in the GG-NER pathway but a functional TC-NER, 
providing some form of explanation for the generally milder symptoms exhibited by 
patients in these two groups in comparison to the others (Diderich et al. 2011). The 
other XP groups present with varying levels of defective TC-NER and GG-NER with 
XPA patients having a completely non-functional NER pathway.   
 TTD patients suffer from a myriad of symptoms such as Photosensitivity, 
Ichthyosis (scaly skin), Brittle hair and nails, Impaired intelligence, Decreased 
fertility and Short stature (PIBIDS). It is generally considered a development 
disorder with no increased susceptibility to the development of skin cancer even 
though the XPB and XPD helicases are affected (Diderich et al. 2011). The hallmark 
of this disease is brittle hair which displays a distinct “tiger tail” banding when 
examined under polarising microscopy (Faghri et al. 2008). TTD patients are 
primarily affected by dysfunctional transcription as the XPB and XPD helicases have 
been found to form part of the basal transcription factor TFIIH. 
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1.4 DNA repair biomarkers 
 Due to the fact that the major emphasis of this thesis is to evaluate DNA 
repair biomarkers for their ability to detect patient sensitivity or resistance to 
chemotherapy, the two principle biomarkers being utilised are reviewed below.  
 
1.4.1 H2AX 
 The histones are a group of proteins responsible for compacting DNA into 
the nucleus. They are found as an octomer that consists of 2 molecules of H2A, 
H2B, H3 and H4; (refer to Figure 1.8). They are positively charged, allowing them to 
bind to negatively charged DNA very tightly; resulting in the formation of 100kDa 
protein complex (Fernandez-Capetillo et al. 2004). The DNA becomes further 
condensed by the linker Histone H1 which compresses the nucleosomes into 
chromatin fibres (Fernandez-Capetillo et al. 2004).  
 
Figure 1.8: Structure of histones adapted from (Bohm and Crane-Robinson 1984) 
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H2AX is one of the isoforms of the Histone H2A protein; distinguished from 
other isoforms by the presence of a short COOH terminal tail. Rogakou et al, (1998) 
first identified a unique phosphorylation event on the Serine 139 residue located 
within the COOH tail. In response to exposure to IR and subsequent formation of 
DSBs, H2AX becomes phosporylated on Serine 139, forming γ-H2AX (Refer to Figure 
1.9). The phosphorylated γ-H2AX accumulated around the break in a 2Mb region. 
Sedelnikova et al, (2002) identified that  γ-H2AX foci form in a 1:1 ratio with DSBs in 
the SF-268 human astrocytoma cell line and HT-1080 human fibrosarcoma cell lines. 
Iododeoxyuridine (125IdU) is known to produce 1 DSB per decay in bacteriophage 
DNA (Sedelnikova et al, 2002). By measuring the radioactivity of 125IdU as well as 
calculating the number of γ-H2AX foci in each cell, Sedelnikova et al, (2002) were 
able to show a direct correlation between DSBs and formation of γ-H2AX foci.  
  
Figure 1.9: Example image of γ-H2AX foci obtained from imaging flow cytometry 
 
The above figure is shown in Brightfield which allows visualisation of cell morphology, AF488 
stained γ- H2AX foci and the cell nucleus which has been stained with Draq-5 
 
H2AX phosphorylation is an integral part of the DNA damage signalling 
network (Olive and Banath 2009). Repair of DSBs caused by IR then takes place 
either through NHEJ or HR. The position of the cell in the cell cycle governs which 
repair pathway will be activated as HR can only take place once cells have 
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progressed through the S phase due to the necessity of a sister strand’s presence. 
Once DNA repair has taken place, H2AX becomes dephosphorylated and reverts 
back to its inactive form. 
γ-H2AX has been demonstrated to be an effective target in identifying cell 
sensitivity to a variety of DNA damaging agents which cause direct DNA double 
strand breaks such as gamma radiation and doxorubicin (Olive and Banath 2009).  
Bourton et al, (2011) have demonstrated that studying γ-H2AX formation could 
potentially be used to predict patient response to radiotherapy. The study was 
carried out on a small cohort of patients who had experienced varying levels of 
normal tissue toxicity in response to radiotherapy. They were able to distinguish 
differences in the patterns of γ-H2AX formation and dephosphorylation post 
exposure to IR between patients who had experienced severe normal tissue toxicity 
compared to patients who had experienced little side effects.  
 Based on these studies, it could be possible to predict patient response to a 
range of chemotherapeutic drugs. However, although there is a significant body of 
work that has defined the formation of γ-H2AX is formed in response to direct DSBs 
such as those caused by IR, there have been diverse conclusions from studies that 
have used this biomarker to predict damage and repair responses to agents that do 
not form direct DSBs. Clingen et al, (2008) investigated the use of γ-H2AX as a 
biomarker of DNA damage in response to treatment with cross-linking agents HN2 
and Pt; concluding that γ-H2AX was a highly sensitive marker of DNA damage. They 
also stated that further work could lead to the use of this marker as a determinant 
of cellular sensitivity or resistance to chemotherapeutic agents. Conversely Olive 
and Banath, (2009) investigated the use of the -H2AX biomarker as an indicator of 
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DNA damage post treatment with Pt with the final conclusions being that this may 
not be the best marker for determining sensitivity to chemotherapeutics. They 
found that one of the main limitations of this biomarker was that the cells had to 
transit S phase of the cell cycle in order to form H2AX foci which forms an obstacle 
when applying this biomarker to non-cycling tumour cells.   
 
1.4.2 Rad-51 
 Due to the potential limitations that may be encountered in utilising -H2AX 
in identifying indirect double strand breaks, Rad51 may be a useful marker to 
predict patient outcome to chemotherapy. HR is thought to be responsible for 
resolving ICLs (Al-Minawi et al. 2009) therefore a more specific marker of 
chemotherapy induced DNA repair may be constructive in this investigation.  
 Rad51 is one of the key proteins utilised in HR and is responsible for 
initiating and driving strand invasion in this pathway. The Rad51 gene is located on 
chromosome 15q15.1; a region implicated in many cancers such as lung, breast and 
colorectal as having loss of heterozygosity. Rad51 was found to be able to bind to 
both ssDNA and dsDNa but Jensen et al, (2010) showed that the binding of Rad51 
to dsDNA was actually counter-productive and inhibited DNA strand exchange.  
  Haaf et al, (1995) showed a dramatic increase in Rad51 foci formation was 
seen post irradiation in normal human fibroblast cell lines. Figure 1.10 shows an 
example of RAD51 foci. More information regarding RAD51 foci formation was 
further elucidated by Raderschall et al, (1999) when they showed Rad51 foci 
formation was occurring at sites of ssDNA; possible indicating the sites where HR 
was taking place.  
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Figure 1.10: Example images of RAD51 foci obtained from imaging flow cytometry 
 
The above image has been depicted in Brightfield to visualise cell morphology, AF488 stained RAD-
51 foci and the nucleus which has been stained with Draq5. 
Yuan et al, (2003) also had similar findings to Raderschall et al, (1999) and were also 
able to demonstrate that Rad51 foci formation was cell cycle dependent.  Graeser 
et al, (2010) explored the use of Rad51 as a marker for measuring the response of 
primary breast cancer tumours to neoadjuvant chemotherapy. The basis for their 
study was that tumours arising from germline mutations of BRCA1/2 would be 
defective in HR and therefore would be highly sensitive to chemotherapeutic 
agents which require HR for the resolution of damage incurred.  
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1.5 Overview of cancer 
Cancer is now the leading cause of death in both men and women in the UK 
according to statistics published by Cancer Research UK. Nearly 300 000 new cases 
are diagnosed each year. Despite more than 200 types of cancer existing, there are 
four types that are predominant in the UK and account for more than half of all new 
cases; these are breast, lung, colorectal and prostate cancers. 
 The onset of cancer is considered to be a multi-step process involving three 
main stages; initiation, promotion and progression (Tysnes and Bjerkvig 2007). 
There are three notable classes of genes which are involved in tumour initiation; 
proto-oncogenes, tumour suppressor genes and genes involved with DNA repair 
mechanisms. Alterations in these genes may lead to disruptions in the control of 
normal cell growth and differentiation; leading to the transformation of normal 
cells into neoplastic cells (Tysnes and Bjerkvig 2007). In 1976, Peter Nowell 
hypothesised that most neoplasms are derived from a single cell; indicating that 
tumour progression was the result of genetic variability through neoplastic 
proliferation of the original transformed cell. However it has since emerged that the 
accumulation of genetic alterations is not the only factor in driving tumour 
progression (Mueller and Fusenig 2004). Tumours have the ability to manipulate 
the surrounding supportive tissue (tumour stroma) through interactive signalling to 
form a more accommodating environment for tumour progression (Mueller and 
Fusenig 2004). 
Chemotherapy, radiotherapy and surgery are the common means of 
treating cancer although there are other treatments such as hormone and 
biological therapies also available. Chemotherapy can involve treatment with a 
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single drug, a combination of drugs or in conjunction with surgery or radiotherapy.  
Treatment can differ from patient to patient and is dependent on numerous factors 
such as the type of cancer, the location of the tumour, the stage at which the 
tumour is at and the age of the patient amongst others.  
Chemotherapeutic drugs exert their effect by damaging the DNA of cancer 
cells thereby causing cell death. However it is not selective in killing cancer cells and 
the destruction of normal cells leads to the manifestation of side effects.  
Side effects are a fundamental limitation of chemotherapy. The extent of 
normal cell damage governs the level of side effects experienced by the patient. 
Side effects can include but are not limited to the following (Conklin 2000) 
 alopecia 
 weight loss 
 loss of appetite 
 destruction of immune system  
 mucositis of the gastrointestinal tract leading to nausea, vomiting and 
diarrhoea 
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1.6 Chemotherapeutic Agents 
 There are diverse classes of chemotherapeutic agents which exert their 
effects through different mechanisms of action. Table 1.3 below gives an overview 
of the main categories. 
 
Table 1.3: Different classes of chemotherapeutic agents 
Category Mechanism Example Treatment Side Effects 
Anti metabolites 
Inhibition of 
cell division. 
5-Fluorouracil 
Methotrexate 
Colorectal, 
Breast 
Fatigue, 
Nausea, 
Alopecia 
Alkylating 
Agents 
Formation of 
ICLs 
Busulfan 
Darcarbazine 
Hodgkins 
and Non 
Hodgkins 
Lymphoma 
Secondary skin 
cancer 
Antimicrotubule 
agents 
Destabilise 
microtubules 
Paclitaxel 
Vincristine 
Ovarian, 
Breast 
Diminished 
Immune System 
Anthracycline 
Antibiotics 
DNA 
intercalator, 
inhibits 
Topoisomerase
s 
Adriamycin 
Broad 
range of 
cancers 
Cardiac Toxicity 
Topoisomerase 
inhibitors 
Inhibition of 
Topoisomerase 
I and II 
Vincristine 
Etoposide 
Stomach, 
Lung 
Neutropenia 
Platinum Based 
Drugs 
Inter and Intra 
strand cross 
links 
Cisplatin 
Carboplatin 
Testicular 
Bladder 
Nephrotoxicity 
 
1.6.1 Anti-metabolites 
Anti-metabolite drugs are structurally similar to purine and pyrimidine bases. They 
exert their effects through the following mechanisms 
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1. Inhibiting vital biosynthetic processes e.g. competing with metabolites to 
bind to key enzymes 
2. Incorporating themselves into DNA or RNA and inhibiting their normal 
functions 
They are phase specific and work only in the S phase of the cell cycle. Most anti-
metabolite drugs have a minimum threshold concentration below which no 
cytotoxic effects are seen regardless of the duration of exposure (Alison 2002).  
5-fluorouracil (5-FU) is a fluoropyrimidine used in the treatment of breast, 
head and neck cancers amongst others. It was introduced over forty years ago as a 
treatment for both advanced and early stage colorectal cancer. Although not highly 
effective as a sole agent, combining it with pro-drugs such as Leucovorin and 
Methotrexate increases its cytotoxicity through greater inhibition of key enzymes  
and minimises tumour resistance arising (Alison 2002). Therefore it remains one of 
the most used treatments of colorectal cancer (Van Cutsem et al. 2000). 
 
Figure 1.11: Chemical structure of Uracil and 5-FU ( adapted from (Van Cutsem et 
al. 2000)) 
 
 
 
Uracil
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 5-FU is an analogue of Uracil; a fluorine atom present in place of Hydrogen 
at C-5 (Refer to Figure 1.11). The compound incorporates both mechanisms of 
action through the integration of fluronucleotides into RNA and DNA as well as 
inhibiting the nucleotide synthetic enzyme thymidylate synthase (TS) (Longley et al. 
2003).  
It enters the cell using facilitated transport mechanism and is then converted into 
active metabolites (Longley et al. 2003) 
 Fluorodeoxyuridine monophosphate (FdUMP) 
 Fluorodeoxyuridine triphosphate (FdUTP)  
 Fluorouridine triphosphate (FUTP)  
These metabolites interfere with RNA synthesis, an integral component of DNA 
replication as well as limiting the actions of TS. TS is a vital enzyme in DNA 
synthesis, catalysing the conversion of deoxyuridylate (dUMP) to Thymidylate 
(dTMP) (Giudice et al. 2007). Limiting its function will lead to a decrease in the 
production of dTMP and an accumulation of dUMP in the cell thereby leading to the 
inhibition of DNA synthesis and repair.   
 
1.6.2 Alkylating Agents 
 Nitrogen mustard (HN2) based compounds have been appraised for anti-
cancer properties since the 1940s. All alkylating agents work by forming covalent 
bonds with macromolecules that possess nucleophillic centres. This group of 
compounds can be broadly categorised into two different groups; monofunctional 
and bifunctional.   
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 Bifunctional agents form covalent bonds on two different bases either 
located interstrand or intrastrand; creating a crosslink. Monofunctional agents only 
have one alkylating group and are unable to form crosslinks. They normally interact 
with DNA through the N7 position of Guanine. Interaction of these agents with DNA 
results in the formation of DNA adducts which inhibits DNA replication and can 
subsequently effect or inhibit RNA and protein production.  
 Mechlorethamine was the first nitrogen mustard based compound to be 
used in the treatment of cancer (Giuliani et al. 1997).  One of the limitations of 
nitrogen mustard is the rapid activation rate of the compound which could 
potentially lead to the development of very severe side effects such as secondary 
skin cancer (Giuliani et al. 1997). This led to the development of structurally 
modified nitrogen mustards such as Cyclophosphamide.   
 
1.6.3 Platinum Based Drugs 
 Pt is a highly effective anticancer agent frequently used in the treatment of 
many cancers (Pabla et al. 2008); with a notably high success rate in the treatment 
of testicular cancer (Masters and Koberle 2003). It is administered intravenously 
and is taken up into the cell either through passive diffusion or facilitated uptake 
although a clear understanding of this mechanism is yet to be clarified.  Once inside 
the cell, Pt has to undergo multiple hydrolysis reactions, resulting in a structural 
change which allows it to bind to and interact with DNA (Siddick et al, 2003).  
Pt exerts its toxicity through the formation of intra and inter strand crosslinks. It 
can form intrastrand crosslinks between adjacent guanine bases or between 
adenine and guanine bases which represents approximately 90% of adduct 
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formation (Crul et al. 2003). ICLs are also formed between guanine bases on 
opposite strands as well as DNA-protein crosslinks. Pt targets proliferating cells and 
the formation of these lesions prevent core cellular processes such as transcription 
and replication (Al-Minawi et al. 2009). Although a number of DNA adducts are 
produced by cross-linking agents, the efficacy of these drugs are usually determined 
by their ability to form ICLs (Welsh et al. 2004).  
However the use of Pt is limited due to increasing resistance to the drug itself 
and also due to the severe toxic effects on normal tissue (Olive and Banath 2009). 
The short term side effects of this agent are typically seen with most 
chemotherapeutic agents such as nausea, weight loss and hair loss. However the 
long term side effects, predominantly linked with high dose treatment regimens, 
are far more dangerous and can leave the patient severely disabled. Some 
examples of these side effects include 
 Loss of hearing with the potential to develop clinical deafness 
 Nephro-toxicity 
 Cerebral herniation and coma 
 Cisplatin neuropathy which manifests as tingling sensations and numbness 
with the possibility of spinal ataxia development leaving the patient disabled 
(Harmers et al. 1991) 
Due to the debilitating side effects associated with Pt, variants of platinum bases 
drugs were produced such as Carboplatin and Oxaliplatin (Vilmar and Sorensen 
2009). 
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1.6.4 Anthracycline Antibiotics 
 Anthracycline antiobiotic are regarded as an integral part of chemotherapy 
and possess great therapeutic potential due to their anti-tumour activity (Rabbani 
et al. 2005). This class of antibiotics all share a common four ring chromophore and 
contain quinine and hydroquinone groups.  
Figure 1.12: The four ring structure seen in all anthracycline antibiotics 
 
Their mechanism of action is a topic of much controversy. Several different 
mechanisms of action have been proposed (Gewirtz 1999) such as  
 DNA intercalator 
 Free radical formation 
 DNA binding and alkylation 
 DNA cross-linking 
 Inhibition of Topoisomerase II 
 
 Adriamycin (ADR, also known as Doxorubicin) is regarded as one of the most 
powerful anticancer agents and is used in the treatment regimen of a broad range 
of cancers with particular success in solid tumour treatment such as breast, bile 
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ducts, osteosarcomas and Non-Hodgkins lymphoma (Satoh et al. 1988). However a 
similar predicament to Pt is encountered with this drug in that the highly potent 
side effects associated with this drug often diminish its clinical use. One of the most 
limiting side effects associated with Adr is the induction of cardiomyopathy which 
can lead to congestive heart failure (Tokarska-Schlattner et al. 2006). This 
complication proves a serious obstacle to prolonged use and also limits the dosage 
that can be administered in one treatment as it has been shown that increased 
doses of Adr has been linked to an increased incidence of cardiotoxicity (Takemura 
and Fujiwara 2007).  
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1.7 Developing resistance to chemotherapy 
 Development of resistance to chemotherapeutic drugs poses a serious 
limitation to the effectiveness of this form of treatment (Boehm et al. 1997; 
Carvalho et al. 2010) This was highlighted by Agarwal and Kaye, (2003) and Coley, 
(2008) who both noted that acquiring resistance to treatment regimens accouted 
for up to 90% of breast and ovarian cancer patients. Resistance can develop in 
many ways. To some extent, genetic instability and increased mutational rates of 
tumour cells attributes to this (Boehm et al. 1997). However there are numerous 
other mechanisms that have been proposed that lead to the development of drug 
resistance such as 
 Increased drug efflux  
 Upregulated DNA repair  
 Inactivation of drug 
 Increased tolerance to DNA damage 
 Increased drug efflux in tumour cells prevents intracellular accumulation of 
chemotherapeutic agents. P-glycoprotein (P-gp) is a membrane transporter protein 
encoded by the multi drug resistance (MDR1) gene and has been found to be 
responsible for preventing drug accumulation in the cytoplasm by transporting the 
drug across the plasma membrane (Thiebaut et al. 1987).  
 Cellular mechanisms such as increased drug inactivation by cellular 
metabolites such as Glutathione (GSH), increased levels of DNA repair or evasion of 
apoptosis may also lead to the development of acquired resistance (Banath and 
Olive 2003; Siddik 2003). This inherent resistance can then be transferred to 
daughter cells during mitosis (Goldie and Coldman 1983). Increased expression of 
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ERCC1 and ERCC2 were found to be associated with Pt resistance in human ovarian 
cancer patients (Dabholkar et al. 1992). ERCC1 is associated with both the NER 
pathway which is thought be responsible for resolving intrastrand crosslinks and 
the HR pathway which repairs ICLs (Dronkert and Kanaar 2001). The A2780/C-series 
of cell lines was established from a human ovarian cancer cell line A2780 and made 
resistant to Pt through repeated exposure to incrementally increasing 
concentrations of Pt (Ferry et al. 2000). They exhibit a number of resistant 
mechanisms such as elevated GSH levels, enhanced repair of adduct formation 
(Johnson et al. 1994) and an enhanced ability to tolerate Pt-induced DNA damage 
(Johnson et al. 1997). 
 A major problem in the development of resistance is that often tumours 
develop cross-resistance not only to drugs with similar mechanisms of action but 
also to functionally and structurally unrelated drugs (Ferry et al. 2000). It is 
important to identify patients who do not have the desired responses to treatment 
regimens as hypersensitive patients will suffer from debilitating and adverse side 
effects which could even lead to death in some cases. Similarly patients who are 
resistant to particular chemotherapeutic agents need to be readily recognised in 
order to avoid them undergoing needless treatments which will not help to slow 
down disease progression and instead be able to initiate alternative forms of 
treatment.  
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1.8 Aims  
The aims of this project were as follows 
1) To validate the use of the Imagestream which employs the novel imaging 
flow cytometry technique for DNA damage assays 
2) To determine the response of repair normal immortalised cell lines to 
classical anti-cancer drugs such as HN2, Pt and Adr  
3) To validate the efficacy of the DNA repair biomarkers -H2AX in assessing 
the rate of DNA repair in normal cells 
4) To validate the efficacy of the DNA repair biomarker RAD51 in measuring 
the rate of DNA repair in normal cells 
5) To determine whether resistance is associated with increased DNA repair as 
measured by -H2AX and Rad51. DNA repair normal cell lines were compared 
with resistant cell lines and a XPF-deficient cell line to evaluate this.   
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Chapter 2                
Materials and Methods 
 
 
 
 
 
 
 
 
 
 45   
 
2.1 General Cell Maintenance 
2.1.1 Cell Culture 
Cells were routinely cultured in Dulbecco’s Modified Eagle Medium (DMEM) 
(PAA Laboratories Ltd., Yeovil, Somerset, UK) which was supplemented with 10% 
foetal calf serum (PAA Laboratories Ltd.), 2mM L-glutamine and 100 units/mL 
penicillin and streptomycin (PAA). Cells were grown in 100mm Petri dishes (Sarstedt 
Ltd, Leicester, UK) as monolayers at 37oC in a humidified atmosphere of 5% CO2 in 
air. All cell culture was carried out in a temperature controlled laboratory. Cell 
culturing was conducted in a Heraeus Class ii Laminar Flow hood. 
2.1.2 Cell Lines 
Secondary immortalised fibroblast cell lines were used throughout the different 
experiments conducted for this thesis. Cell lines with a range of DNA repair capacity 
were selected for this study. Details of cell lines are shown below in Table 2.1. 
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Table 2.1: Details of cell lines used  
Cell line 
DNA repair 
capacity 
Details 
MRC5-SV1 
(Arlett et al. 
2006) 
DNA repair 
normal 
Derived from fibroblast foetal lung cells and 
immortalised through expression of the SV 40 
Large T antigen  
NB1-HTERT  
(Ulus-
Senguloglu et 
al. 2012) 
DNA Repair 
normal 
Derived from normal individual and immortalised 
through transfection of the HTERT gene 
MRC5-SV1R 
Resistant to 
HN2  
Developed through continual exposure to 
gradually incremented doses of HN2. Resistant to 
5.3µg/mL HN2 
NB1-HTERTR 
Resistant to 
HN2 
Developed through continual exposure of 
parental cell line NB1-HTERT to gradually 
incremented doses of HN2. Resistant to 3.5µg/mL 
HN2  
AT5BIVA 
(Murnane et 
al. 1985) 
DSB repair 
defective 
Derived from classical A-T patient and 
immortalised through expression of Simian Virus 
Large T antigen. A-T patients have defective ATM 
gene involved in cell signalling post formation of 
DSBs and exhibit increased sensitivity to IR 
XP14BRNeo17 
(Abbaszadeh 
et al. 2010) 
DSB repair 
defective 
Derived from XP patient with additional defective 
DNA-PKcs gene and immortalised through 
transfection of the pSV3neo immortaling vector. 
Patient exhibits sensitivity to both UV light and IR 
GM08437B 
(Coriell 
Institute, New 
Jersey, USA) 
Impaired GG-
NER function 
Deficient in XPF which forms part of the 
endonuclease complex with ERCC1.  Exhibits 
sensitivity to cross-linking agents such as Pt and 
HN2 
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2.1.3 Trypsinisation of cells 
Cells were left to reach about 95% confluency before sub-culturing them. 
When sub- culturing cells, medium was first aspirated off using a glass Pasteur 
pipette and cells were rinsed with 10 mL of Versene (Phosphate Buffered Saline 
(PBS) + 0.2% EDTA) to remove any traces of medium. Approximately 1 mL of 0.25% 
Trpysin-EDTA (Fisher Scientific, Loughborough, Leicester, UK) was added to the 
plate and the cells were kept at 37oC for 10 minutes to allow cells to detach from 
the dish. Cells were then recovered from the plate in 10 mL of medium and seeded 
into plates at an approximate density of 1x105 cells per plate. 
 
2.1.4 Cell Counting 
Cell counting was performed using either a glass haemocytometer or the 
Countess (Invitrogen, Life Technologies, Paisley, UK). Cell counts were primarily 
performed using the Countess. However the Countess is limited by its 
measurement range (1x104 - 1x107 cells/mL). Therefore if cell concentrations were 
below this, then accurate cell counts could not be obtained. In these circumstances, 
a traditional Neubauer glass haemocytometer was used instead. 
When counting cells using the haemocytometer, cells were detached from 
petri dishes using 1 mL of Trypsin (Fischer-Scientific). Once cells had detached, they 
were recovered in 10 mL of complete medium. 10 µL of the cell suspension was 
added to 10 µL of Trypan Blue to allow for exclusion of dead cells from the cell 
count. 10 µL of the cell suspension mixed with the Trypan blue was loaded onto a 
glass haemocytometer and cell counts were performed at 20x magnification using 
an Olympus CK2 microscope. 
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2.1.5 Cell Freezing 
Cell freezing was deemed necessary to conserve stocks of the cell lines being 
used. They were frozen in freezing medium which was comprised of 20% FCS, 10% 
DiMethyl Sulfoxide (Sigma-Aldrich) and 80% DMEM medium containing 
penicillin/streptomycin and L-glutamine.  
Cells were grown in 10mm Petri dishes until they were 95% confluent. 
Medium was aspirated off the cells and the cells were then rinsed with 10mL of 
PBS. Cells were then detached from the dish using 1 mL of 0.25% Trpysin-EDTA. 
After recovering the cells in 10 mL of medium, they were transferred into a 15 mL 
tube (Sarstedt) and centrifuged for 5 minutes at 1500rpm. The supernatant was 
then discarded and the cell pellet was resuspended in 1 mL of freezing medium. 
 The cell suspension was transferred to cryo-vials (Sarstedt) and placed in cell 
freezing containers (Nalgene, Sigma-Aldrich). These containers have a foam insert 
soaked in isopropanol which allows for a gradual freezing rate of 1oC/minute. Cells 
were kept in these containers at -80oC for twenty-four hrs to ensure they had 
reached the correct temperatures before being relocated to liquid nitrogen dewers 
for long term storage. 
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2.2 Imaging flow cytometry protocol for the γ-H2AX radiation assay 
 Cell lines 2.2.1
The cell lines used for this study were 
 XP14BRneo17 (Abbaszadeh et al. 2010) 
 AT5BIVA  (Murnane et al. 1985) 
 MRC5-SV1 (Arlett et al. 2006) 
 Cell fixation 2.2.2
Untreated control cells and cells exposed to 2 Gy of gamma radiation were 
fixed at 30 min, 3, 5 and 24 hours (hrs) post irradiation. Cells were detached using 
1 mL of 0.25% Trypsin-EDTA and washed twice in ice-cold PBS). They then were 
fixed in 50:50 (V:V) methanol:acetone at 4oC. Cells were stored no longer than 72 
hrs prior to γ-H2AX antibody staining. 
 Gamma Radiation Dose Response Curve 2.2.3
To determine the level of fluorescence induced by different doses of gamma 
radiation and thus the level of γ-H2AX induction and DNA damage, each of the 
three cell lines were irradiated as proliferating monolayers with 0,2,4,6,8 Gy gamma 
irradiation from a 60Cobalt source (Puridec Irradiation Technologies Ltd, Oxon, UK) 
at a distance of 25cm from the gamma source. This provided a dose rate of 1.3 – 1.4 
Gy/min. They were fixed 30 minutes post irradiation and total nuclear fluorescence 
was determined through Imagestreamx analysis (as described in Section 3.28).  On 
the basis of the dose response curves generated for each cell line, all future 
experiments were conducted following a dose of 2 Gy gamma irradiation. 
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 Antibodies and Immunocytochemistry 2.2.4
Fixed cells were rehydrated with three washes in PBS and then 
permeabilised in PBS containing 0.25% Triton X-100 (Sigma-Aldrich, Dorset, UK) for 
5 minutes at room temperature (RT). After blocking the cells in blocking buffer 
comprised of PBS containing 0.1% Triton X-100 and 0.5% nonfat milk protein 
(Premier International Food Ltd. UK, Spalding, Lincolnshire, UK), cells were 
incubated at 4oC overnight in mouse monoclonal anti-serine139 γ-H2AX antibody 
(Clone JBW 301, Millipore UK Ltd., Hampshire, UK) at 1:10000 dilution.  
 Following three washes in wash buffer made up of PBS containing 0.1% 
Triton X-100, cells were incubated for  1hr at RT in anti-mouse IgG (whole molecule) 
R-phycoerythrin (PE) conjugated antibody diluted in block buffer to 1:50. Cells were 
washed again in wash buffer three times and once in PBS. Samples were then 
resuspended in 100 μL of Accumax flow cytometry buffer with 5 μM Draq5 
(Biostatus Ltd., Leicestershire, UK). Two samples for fluorescence compensation 
were prepared with either the secondary antibody (R-phycoerythrin conjugate) or 
Draq5 being omitted from the process. These were fixed at 30 minutes post 
irradiation.  
 In Situ Detection of γ-H2AX foci 2.2.5
The number of γ-H2AX foci detected using in situ fluorescence microscopy 
was compared with the results generated from the ImagestreamX.  
 The three cell lines were grown to approximately 70% confluence on 13 mm 
glass cover slips and exposed to 2 Gy gamma radiation as previously described 
above. Cell fixation and antibody staining was also carried out as described above.  
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 γ-H2AX foci were counted in the nuclei of at least 100 cells for each cell line 
in untreated cells as well as treated cells fixed at 30 min, 3, 5 and 24 hrs post 
irradiation. Microscopy carried out using an Axioscope 2 fluorescence microscope 
with a 100-fold magnification objective (Zeiss, Goettingen, Germany).   
 Imaging Flow Cytometry 2.2.6
 The Imagestream (Amnis Inc., Seattle, Washington) enables images of 
individual cells in flow to be captured using up to six different optical channels 
(Refer to Table 2.2). Using the Inspire TM data acquisition software, 20 000 images 
were captured using Channel (Ch) 01 for brightfield (BF), Ch03 for PE representing 
the γ-H2AX foci and Ch05 for Draq5 to represent the nuclear staining of each cell. 
The lasers used were 
 800nm to capture BF images 
 488nm to capture PE and Draq5 fluorescence 
 765nm to capture side scatter images 
Cell classifiers were applied to BF in order to only capture objects between 50 and 
300 units on an arbitrary scale. This range of values was previously established 
empirically from preliminary experiments to primarily show single cell images. 
Using a 488nm laser set at 75mW power, images were captured at 40X 
magnification at an approximate rate of 150 images per second, creating a raw 
image file (rif).   
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Table 2.2: ImagestreamX Fluorochrome Chart 
 
This table shows the broad range of fluorescents ligands that can be used with the Imagestream. The fluorochromes used for studies carried out in this thesis are 
highlighted in red.
QD705, eFluor6505
APC-Cy7, APC-AF750, 
APC-eFluor750, Cy7, 
AF750, DyLight750, 
eFluor750, PE-Cy7, PE-
AF750
APC-Cy7, APC-AF750, 
APC-eFluor750
SSCPE-Cy7, PE-AF750
PE-Cy7, PE-AF750, 
QD800
QD800745-8006
PE-Cy5, PE-AF647, 
DRAQ5
PE-Cy5, PE-AF647, 
PerCP, PerCP-Cy5.5, 
DRAQ5, 
QD705,eFluor650
660-745
DRAQ5, AF647, 
AF660, AF680, APC, 
Cy5, DyLight649, 
DyLight680, PE-AF647, 
PE-Cy5, PerCP, PerCP-
Cy5.5
AF647, AF660, AF680, 
APC, Cy5, DyLight649, 
PE-AF647, PE-Cy5, 
DRAQ5
TexRed, AF594, 
AF568, AF610, 
DyLight594, PE-
TexRed, ECD, TexRed, 
PE-AF610, RFP, 
mCherry, 7AAd, PI
595-660
560-5953
4
AF488, FITC, GFP, YFP, 
DYlIGHT488, PKH67, 
Syto 13, Spectrum 
Green, Lyso 
TrackerGreen, Mito 
TrackerGreen, QD525  
PacOrange, 
CascadeYellow, 
AF430, QD525
480-5602
PE, PKH26, Cy3, 
AF555, DSRed
DAPI, Hoechst, 
PacBlue, CascadeBlue, 
AF405,eFluor405,DyLi
ght405, CFP, 
LIVE/DEAD Violet
Ch Band (nm) 488
430 -5051
561 592 658 785
PE, Cy3, AF546, AF55, 
DyLight549, 
PKH26,DSRed, 
SpectrumOrange, 
Milto TrackerOrange
QD564, QD585
AF568, AF594, AF610, 
DyLight594, PE-
TexRed, ECD,TexRed, 
PE-Af610, 
RFP,mCherry, 7AAD, PI
PE-TexRed, ECD, PE-
AF610, 7AAD, PI, RFP, 
QD625, eFluor625
QD625, eFluor650
 53   
 
 Image Compensation 2.2.7
 Compensation was performed using the samples that had been stained with 
either PE or Draq5 only. Images for these samples were captured without the BF 
illumination or scatter as it was important to detect intensity of fluorescence in 
these samples with only a single source of illumination, the 488nm laser set at 
75mW. A compensation matrix was generated using the IdeasTM software using 
control files created for the PE and Draq5 samples. This is a table of coefficients 
whereby detected light from each image is placed into the proper channel (Ch03 for 
PE and Ch05 for Draq5) on a pixel by pixel basis. The coefficients are normalised to 
1 and each coefficient represents the leakage of either fluorochrome into 
juxtaposed channels.  
Figure 2.1: Image compensation 
 
The above figure shows an example of uncompensated images obtained using a Imagestream
X
. It 
can be seen to which extent the fluorochrome (AF488, normally depicted in Ch02 only) leaks into 
nearby channels. The compensation tool with the IDEAS software allows for the correction of this 
leakage. 
 Compensation is performed to eliminate any crosstalk that may occur where 
the fluorochrome leaks into other channels. This allows for accurate and true 
representation of fluorescence for each cell image. Table 2.3 shown below is an 
example of a typical compensation matrix table. Calculated compensation values 
were then applied to each sample file during analysis. 
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Table 2.3: Typical compensation matrix created in IdeasTM software 
 
Ch01 Ch02 Ch03 Ch04 Ch05 Ch06 
Ch01 
1 0 0.061 0 0.036 0 
Ch02 
0 1 0.277 0 0.125 0 
Ch03 
0 0 1 0 0.100 0 
Ch04 
0 0 0.518 1 0.143 0 
Ch05 
0 0 0.208 0 1 0 
Ch06 
0.02 0 0.087 0 0.352 1 
The values in this table represent coefficients of leakage into juxtaposing channels. It can be seen 
that as you move away from the principal channel (indicated as having a value of 1), the 
coefficient of leakage is decreasing. We use values that have a margin of error that is less than 
0.001 
 
 Analysis using IdeasTM software and calculation of foci numbers 2.2.8
 The sample fixed 30 minutes post irradiation with 2Gy gamma radiation was 
used to create a template file with which all other samples in the investigation 
would be analysed with. This file was chosen due to it being likely to be the highest 
induction of γ-H2AX foci and therefore the brightest intensity of PE. Templates 
were created for each individual cell line.  
 The rif file created by the InspireTM software was loaded into the IdeasTM 
software. Cell images were examined in BF, PE (γ-H2AX foci) and Draq5 (nuclear 
morphology) channels. The image gallery properties were adjusted to optimise the 
displayed fluorescent images. 
 The analysis process comprises a multistep process and initially uses a series 
of predefined “building blocks” provided within the software. These tools generate 
a series of scatter and histogram plots which allow for the identification of single 
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and focussed cells, stained for both Draq5 and PE. Identification of single cells is 
determined by the creation of a scatter plot of the population defined by cell area 
and cell aspect ratio from the BF images whereby each dot within the scatter 
represents a single cell. The single cell region was defined by visually validating the 
BF images and gated using the polygon region tool (refer to Figure 2.2 below.)  
 
Figure 2.2: Gating for single cells  
 
Identification of single cells within the population based upon cell area and aspect ratio.  Single 
cells are gated using the polygon tool. The area marked in red indicates either debris or beads that 
have been collected during the run and the area indicated in blue represents doublet cells. These 
are all excluded from the single cell population that has been gated. 
 
 Using the “In Focus” tool, a histogram of the single cell population gated 
above was produced. The cells were distributed into “bins” based on the calculated 
focus of the BF images. Clicking on individual bins enables visualisation of all images 
within that particular bin in the image gallery. Single cells in focus were defined 
using the line region tool as shown in Figure 2.3. 
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Figure 2.3: Gating for cells in focus  
 
Identification of cells within the population that are in focus. (A) A histogram is produced of the 
single cell population and cells are distributed according to focal plane. Cells are gated using the 
Line region tool (shown in green). (B) Image of cell out of focus and (C) Image of cell in focus  
 
 Using the fluorescence positive two colour tool, a scatter plot was then 
generated of the single cells in focus that stained for both PE and Draq5. The 
polygon tool was utilised to gate the cells that satisfied these parameters (Refer to 
Figure 2.4 below). 
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Figure 2.4: Gating for cells stained positive for PE and DRAQ5 
 
A histogram representing the population of single cells in focus. Using the polygon region tool, the 
portion of cells that were positive for both PE and Draq5. 
 
 Masking strategy to determine the Number of γ-H2AX foci in each nucleus 2.2.9
 To determine the number of γ-H2AX foci within the nucleus of each cell, a 
series of masks were created which identified the region of interest. To ensure that 
γ-H2AX foci within each cell were identified correctly, a “truth population” of cells 
with known numbers of γ-H2AX foci ranging from 0 - 30 or more was created. Using 
this population of cells, a spot mask was created using the spot function of the 
Mask Manager. Using the spot to background ratio, foci were masked that were at 
least two-fold brighter than the background with a minimum diameter of 2 pixels. A 
nuclear morphology mask was then created using the Draq5 (Ch05, nuclear 
staining) image of each cell. To determine the number of γ-H2AX foci within the 
nuclear region of each cell, these two masks were combined using Boolean logic. 
This process has been shown below in Figure 2.5. Images are shown in BF (Ch01), PE 
PE and Draq5 Positive cells
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for γ-H2AX staining (Ch03) and Draq5 for nuclear staining (Ch05). Cells are first 
shown unmasked, then with the application of a morphology mask and spot mask; 
finally showing localisation of γ-H2AX foci within the nuclear region of the cell.  
 
Figure 2.5: Masking strategy workflow to determine γ-H2AX Foci 
 
Masking workflow whereby γ-H2AX foci were identified, masked and enumerated. This first row 
of images depicts an example cell in BF, PE (Ch03) and Draq5 (Ch05). Then a nuclear morphology 
mask is created using the Draq5 stained images from Ch05 as its reference. Next a spot mask is 
applied to the images seen in Ch03 (γ-H2AX foci). Finally these two masks are combined to allow 
for foci calculation within the nucleus only. The associated name path for foci calculation from the 
Ideas software is shown to the right of each row of images.   
 
 The final mask that was created was converted using the Features tool in 
the software to allow enumeration of foci and creates a histogram of normalized 
frequency of foci against foci number. An example of this is shown below in Figure 
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2.6. The Morphology mask was also used to create an Intensity feature set to 
measure intensity on Ch03 which allows for the calculation of total nuclear intensity 
within each cell.  
Figure 2.6: Typical foci distribution seen 30 minutes post irradiation 
 
The above shows a typical distribution plot of γ-H2AX foci for a sample fixed 30 minutes post 
exposure to 2 Gy of gamma radiation.  
 
 Once the analysis was completed for the 30 minute time point, the data 
analysis file (daf) that was created was saved as a template file. This allows you to 
apply the same Spot masks and Intensity masks across all the time points that were 
collected for each cell line. A separate template file was created for each of the 
different cell lines used in this study. 
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2.3 Clonogenic Assays 
2.3.1 Cell lines and Chemotherapeutic Agents 
The immortalised cell lines used in this investigation were the  
 NB1 - HTERT (Ulus-Senguloglu et al. 2012)  
 AT5BIVA  (Murnane et al. 1985) 
 MRC5-SV1 (Arlett et al. 2006) 
 During the preliminary experiments performed, it was observed that the 
three cell lines formed colonies at different rates. Therefore the cell numbers that 
were plated for each of the cell lines after drug exposure were adjusted according 
to rate of growth.  The details of this can be seen below in Table 2.4. 
 
Table 2.4: Cell numbers plated for each cell line.  
Dose AT5BIVA MRC5-SV1 NB1-HTERT 
Control 500 250 250 
Dose 1 750 250 500 
Dose 2 1000 500 750 
Dose 3 1000 500 750 
Dose 4 2000 750 1000 
Dose 5 2000 750 1000 
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 The four chemotherapeutic agents that were used were Adr, Pt, HN2 and 5-
FU. Each drug was seen to exert different levels of toxicity on the cells and the 
concentration ranges used for each drug were optimized in a series of preliminary 
experiments. Table 2.5 shows the final concentration ranges used for each agent.  
 
Table 2.5: Dose ranges used for each chemotherapeutic agent 
Dose HN2 (μg/mL) Pt (μg/mL) Adr (ng/mL) 5-FU (μg/mL) 
1 0.5 15 50 50 
2 1 20 75 100 
3 1.5 25 100 150 
4 2 30 125 200 
5 2.5 35 150 250 
 
All dilutions were carried out in serum-free medium. HN2 was obtained in powder form and was 
initially dissolved into serum free medium. Pt was also obtained in powder form but initially 
dissolved in DMSO due to poor solubility in serum-free medium. Adr was obtained in aqeous form 
and diluted in serum-free medium. 
 
 2x105 cells were plated into 6 cell culture plates (60mm, Sarstedt). They 
were left to grow over a 48 hour period to reach approximately 70 – 80% 
confluence before drug treatment commenced. The plates were then incubated 
with increasing doses of each drug for 1 hr at 37oC. After the 1 hr treatment; cells 
were rinsed with 5mL of Versene and then harvested with 1ml of Trypsin for 10 
minutes. Cells were then recovered into 15 ml tubes in 10 ml of DMEM medium.  
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10 µL of the cell suspension was mixed with 10 µL of Trypan blue (Sigma Aldrich) to 
exclude dead cells from the total count. The cells were then loaded onto glass 
haemocytometers and counted under a microscope at 10 X magnification. 
 Cells were then diluted to the appropriate counts as shown in Table 1 and 
plated out into 3 cell culture plates (100mm, Sarstedt) for each dose of the drug. 
These cells were then left to form colonies over a 14 – 21 day period. 
 When plates were deemed ready to fix, the medium was decanted and they 
were rinsed with water. Cells were fixed over a 20 minutes period using 100% 
Industrial Methylated Spirit. This was then rinsed off and the cells were stained 
using Methylene Blue (BDH Laboratory Supplies, Poole UK) for 1 hr. After this time, 
the stain was decanted and the plates were rinsed with water.  
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2.4 Imaging flow cytometry protocol for the γ-H2AX chemotherapy assay 
 Cell lines 2.4.1
The cell lines employed in this study were the same ones previously described in 
Section 2.3.1.  
 
 Chemotherapeutic Agents  2.4.2
Table 2.6 shows the drug doses used for each of the cell lines. These doses were 
established as being the IC50 values for each individual cell line as determined by 
clonogenic assays performed (described in detail in Section 2.3). The IC50 value was 
defined as being the dose seen to kill approximately 50% of the cell population post 
1 hr exposure to each chemotherapeutic agent. 
 
Table 2.6: Drug doses used for each cell line in the in the γ-H2AX assay 
Cell line HN2 Pt Adr 
MRC5-SV1 0.5 μg/mL 12 μg/mL 56 ng/mL 
NB1-HTERT 0.3 μg/mL 6 μg/mL 93 ng/mL 
AT5BIVA 0.2 μg/mL 7 μg/mL 84 ng/mL 
   
 To determine the level of γ-H2AX- associated fluorescence induced by the 
different chemotherapeutic agents, each of the three cell lines were treated with 
their individual IC50 dose of each drug derived from clonogenic assays (Refer to 
Table 2.6). All cell lines were treated as proliferating monolayers and were at 
approximately 80% confluency when treated.    
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 HN2 Dose Response 2.4.3
 All three cell lines were exposed to a range of HN2 concentrations - 0.5, 1.5 
and 2.5 μg/mL for 1 hr. This was done to examine whether fluorescence levels 
increased in an exponential manner as the dose of HN2 was increased. All cells 
were fixed at 24 hrs post treatment as detailed in Section 2.2.2 
 
 Cell Fixation 2.4.4
 Cells were fixed as described in Section 2.2.2 at 3, 5, 24, 30 and 48 hrs post 
treatment for HN2. However following preliminary experiments for Adr and Pt, 
these fixation points were altered following to 6, 12, 24, 30, 48 and 72 hrs post 
treatment with these drugs as it was seen that DNA repair had not completed in the 
48 hr period.   
 
 Immunocytochemistry 2.4.5
 A similar protocol was followed for immunocytochemistry of these cells as 
described in section 2.2.4 with two alterations. 
 The first decision was to switch one of the constituents of the blocking 
buffer from 0.5% nonfat milk to 10% rabbit serum. This showed an improvement in 
the level of background seen. Secondly, the secondary antibody was switched from 
PE to Alexa Fluor (AF) 488 rabbit anti-mouse IgG (Life Technologies, Paisley, UK). 
The reason for this was two-fold, firstly it was seen to produce brighter, more 
distinct staining at much lower concentrations (1:1000 compared to 1:40 required 
for PE). There was also less leakage to juxtaposed channels during imaging, making 
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flow cytometry compensation more robust and reliable between the fluorescence 
emitted by AF488 and the nuclear stain Draq5.  
 Two samples for fluorescence compensation were prepared with either the 
secondary antibody (AF488) or Draq5 being omitted from the process. These were 
fixed at 24 hrs post treatment with all drugs.  
 
 Imagestream data acquisition and image compensation 2.4.6
 The protocol undertaken to acquire images and compensate for 
fluorescence was as previously described in Section 2.2.6 and Section 2.2.7. 
 
 Analysis using IdeasTM software and calculation of foci numbers using the 2.4.7
Spot Wizard 
 The concept of the Imagestream is a novel technique; having only recently 
emerged in the last five years. Subsequently the IdeasTM software is constantly 
being upgraded with new features being added to aid swift and competent analysis 
of data. Therefore the procedure used for analysis of data was adapted to 
accommodate these new features and differs slightly from the method that has 
been described in section 2.2.8. The new feature was an automated Spot wizard 
which selects the best mask for foci enumeration and represents a more reliable 
and enhanced method for analysis of DNA damage foci in cells.  
 The sample fixed 24 hrs post treatment with all drugs was used to create a 
template file with which all other samples collected during the experiment would 
be analysed with. This file was chosen due to it being likely to show the highest 
induction of γ-H2AX foci and therefore the brightest intensity of AF488. Two 
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principal methods were utilised for the quantification of γ-H2AX foci. Enumeration 
of individual γ-H2AX foci was calculated as well as determining the overall intensity 
emitted by the AF488 probe within the nuclei of the cells.  Templates were created 
for each individual cell line.  
 The Spot Wizard initially directs the gating of the sample for the single and 
in focus cells according to the parameters described in section 2.2.8 (refer to Figure 
2.2 and Figure 2.3). The wizard then requires the definition of two distinct 
populations; one population of cells that have low numbers of foci (usually 0 or 1) 
and another population of cells which represent high numbers of foci (Refer to 
Figure 2.7).  
 
Figure 2.7: Truth populations identified by the Spot Wizard 
 
Figure 2.7(A) shows a population of cells with no foci and Figure 2.7(B) depicts a population of 
cells with high numbers of foci. Images above are shown in Ch01 (representing BF images) and 
Ch02 (representing AF488 staining of γ-H2AX foci) 
 
 50 cells were identified for each population by using the “Tagging tool”. The 
population of cells which identified the high number of foci accounted for different 
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types of staining patterns seen such as foci shape and size, intensity of the staining 
and the level of background.  The identification of these two diverse populations 
directs the software to choose a mask and feature most suitable to account for all 
the factors and generates a histogram representing the γ-H2AX foci distribution for 
that sample.   
 However a manual modification then needs to made to the auto-generated 
mask as this wizard does not distinguish whether the spots being counted are solely 
in the nucleus. Therefore a Morphology Mask is created using the Mask manager 
(as described in Section 2.2.9). Utilising Boolean logic, the mask generated by the 
software is combined with the Morphology Mask and a new histogram is generated 
showing the distribution of γ-H2AX foci within the nuclei of the cells in the 
population of cells that has been gated for the parameters described earlier (Refer 
to Figure 2.8 below).  
Figure 2.8: Histogram representing distribution of γ-H2AX foci within nuclear 
region of cells 
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 The Morphology Mask was also used to create an Intensity feature which 
calculates the intensity of AF488 within the nucleus of these cells (Refer to Figure 
2.9 below). 
Figure 2.9: Histogram showing the nuclear intensity of a sample 
 
 Once these masks and features were created for the template file, it was 
then applied to all other time points collected for each cell line for each drug. A new 
template was created for each cell line for the repeats of these experiments as the 
staining patterns such as background and intensity can vary considerably from 
experiment to experiment. 
 The following figure (refer to Figure 2.10) depicts examples of cells with 
differing numbers of foci which the Spot Mask feature was able to differentiate 
between. The same image is also shown in greyscale (refer to Figure 2.11) to show 
clearer visualisation of the mask over the γ-H2AX foci in these cells.  
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Figure 2.10: Multispectral images with increasing numbers of foci masked by the 
Spot Wizard 
 
The above figure shows example images of cells with increasing numbers of foci. Ch01 shown in 
the first column depicts the BF image of these cells with the morphology mask shown in blue 
which highlights the nuclei of the cells. Ch02 shown in the second column (representing AF488 
staining) depicts the unmasked cells whilst the third column depicts the same images masked with 
the γ-H2AX foci mask. Ch05 shows the morphology of the nucleus of these cells. 
Figure 2.11: Multispectral images with increasing numbers of foci shown in 
greyscale 
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 The validity of the auto-generated mask was verified by comparing its 
accuracy to the masks that were being created manually earlier. This was done by 
utilising an aspect of the Ideas software called “Find the best feature”. This tool 
analyses and evaluates all the possible features that could be used to extract the 
information required from the data and generates a RD value derived using 
Fischer’s Discriminate Ratio for all suitable features. Table 2.7 below gives an 
example of the data that can be generated using this tool. 
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Table 2.7: Example table of Fischers Discriminate Ratio values generated in 
IDEASTM 
Population High 
Spot Count_Peak(M02, Channel 2, Bright, 3.5), low, Mean RD 4.234 
NUCLEAR GAMMA H2AX FOCI (PEAK), low, Mean RD 4.165 
NUCLEAR GAMMA H2AX FOCI (SPOT), low, Mean RD 3.109 
Bright Detail Intensity R3_Morphology(M05, Ch05)_Ch02, low, 
Mean RD 
2.866 
Std Dev_Morphology(M05, Ch05)_Ch02, low, Mean RD 2.826 
Modulation_M02_Ch02, low, Mean RD 2.738 
Bright Detail Intensity R7_Morphology(M05, Ch05)_Ch02, low, 
Mean RD 
2.737 
Bright Detail Intensity R3_MC_Ch02, low, Mean RD 2.697 
Modulation_Morphology(M05, Ch05)_Ch02, low, Mean RD 2.298 
Gradient Max_Morphology(M05, Ch05)_Ch02, low, Mean RD 1.23 
Bright Detail Intensity R3_MC_Ch03, low, Mean RD 1.083 
Bright Detail Intensity R3_MC_Ch01, low, Mean RD 0.9567 
Bright Detail Intensity R3_MC_Ch05, low, Mean RD 0.9009 
Gradient RMS_Morphology(M05, Ch05)_Ch02, low, Mean RD 0.8409 
Bright Detail Intensity R3_MC_Ch06, low, Mean RD 0.7807 
Bright Detail Intensity R3_MC_Ch04, low, Mean RD 0.7599 
Contrast_Morphology(M05, Ch05)_Ch02, low, Mean RD 0.6983 
Contrast_M02_Ch02, low, Mean RD 0.6105 
H Entropy Std_Morphology(M05, Ch05)_Ch02_5, low, Mean RD 0.5995 
Contrast_M01_Ch01, low, Mean RD 0.5549 
H Contrast Std_Morphology(M05, Ch05)_Ch02_5, low, Mean RD 0.5517 
H Homogeneity Std_Morphology(M05, Ch05)_Ch02_5, low, Mean 
RD 
0.4757 
H Energy Std_Morphology(M05, Ch05)_Ch02_5, low, Mean RD 0.4388 
Gradient RMS_M05_Ch05, low, Mean RD 0.4218 
H Variance Std_Morphology(M05, Ch05)_Ch02_5, low, Mean RD 0.4146 
Gradient RMS_M02_Ch02, low, Mean RD 0.3535 
H Energy Mean_Morphology(M05, Ch05)_Ch02_5, low, Mean RD 0.3145 
Gradient RMS_M04_Ch04, low, Mean RD 0.2888 
Modulation_M04_Ch04, low, Mean RD 0.2888 
Gradient RMS_M01_Ch01, low, Mean RD 0.2887 
Contrast_M04_Ch04, low, Mean RD 0.2869 
The above values were generated using the “Find the best feature” tool in the Ideas
tm
 software. 
The values represents RD values derived using the Fischers Discriminate ratio. In this table, the RD 
value indicates the ability of that particular feature to distinguish individual foci and the higher 
the value, the better the feature is. The feature highlighted in red (at top of table) was created 
using the Spot wizard. The two features highlighted in blue (second and third row of table) were 
created manually. These values show that the auto-generated feature provides better statistical 
separation of foci not only in comparison to the manually created features but all available 
features in the software. 
 72   
 
2.5 Analysis of DNA repair in chemosensitive and chemoresistant cell lines using 
γ-H2AX 
2.5.1 Developing Resistant Cell lines 
 Two parental repair normal cell lines MRC5-SV1 and NB1-HTERT were taken 
to develop resistant cell lines. This was achieved by exposing them to gradual 
increasing doses of HN2. This was made up in complete medium containing HN2 
concentrations starting from 0.5 μg/mL. Cells were then left to grow until they 
became confluent before increasing the concentration by 1.5 fold of the previous 
dose. Please refer to Table 2.8 for the range of doses used. The NB1-HTERTR cell line 
was maintained at 3.5 μg/mL HN2 as this was approximately 10 fold higher than the 
IC50 of the parental cell line. Similarly the MRC5-SV1R cell line was maintained at 
5.3 μg/mL HN2. Cells were cultured in drug-treated medium at the relevant 
concentration every third passage to maintain resistance. Cells were cultured in 
drug-free medium for a minimum of seven days prior to any experiments being 
carried out on them. 
Table 2.8: Dose ranges used to induce resistance in parental cell lines 
Dose Concentation (μg/mL) 
1 0.5 
2 0.75 
3 1 
4 1.5 
5 2.3 
6 3.5 
7 5.3 
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Cells took approximately 3 – 4 weeks to grow through each dose of drug and 
become confluent. 
2.5.2 Clonogenic Assays 
 Clonogenic assays were carried out as described in section 2.3. These were 
performed on the resistant cell lines to establish that they exhibited higher levels of 
resistance to HN2 in comparison to the parental cell lines. These were also carried 
out on the XPF-deficient cell line to highlight the sensitivity of this cell line to cross-
linking agents.  
 The chemotherapeutic agents utilised in this study were HN2 and Pt. The 
dose ranges used in these experiments were as detailed in Table 2.9 below. 
Table 2.9: Dose ranges used for clonogenic assays 
Dose 
HN2 (μg/mL) 
for resistant cell 
lines 
HN2 (μg/mL) for 
GM08437B 
Pt (μg/mL) for 
resistant cell 
lines 
Pt (μg/mL) for 
GM08437B 
1 0.5 0.1 15 4 
2 1 0.2 20 8 
3 1.5 0.3 25 12 
4 2 0.4 30 16 
5 N/A 0.5 35 20 
The above table details the dose ranges used in the clonogenic assays. Lower concentration ranges 
had to be used for the GM08437B cell line due to their sensitivity to these agents. 
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2.5.3 γ-H2AX Assay with HN2 
 The IC50 values of HN2 derived for the parental cell lines were used on the 
resistant cell lines, this was to allow for comparable results with the repair normal 
cell lines as described in Section 2.4. The GM08347B cell line was subjected to the 
same dose of HN2 that the NB1-HTERT parental cell line had been exposed to. This 
was to account for the sensitivity of this cell line to cross-linking agents as the 
concentrations derived for the NB1-HTERT parental cell line were lower than those 
derived for the MRC5-SV1 parental cell line. Refer to Table 2.10 for details of the 
concentrations used. All cell lines were treated as proliferating monolayers and 
were at approximately 80% confluency when treated. Cells were fixed in 50:50 
methanol:acetone (V:V) at 3, 5, 24, 30 and 48 hrs post treatment. They were stored 
at 4oC prior to undergoing the immunocytochemistry protocol as detailed in Section 
2.4.5. 
Table 2.10: Concentrations of HN2 used in the γ-H2AX assay 
Cell line HN2 
MRC5-SV1 0.5 μg/mL 
MRC5-SV1R 0.5 μg/mL 
NB1-HTERT 0.3 μg/mL 
NB1-HTERTR 0.3 μg/mL 
GM08437B 0.3 μg/mL 
These values represent the IC50 values derived for the 
parental cell lines in response to treatment with HN2 
 
 
 75   
 
2.5.4 ERCC1 expression levels post treatment with HN2 
 Cell lines were exposed to the relevant IC50 dose as detailed above in Error! 
eference source not found. for 1 hr and fixed at 24 hrs and 48 hrs post treatment. 
Compensation samples were fixed at 24 hrs post treatment. All samples were fixed 
in 50:50 methanol:acetone and stored at 4 oC. 
2.5.5 Immunocytochemistry 
Cells were stained as described in Section 2.4.5. ERCC1 expression levels 
were detected using a mouse monoclonal anti-ERCC1 primary antibody (Abcam) at 
a 1:200 dilution.  
 
2.5.6 Imagestream data acquisition and image compensation 
 The protocol undertaken to acquire images and compensate for 
fluorescence was as previously described in Section 2.2.6 and Section 2.2.7. 
 
2.5.7 Imagestream data analysis using IdeasTM software and calculation of foci 
numbers 
 Foci counts and overall nuclear intensity was determined for each of the cell 
lines. Data analysis was carried out as described in Section 2.4.7 
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2.6 Analysis of DNA repair in chemosensitive and chemoresistant cell lines using 
RAD51 
All cell lines described in Section 2.5 were employed in this study. 
 Chemotherapeutic Agents 2.6.1
Table 2.11: HN2 doses used for each cell line in the Rad51 assay 
Cell Line IC50 for HN2 
MRC5-SV1 Parental and MRC5-SV1R 
 
0.5 μg/mL 
NB1-HTERT Parental, NB1-HTERTR, 
GM08437B 
 
0.3 μg/mL 
 
 To determine the level of RAD51 foci formation induced by HN2 treatment, 
the cell lines were treated with their respective concentration of HN2 detailed in 
Table 2.11. IC50 doses derived for the parental cell lines (as detailed in Chapter 4) 
were utilised for this study. The XPF cell line was treated with the IC50 dose 
obtained for the NB1-HTERT cell line as the concentrations derived for the NB1-
HTERT parental cell line were lower than those derived for the MRC5-SV1 parental 
cell line. This was to account for the sensitivity of this cell line to cross-linking 
agents. All cell lines were treated as proliferating monolayers and were at 
approximately 80% confluency when treated.    
 
 Cell fixation and Permeabilisation 2.6.2
 Cells were fixed at 6, 12, 24, 30 and 48 hrs post treatment with their 
respective doses of HN2. These time points were selected to encompass a 2 day 
period to allow for evaluation of DNA repair kinetics. Cells were detached using 
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1 mL of 0.25% Trypsin-EDTA and washed twice in PBS. They were then fixed and 
permeabilised in 100% methanol at -20oC.   
 
 Immunocytochemistry 2.6.3
 Cells were rehydrated with three washes in PBS and then blocked in 
blocking buffer comprised of PBS containing 20% rabbit serum (PAA) and 0.1% 
Triton-X 100. Cells were incubated at 4oC overnight in mouse monoclonal anti-
RAD51 antibody (Clone 14B4, Abcam) at 1:200 dilution.  
 Following three washes in wash buffer made up of PBS containing 0.1% 
Tritox X-100, cells were incubated for 1 hr at RT in AF488 antibody diluted in block 
buffer to 1:1000. Cells were washed again in wash buffer three times and once in 
PBS. Samples were then resuspended in 100 μL of Accumax flow cytometry buffer 
with 5 μM Draq5 (Biostatus Ltd., Leicestershire, UK). Two samples for fluorescence 
compensation were prepared with either the secondary antibody (AF488) or Draq5 
being omitted from the process. These were fixed at 24 hrs post treatment for all 
cell lines.   
 
 Imagestream data acquisition and image compensation 2.6.4
 The protocol undertaken to acquire images and compensate for 
fluorescence was as previously described in Section 2.2.6 and Section 2.2.7. 
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 Imagestream data analysis using IdeasTM software and calculation of foci 2.6.5
numbers 
 Foci counts and overall nuclear intensity was determined for each of the cell 
lines. Data analysis was carried out as described in Section 2.4.7 
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Chapter 3                                   
Validation of imaging flow cytometry for 
the identification of DSBs in human cells 
following gamma radiation exposure 
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3.1 Introduction 
 DSBs are potentially lethal lesions that must be rapidly repaired in order to 
ensure cell survival and maintain genomic integrity (Hoeijmakers 2001). They can 
occur for many reasons such as exposure to IR during clinical radiotherapy (Bourton 
et al. 2011), exposure to anticancer chemotherapeutic drugs (Clingen et al. 2008) 
and through interaction with endogenously derived ROS formed through normal 
cellular metabolism (Conklin 2000).  
 A critical event in the signalling and subsequent repair of DSBs is the 
phosphorylation of H2AX by ATM and ATR to form the γ-H2AX protein. The number 
of foci seen is thought to correlate on a 1:1 basis with the number of DSBs formed 
(Sedelnikova et al. 2002). The accumulation of γ-H2AX molecules seen at the site of 
these DSBs leads to the formation of nuclear foci (Rogakou et al. 1998). The repair 
of these DSBs are normally carried out through two pathways; HR and NHEJ (Scott 
and Pandita 2006). HR and NHEJ pathways are the main route taken in the repair of 
DNA DSBs in vertebrate cells (Takata et al. 1998).  The point at which the cell is 
progressing through the cell cycle plays a role in determining the pathway that will 
become activated to repair the DSB (Lees-Miller and Meek 2003). It is generally 
agreed that in the G1/G0 phase of the cell cycle, DSBs are repaired by NHEJ while 
HR is more prominent during the late S/G2 phase (Valerie and Povirk 2003). Takata 
et al, (1998) demonstrated that HR and NHEJ are complementary in repairing the 
DSBs and concluded that both play a big role in maintaining the integrity of 
chromosomes.   
 In repair normal mammalian cells, the induction of γ-H2AX foci occurs 
rapidly following the formation of DSBs. Within 1 - 3 hrs, the majority of these DSBS 
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have been repaired and subsequently leads to the dephosphorylation and loss of 
the γ-H2AX foci within the nucleus (Rogakou et al. 1998). In cells which exhibit signs 
of defective DNA repair mechanisms, there is a persistence of γ-H2AX foci seen 
which is due to failure to resolve these DNA DSBs (Bourton et al. 2011). This has 
been shown in a variety of cells derived from patients with different DNA repair 
disorders such as A-T or FA. The ATM gene is mutated in this disorder which is 
thought to inactivate the induction of DSB repair resulting in the persistence of γ-
H2AX foci within the nucleus (Friesner et al. 2005).  Furthermore, Abbaszadeh et al, 
(2010) demonstrated that the prolonged appearance of γ-H2AX foci in the nuclei of 
irradiated cells was due to a defect in the DNA-PKcs gene, a vital component of the 
NHEJ pathway. The persistence of γ-H2AX foci in cells hypersensitive to DNA 
damaging agents has prompted extensive research into the application of γ-H2AX 
as a biomarker to predict tumour response and the level of side effects experienced 
in patients receiving clinical radiotherapy and/or chemotherapy (Bourton et al. 
2011).  
 In this study, the novel technique of imaging flow cytometry was employed 
to estimate the number of foci induced in normal and repair defective immortalized 
human fibroblasts exposed to 2 Gray (Gy) gamma radiation.  The counting and 
imaging of more than 20000 cells demonstrated a persistence of γ-H2AX foci in the 
nuclei of two DSB repair defective cell lines (XP14BRNeo17 and AT5BIVA) for up to 
24 hrs post irradiation. However in a repair normal cell line (MRC5-SV1), rapid 
induction of foci was followed by DNA repair and disappearance of foci within 3 hrs 
post irradiation. Significantly higher numbers of foci were induced in the DSB repair 
normal cell line compared with the two repair defective cell strains. These findings 
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indicate that application of imaging flow cytometry provides an accurate 
assessment of the levels of DNA damage in cells and adds to the growing number of 
high throughput methods for the analysis of DNA damage in cells.  
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3.2 Results 
 Gamma Radiation Dose Response Curve 3.2.1
 The induction of fluorescence in the three cell lines was determined by 
counting 20 000 cells with the Imagestreamx following exposure to 0,2,4,6,8 Gy 
gamma radiation. A nuclear morphology mask was created using the Mask Manager 
in IdeasTM and was used to derive the intensity of PE staining (γ-H2AX) in the 
nucleus. A dose response curve was produced (Refer to Figure 3.1) using the mean 
level of intensity seen in each of the samples exposed to an increasing level of 
gamma radiation.  
Figure 3.1: Dose response curve post irradiation with increasing doses of gamma 
radiation  
 AT5BIVA, MRC5-SV1 and XP14BRneo17 cell lines were exposed to 0, 2, 4, 6, 8 Gy gamma 
radiation. The fluorescence is indicative of γ-H2AX foci which were labelled with PE. In all three 
cell lines, an increasing level of fluorescence is seen as the dose of gamma radiation is increased.  
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It was observed that as the dose of gamma radiation was incremented, there was a 
1 - 1.5 fold increase in the level of nuclear fluorescence. For all subsequent 
experiments in this study, a dose of 2 Gy gamma radiation was used to induce γ-
H2AX foci. The 2 Gy dose was seen to fall within the linear phase of the dose 
response curves generated for each of the cell lines and it relates to the clinical 
doses used for treatment which are generally a series of 2 Gy fractionated doses. 
 
 γ-H2AX Foci Quantification Using the ImagestreamX 3.2.2
 The average number of foci per cell in each of the three cell lines was 
analysed and quantified using the Imagestreamx. The data was derived from three 
independent experiments and is shown in Figure 3.2. γ-H2AX foci were enumerated 
by applying a Morphology and Spot mask to each of the cell images produced for 
each time point as  shown in Figure 2.5. In unirradiated cells, the mean number of 
foci per nucleus is 1.13 for the repair normal MRC5-SV1 fibroblasts and 0.76 for the 
repair defective AT5BIVA cells while a mean number of 2.21 foci were seen in the 
repair defective XP14BRNeo17 cell line. Following exposure to 2 Gy gamma 
radiation at a dose rate of 1.3 - 1.4 Gy per minute, there was a significant increase 
in the number of foci in all cell lines at 30 minutes post irradiation. This is consistent 
with the induction of DNA DSB repair as a consequence of exposure to gamma 
radiation. The MRC5-SV1 cells exhibit 14.04 foci per cell whilst the AT5BIVA cells 
show an average of 17.17 foci and the XP14BRNeo17 cells have a mean number of 
12.26 foci per cell. During the ensuing 24 hr period, the three cell lines were 
examined at three different time points, 3, 5 and 24 hrs post exposure to 2 Gy 
gamma radiation. There was a distinct variance in the behaviour of the three cell 
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lines during this time period in terms of resolving the DNA DSBs that had occurred 
during the treatment. The repair normal cells, MRC5-SV1 cells show that the 
majority of the γ-H2AX foci have disappeared with the average foci count dropping 
to 1.58, indicating that most of the DNA DSBs have been repaired. The AT5BIVA 
cells are known to have defective DNA repair mechanisms and the results show that 
even at 24 hrs post irradiation, there is an average of 18.72 foci per cell. The 
XP14BRNeo 17 cells show an intermediate response in comparison to the MRC5-
SV1 and AT5BIVA cells with an average of 8.10 foci per cell after 24 hrs.  
 The application of a Student’s unpaired t-test reveals that differences in the 
persistence of γ-H2AX foci within the three cell lines are statistically significant with 
95% confidence levels. The AT5BIVA cells retain a significant number of foci after 24 
hrs in comparison to the repair normal cell line, MRC5-SV1 (P < 0.008) as do the 
XP14BRNeo17 cells (P < 0.001). The AT5BIVA cells also retain significantly more foci 
than the XP14BRNeo17 cells at 24 hrs (P < 0.05).   
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Figure 3.2: Average number of H2AX foci seen post irradiation with 2 Gy gamma 
irradiation over 24 hrs 
 
The mean number of γ-H2AX foci seen in MRC5-SV1, AT5BIVA and XP14BRNeo17 cell lines over a 
24 hr period post exposure to 2Gy gamma radiation. Error bars represent the standard error of the 
mean derived from three independent experiments in which 20 000 cells were analysed at each 
time point for each cell line. 
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Figure 3.3: Foci Distribution in the three cell lines over the ensuing 24 hour period 
post exposure to 2 Gy gamma radiation 
 
The above figure shows the foci distribution seen in (A) MRC5-SV1, (B) XP14BRNeo17 and (C) 
AT5BIVA. A dramatic induction in γ-H2AX foci induction was seen in all three cell lines at 30 
minutes post exposure to 2 Gy gamma radiation. At 24 hrs post irradiation, the MRC5-SV1 foci 
distribution is similar to its untreated control whereas the AT5BIVA cell lines still retained the 
majority of the γ-H2AX foci. The XP14BRNeo17 cell line shows an intermediate response with 
some retention of γ-H2AX foci. 
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 In Situ Quantification of γ-H2AX Foci 3.2.3
 To validate the γ-H2AX foci counts derived from the ImagestreamX analysis, 
the induction of foci within the three cells lines was also determined using in situ 
immunofluorescence. Cells were examined using a fluorescence microscope with 
x100 magnification objective and it can be seen that the mean number of foci 
observed in the cell lines following 2 Gy gamma radiation exposure is higher than 
the numbers derived from the ImagestreamX. However there is still a similar 
relationship observed in the differences in the number of foci retained at the end of 
the 24 hr period. The results for this experiment are shown in Figure 3.4.  
 
Figure 3.4: Average number of γ-H2AX foci calculated post irradiation with 2 Gy 
gamma irradiation using in situ immunofluorescence 
 
The mean number of γ-H2AX foci seen in MRC5-SV1, AT5BIVA and XP14BRNeo17 cell lines over a 
24 hr period post exposure to 2 Gy gamma radiation measured using in situ immunofluorescence. 
Error bars represent the standard error of the mean derived from three independent experiments 
in which 100 cells were analysed at each time point for each cell line.  
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 Comparison of Total and Nuclear Fluorescence 3.2.4
 The relative nuclear fluorescence exhibited by the γ-H2AX foci induction 
(seen in Ch03) can be readily compared with the total cellular fluorescence (also 
seen on Ch03 but measured without the application of the Morphology Mask which 
would direct the analysis software to exclude any staining that fell outside the 
nucleus). The total cellular fluorescence data is similar to data that would be 
derived from using classical flow cytometry which has zero resolution. Subsequently 
this enables a comparison between imaging and classical flow cytometry.  
Figure 3.5 compares the total cellular fluorescence in comparison to the nuclear 
cellular fluorescence in the three cell lines post exposure to 2 Gy gamma radiation. 
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Figure 3.5: Comparison of total and nuclear fluorescence levels 
 
The relative levels of nuclear and total fluorescence exhibited in the three cell lines. Closed 
symbols indicate the nuclear fluorescence whilst the open symbols indicate total cellular 
fluorescence. Relative fluorescence was calculated by diving actual fluorescence levels seen at 
each time point by the fluorescence exhibited in the control cells for each cell line. The dramatic 
increase in fluorescence indicates the presence of γ-H2AX foci in the nuclei of the cells. A rapid 
drop in fluorescence is seen in the MRC5-SV1 repair normal cells after 3 hrs whilst the AT5BIVA 
and XP14BRNeo17 cells show to retain high levels of fluorescence even after 24 hrs. Error bars 
represent the standard error of the mean where approximately 20000 cells were collected from 
three independent experiments.    
  
 In all cell lines, the level of fluorescence induction appears to mimic similar 
patterns to foci induction and repair seen; be it total or cellular fluorescence. In the 
repair normal MRC5-SV1, there is approximately a 2.5 fold increase in the level of 
nuclear fluorescence 30 minutes post exposure to 2 Gy gamma radiation. These 
levels are seen to drop considerably by 3 hrs postirradiation which is consistent 
with the repair of DNA DSBs induced by the exposure to gamma radiation and by 24 
hrs, the level of nuclear fluorescence has returned to similar levels to that of the 
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after 24 hrs, thought to be seen due to the lack of DNA DSB repair taking place and 
are in line with the level of foci retention exhibited at 24 hrs.   
 The XP14BRNeo17 cell line also exhibits defective DNA repair where one of 
the vital components of the NHEJ pathway, the DNA-PKcs gene has lost its 
functionality, rendering the cells hypersensitive to the effects of ionising radiation. 
It can be seen that the levels of nuclear fluorescence in the AT5BIVA cells and the 
XP14BRNeo17 cells are quite similar at 24 hrs despite the AT5BIVA showing higher 
levels of foci retention. This could be due to differences in the size of foci seen and 
subsequently the intensity of foci staining in the different cell line nuclei.     
 When comparing the total cellular fluorescence with the nuclear cellular 
fluorescence, it can be seen that the total cellular fluorescence is higher for each 
cell line. This could be due to non-specific staining within the cytoplasm of the cells. 
However, the total cellular fluorescence retention patterns are similar for each of 
the cell lines when compared to the nuclear cellular fluorescence levels. For 
example, the total cellular fluorescence for the MRC5-SV1 repair normal cells 
increase by approximately 2.7 fold in comparison at 30 minutes post exposure to 
2 Gy gamma radiation in comparison to the untreated cells. However at 3 hrs, these 
levels drop down to approximately 1.5 fold of the control cells as DNA DSB repair 
has begun in these cells and by 24 hrs, fluorescence levels are similar to those 
exhibited by the control cells.  
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3.3 Discussion 
 This investigation was a quantitative study of radiation-induced γ-H2AX foci 
induction in the repair normal MRC5-SV1 cell line and two DNA repair defective cell 
lines, XP14BRNeo17 and AT5BIVA. The novel technique of imaging flow cytometry 
was employed to conduct this study using the Imagestreamx. Using the 
Imagestreamx allowed for images of every individual cells to be captured in flow on 
a maximum of 6 optical channels. There were three main channels used for these 
series of experiments which were Ch0 1 (BF), Ch03 (PE for γ-H2AX staining) and 
CH05 (Draq5 for nuclear staining), enabling the measurement of the intensity and 
number of nuclear γ-H2AX foci localised to the nucleus of each cell. It also enabled 
the collection and analysis of over 20000 cells which was never considered a 
practical approach when using fluorescence microscopy.  Similarly, analysing 
samples using flow cytometry allowed for the collection of higher numbers of cells 
but it was not possible to analyse the number of foci seen in each cell.  
 Using imaging flow cytometry, it has been possible to detect differences in 
the induction and repair of DNA DSBs (measured by quantifying the number of γ-
H2AX foci) in the three different cell lines.  The MRC5-SV1 cells exhibit a repair 
profile typical of many other repair competent cell lines (Abbaszadeh et al. 2010). 
 The AT5BIVA cell line derived from an AT patient exhibits a similar induction 
of DNA DSBs, indicated by the increase in the number of γ-H2AX foci seen at 30 
minutes postirradiation. However at 24 hrs, high levels of foci are still seen which is 
thought to be due to the defective ATM gene which renders the DNA repair 
mechanisms inept to resolve DNA DSBs.  
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 The XP14BRNeo17 cell line also shows a similar increase in the number of γ-
H2AX foci seen 30 minutes after 2 Gy gamma irradiation. However at 24 hrs, there 
is only a partial retention of γ-H2AX foci seen. Earlier investigations with this cell 
line revealed a splicing defect in the DNA-PKcs gene which is integral in the NHEJ 
pathway (Abbaszadeh et al. 2010). This defect resulted in a heterozygous 
phenotype whereby both the normal and a defective splice variant of the gene 
were produced in the patient; ultimately leaving the cells hypersensitive to clinical 
radiation. It is likely that the intermediate retention of foci after 24 hrs could be due 
to the haploinsufficiency of the DNA-PKcs gene which resulted in only partial repair 
of the DNA DSBs taking place.  
 In this study, the results obtained from imaging flow cytometry were 
compared with those derived from in situ microscopy. While similar profiles of γ-
H2AX foci induction were seen within the three cell types, there was a noticeable 
increase in the number of foci scored using the in situ methods (Figure 3.4 and 
Figure 3.5). The most likely reason for this may be due to the difference in 
magnification used for the in situ microscopy (x100 objective) in comparison to the 
ImagestreamX (x40 objective). However the relative differences in foci induction 
profiles remained the same; regardless of the method used to quantify them. 
 It was also possible to compare nuclear fluorescence with total 
fluorescence, thereby enabling comparison of imaging flow cytometry and classical 
flow cytometry. Both approaches showed differences in the DNA repair capacity of 
the three cell lines employed in this study; however the increases in total cellular 
fluorescence were higher than the total nuclear fluorescence. As this was seen in all 
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cell lines, it is likely that these differences were due to non-specific staining of the 
cytoplasm.  
 Overall, imaging flow cytometry has provided a novel technique for 
quantification of γ-H2AX foci in cells. Comparisons with classic methods such as in 
situ immunofluorescence and conventional flow cytometry have shown the data 
derived from the ImagestreamX yields similar patterns of foci induction in the 
different cell lines employed in this investigation. The ability to image cells in flow 
has allowed for a quick and accurate method for detecting differences in DNA 
repair profiles of different cell lines. Allowing for this analysis to be carried out on 
large numbers of cells (approximately 20 0000) provides robust data and the 
technically simple and rapid method permits for high throughput and prompt data 
analysis. The volume of data that can be captured in a relatively short time 
compensates for the lower resolution images that are produced by the 
ImagestreamX in comparison to other microscopy image capture methods. 
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Chapter 4                       
Determining cellular sensitivity to a range 
of cytotoxic chemotherapeutic drugs 
using clonogenic assays 
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4.1 Introduction 
 The γ-H2AX assay described in the previous chapter was designed to assess 
the validity of the Imagestreamx to measure γ-H2AX expression levels in cell lines 
with different defects in DNa DSB after exposure to 2 Gy gamma radiation. The 
study successfully identified differences in DNA repair levels between the repair 
normal MRC5-SV1 cell line and the two DNA repair defective cell lines AT5BIVA and 
XPBR14neo17.  
 Chemotherapy is one of the other main forms of treatment for cancer 
patients either in conjunction with radiotherapy and surgery or as a treatment 
regimen on its own (Clingen et al. 2008). Chemotherapy primarily works by 
damaging DNA of dividing cells. However its toxicity is not limited to tumour cells 
and healthy cells are also targeted which may lead to the manifestations of 
debilitating side effects such as alopecia, weight loss and destruction of the 
immune system. Subsequently there is an increasing need emerging for a predictive 
assay which could map response to this type of treatment to identify hypersensitive 
patients. 
 There is an array of chemotherapeutic agents currently in clinical use which 
exhibit different modes of action which would presumably have an effect on the 
level of toxicity they exert.  This therefore would be reflected in the concentration 
of each drug required to inflict a level of DNA damage on patient cells without 
causing irreversible effects to cell function and viability. The drugs that were 
selected for this study are Pt (Sigma Aldrich), HN2 (Sigma-Aldrich) ADR (Duchefa 
Biochemie, 2003 RV Haarlem, The Netherlands) and 5-FU (Duchefa Biochemie) 
(Refer to Table 4.1 for more details).  
 97   
 
Table 4.1: Overview of chemotherapeutic agents used and their mechanism of 
action 
Chemotherapeutic 
Agent  
Mechanism of Action Treatment 
Cisplatin 
(Pt) 
Formation of interstrand 
crosslinks 
Broad range of cancers such 
as breast cancer 
Nitrogen Mustard 
(HN2) 
Formation of interstrand 
crosslinks 
Non Hodgkin’s Lymphoma 
5-Fluorouracil 
(5-FU) 
Inhibition of thymidylate 
synthase and incorporation of 
metabolites into RNA and DNA 
Colorectal Cancer 
Adriamycin 
(ADR) 
Inhibition of Topoisomerase II, 
DNA intercalator, DSB 
formation 
Broad range of solid 
tumours 
 
 These agents were chosen as they are commonly used chemotherapeutics 
in the treatment of various cancers such as breast cancer, colon cancer, prostate 
cancer and lymphomas (Harmers et al. 1991; Longley et al. 2003) and differ in their 
mechanisms of action.  
 HN2 and Pt cause inter or intra strand DNA cross links which can lead to the 
inhibition of DNA synthesis (Smith et al. 1995). 5-FU is an anti-metabolite capable of 
incorporating itself into the DNA subsequently inhibiting normal functions as well as 
inhibiting vital biosynthetic processes (Longley et al. 2003). The full extent of the 
damage that Adriamycin is able to exert has not been completely elucidated as yet 
but it is thought to have multiple mechanisms of actions such as inducing free 
radical formation, inhibiting Topoisomerase II activity, DNA intercalator and causing 
DNA cross links.    
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 Following the method of developing the γ-H2AX assay for radiation, it was 
deemed necessary to determine the toxicity of each drug on each cell line prior to 
designing a predictive assay for chemotherapy. The clonogenic assay was selected 
as the assay of choice for evaluating cellular response to each drug. 
 Clonogenic assays were first established by Puck and Marcus in 1956 and 
were considered the “gold standard assay” in radiobiology by the early 1970s 
(Hoffman 1991). It is the only viability assay capable of measuring a cell’s ability to 
form a colony after treatment, thereby providing an assessment of reproductive 
cell survival (Katz et al. 2008).  It is also able to detect the cytotoxic effects of any 
drug as long as the agent interferes with cell reproducibility (Katz et al. 2008).    
 There are drawbacks to this technique such as the lengthy period taken for 
the formation of colonies. However it is still considered a reliable method of 
determining cellular responses to chemotherapy although it has been argued that 
there are quicker and more effective methods such as the tetrazolium salt, 3-4,5 
dimethylthiazol-2,5 diphenyl tetrazolium bromide (MTT) assay or the Lactate 
Dehydrogenase (LDH) release assay (Hoffman 1991).  
 The MTT assay involves quantifying the rate of conversion of MTT into 
purple coloured formazan by oxidative activity of living cells. A decline in the level 
of MTT conversion, measured by a spectrophotometer is thought to indicate cell 
damage (Abe and Matsuki 2000). The Lactate Dehydrogenase Assay has similar 
principles where the release of the intracellular enzyme LDH is measured upon 
damage of the plasma membrane. It is agreed that there are disadvantages to using 
clonogenic assays such as the lengthy time involved to elicit results which ranges 
from 10 to 21 days in comparison to the MTT assay which can yield results in 72 hrs. 
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However there are other advantages such as the simplicity of performing this 
experiment and obtaining survival data, low costs of performing these types of 
experiments and most importantly, it is able to distinguish between cytotoxic and 
cytostatic cells which the MTT assay is not able to (Hoffman 1991).   
 The purpose of this study was to determine the half maximal inhibitory 
concentration of the chemotherapeutic agents, also known as the IC50. This 
concentration kills 50% of the target cell population. By visually counting the 
number of colonies that form after the cells have been exposed to a range of 
different concentrations of each drug and making a comparison against the number 
of colonies that have formed on the control plates, the IC50 can be determined.  
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4.2 Results  
 Colony counting 4.2.1
 Colony counting was performed using the rule that a minimum of 50 cells 
will be considered to be a colony (Franken et al. 2006). Individual colonies were 
counted by eye with the aid of a microscope to verify the number of cells in smaller 
colonies. There was a decrease in the number of colonies seen as the drug 
concentration was increased as shown in Figure 4.1 below. 
Figure 4.1: Typical colony formation seen 10 - 21 days post exposure to drugs 
 
The above figure shows example plates from a typical clonogenic assay; depicting the reduction of 
colony formation as the dose of the drug is increased 
 
 Calculating survival rates 4.2.2
 Plating efficiency (P.E.) was first determined by analyzing colony growth on 
the control plates using the following formula which provides the percentage of 
colonies that will form from the total number of cells initially plated. 
Number of colonies formed/Number of cells initially plated x 100 
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Survival rates in the treated plates was then determined in two steps using the 
following formulas. First the number of colonies that would theoretically have 
formed had the plates not been treated with drug was determined using the 
following formula 
P.E. x number of cells plated at that dose 
Then the survival rate was determined by the following formula 
Number of colonies formed/ number of colonies that should have formed x 100 
This was then plotted to determine IC50 values of each drug for each individual cell 
line. 
 
 Determining IC50 values of HN2 4.2.3
 All cell lines were exposed to a range of concentrations of HN2 from 
0.5 g/mL to 2.5 g/mL. Figure 4.2 shows the survival rates of the cells at each 
concentration. It was observed that the survival rates of all cell lines decreased as 
the concentration of HN2 was increased. There was not much change in survival 
rates between 2 g/mL and 2.5 g/mL, resulting in the formation of a plateau of 
survival at the top end of the dose range for the NB1-HTert and MRC5-SV1 cell 
lines. The IC50 was graphically determined to be 0.45 g/mL for the MRC5-SV1 cell 
line, 0.3 g/mL for the NB1-HTERT cell lines and 0.2 g/mL for the AT5BIVA cell line.  
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Figure 4.2: Cell survival for all cell lines post exposure to HN2 
 
The effect of HN2 on the three cell lines, AT5BIVA, MRC5-SV1 and NB1-HTERT. Data was derived 
from 3 independent experiments and error bars represent standard error of the mean. All cell 
lines were treated with HN2 concentrations ranging between 0.5 and 2.5 µg/mL. There was a 
decrease in survival seen as the concentration of HN2 was increased in all cell lines. IC50 values 
were graphically determined as being 0.5 µg/mL for MRC5-SV1, 0.3 µg/mL for NB1-hTERT and 0.2 
µg/mL for AT5BIVA.   
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 Determining IC50 values of Pt 4.2.4
 All cell lines were exposed to a range of concentrations of Pt from 15 g/mL 
to 35 g/mL. Figure 4.3 shows the effect of this drug on all three cell lines. Cell kill 
was seen over 2 decades with MRC5-SV1 and NB1-HTERT survival levels forming a 
plateau again when survival rates at the 2 highest doses were analysed. The IC50 
values for the MRC5-SV1 cell line was 12 μg/mL, 6 μg/mL for the NB1-HTERT cell 
line and 7 μg/mL for the AT5BIVA cell line.  
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Figure 4.3: Cell survival for all cell lines post exposure to Pt 
 
The effect of Pt on the three cell lines, AT5BIVA, MRC5-SV1 and NB1-hTERT. All cell lines were 
treated with Pt concentrations ranging between 15 and 35 µg/mL. There was a decrease in 
survival seen as the concentration of Pt was increased in all cell lines. IC50 values were graphically 
determined as being 12 µg/mL for MRC5-SV1, 6 µg/mL for NB1-hTERT and 7 µg/mL for AT5BIVA. 
Data was derived from 3 independent experiments and error bars represent standard error of the 
mean.   
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 Determining IC50 values of Adr 4.2.5
 All cell lines were exposed to a range of concentrations of ADR from 50 
ng/mL to 150 ng/mL. Figure 4.4 depicts the survival levels of all 3 cell lines after a 1 
hour exposure to Adriamycin. As seen with the other drugs, the level of survival 
decreased proportionately as the concentration of drug was increased. The IC50 was 
graphically determined to be 56 ng/mL for the MRC5-SV1 cell line, 93 ng/mL for the 
NB1-HTERT cell line and 84 ng/mL for the AT5BIVA cell line. 
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Figure 4.4: Cell survival for all cell lines post exposure to Adr  
 
The effect of ADR on the three cell lines, AT5BIVA, MRC5-SV1 and NB1-HTERT. All cell lines were 
treated with Pt concentrations ranging between 50 and 150 ng/mL. There was a decrease in 
survival seen as the concentration of Pt was increased in all cell lines. IC50 values were graphically 
determined as being 56 ng/mL for MRC5-SV1, 93 ng/mL for NB1-HTERT and 84 ng/mL for AT5BIVA. 
Data was derived from 3 independent experiments and error bars represent standard error of the 
mean.   
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 Determining IC50 values of 5-FU 4.2.6
 All cell lines were exposed to a range of concentrations of 5-FU from 50 
μg/mL to 200 μg/mL. Figure 4.5 represents the survival levels of all 3 cell lines after 
a 1 hour exposure to 5-Fluorouracil. Survival rates steadily declined between cells 
treated at 50 μg/mL to the cells treated at 100 μg/mL after which point a sharp 
decline in survival was seen between the two highest doses The IC50 was graphically 
determined to be 190 μg/mL for the MRC5-SV1 cell line, 161 μg/mL for the NB1-
HTERT cell line and 132 μg/mL for the AT5BIVA cell line. 
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Figure 4.5: Cell survival for all cell lines post exposure to 5-FU 
 
 
The effect of 5-FU on the three cell lines, AT5BIVA, MRC5-SV1 and NB1-HTERT. All cell lines were 
treated with 5-FU concentrations ranging between 50 and 250 μg/mL. There was a decrease in 
survival seen as the concentration of Pt was increased in all cell lines. IC50 values were graphically 
determined as being 190 μg/mL for MRC5-SV1, 161 μg/mL for NB1-HTERT and 132 μg/mL for 
AT5BIVA. Data was derived from 3 independent experiments and error bars represent standard 
error of the mean.   
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Table 4.2: IC50 values derived for all cell lines 
Cell line HN2 Pt Adr 5-FU 
MRC5-SV1 0.5 μg/mL 12 μg/mL 56 ng/mL 190 μg/mL 
NB1-HTERT 0.3 μg/mL 7 μg/mL 93 ng/mL 161 μg/mL 
AT5BIVA 0.2 μg/mL 6 μg/Ml 84 ng/mL 132 μg/mL 
 
 The above table summarises the IC50 values derived for each cell line with 
each of the four chemotherapeutic agents. The MRC5-SV1 cell line was observed as 
being the most resistant cell line to all chemotherapeutic agents with the exception 
of Adr. However the AT5BIVA cell line demonstrated unexpected resistance to the 
cross-linking agents with similar IC50 values derived in comparison to the repair 
normal NB1-HTERT cell line. However when the second repair normal cell line, 
MRC5-SV1, is considered, AT5BIVA cell line exhibited a 50% decrease in resistance. 
This may be an indication of previously undetected sensitivity to cross-linking 
agents in the NB1-HTERT cell line.    
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4.3 Discussion 
 The IC50 values that were obtained from the colony forming assays provides 
a dose of the drug that will inflict damage onto cells without killing off the entire 
population (i.e. killing approximately 50% of the cell population). It is crucial to have 
accurate data regarding these values as they form the basis of the drug 
concentrations that will be used in the -H2AX assay being designed to predict 
patient response to chemotherapeutic agents.  
 The results of these clonogenic assays support the theory that all drugs have 
different levels of toxicity as demonstrated by the differing ranges of 
concentrations used for each drug and it also shows it is possible for the toxicity of 
the drug to vary between individuals as indicated by the differing IC50 values 
obtained for each cell line treated with the same drug.    
 The MRC5-SV1 repair normal cell line was seen to be the most resistant to 
the effects of the cross-linking agents, HN2 and Pt with its IC50 values being nearly 
double the values obtained for the other two cell lines (Refer to Table 4.2). It was 
hypothesized that AT5BIVA, a cell line derived from an individual with the DNA 
repair defective Ataxia Telangiectasia disorder, would exhibit an increased 
sensitivity to these drugs and require a much lower concentration of each drug to 
achieve a cell kill of 50% due to having an impaired ATM gene, rendering the cells 
DNA repair defective (Hickson et al. 2004). However it was seen that this cell line 
had very similar IC50 values for all drugs to the NB1-HTERT cell line which was 
derived from a repair normal individual. This suggests that the DNA DSB repair 
pathways are not required for the repair of lesions caused by these drugs. However 
when compared to the other DNA repair normal cell line, MRC5-SV1, a 2-fold 
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increase in colony forming ability was seen in the MRC5-SV1 cell line. The 
contradicting results between the two DNA repair normal cell lines indicates a need 
for a larger number of cell lines to be included in this study such as more DNA 
repair normal individuals as well as cell lines with known repair deficiencies in other 
DNA repair pathways.    
  Interestingly it was observed that the results derived from the ADR 
clonogenic assay showed MRC5-SV1 as being the most sensitive cell line to this drug 
with the NB1-HTERT cell line having an IC50 value nearly double that of MRC5-SV1. 
ADR has a different mode of action to the two cross-linking agents, Pt and HN2 and 
this may have had an impact on the sensitivity exhibited by the MRC5-SV1 cell line 
to this drug.   
 The IC50 values derived for the cell lines from the other clonogenic assays 
will now be utilised in designing a chemotherapy γ-H2AX assay for each drug; the 
results of which are detailed in Chapter 5. Although survival data was obtained for 
all cell lines in response to treatment with 5-FU, this was a very challenging process 
and it was very difficult to obtain consistent data for the cell lines. Therefore the 
decision was taken to exclude this drug from the remainder of the project. It is 
thought that the cell line exhibiting higher resistance to each chemotherapeutic 
drug will show increased expression of γ-H2AX levels. γ-H2AX expression in 
response to chemotherapeutic drugs which do not induce direct DSB are thought to 
be indicative of incisions being made at the site of lesion formation (i.e. ICL 
formation in response to Pt treatment). Therefore increased γ-H2AX expression 
would likely indicate an upregulated rate of DNA repair through increased incisions 
of the DNA damage being formed.  
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Chapter 5                       
Evaluation of γ-H2AX as a biomarker 
for chemotherapeutic drug response in 
human cells 
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5.1 Introduction 
 The role of γ-H2AX in response to IR has been well established since its 
unique phosphorylation events in response to the formation of DSBs were first 
identified nearly 15 years ago by William Bonner and co-workers (Rogakou et al. 
1998). The induction of direct DSBs through exposure to agents such as X-rays or IR 
leads to rapid formation of γ-H2AX foci. Cytotoxic agents such as DNA synthesis 
inhibitors, alkylating agents and Topoisomerase I and II inhibitors can also induce γ-
H2AX foci formation in response to DNA strand breaks arising during the repair 
process of non-DSB lesions (Dickey et al. 2009). Investigations such as the 
retrospective study by Bourton et al, (2011) which employed γ-H2AX as a marker of 
DNA damage successfully identified patients who were hyper-sensitive to IR thus 
revealing the potential application of this biomarker as a predictive diagnostics tool 
for identifying over-reactions to standard clinical radiotherapy. This was 
determined by the persistence of γ-H2AX foci seen 24 hrs after exposure to 2 Gy of 
gamma radiation in peripheral blood lymphocytes derived from cancer patients.  
Bourton et al (2012) explored the viability of using the Imagestream to assess DSB 
formation in response to IR and we were able to demonstrate the differences in 
repair levels between three cell lines known to exhibit different repair kinetics in 
response to IR (Refer to Chapter 3). γ-H2AX foci detection has been shown to be a 
much more sensitive indication of DNA damage in comparison with other 
techniques such as pulsed field gel electrophoresis or comet assays (Sedelnikova et 
al. 2002). γ-H2AX expression levels can be quantified through immunofluorescence, 
flow cytometry or western blotting and persistence of foci after the initial induction 
of damage implies unrepaired DNA damage (Dickey et al. 2009). The central role 
 114   
 
that γ-H2AX plays in the detection of DNA damage and/or repair has been exploited 
to improve treatment efficacy. These areas include  
 measuring levels of X-ray induced DSBs in angiography patients  (Kuefner et 
al. 2009) 
 toxicity studies on novel chemotherapeutic agents (Banath and Olive 2003)   
 measuring tumour response to anti-cancer agents (Garcia-Villa et al. 2012). 
Kuefer et al (2009) employed γ-H2AX to monitor the effects of radiation by 
measuring X-ray induced DNA DSBs and this revealed that analysing H2AX 
formation elicited additional information regarding cardiac toxicity in patients post 
treatment. 
 Cytotoxic chemotherapy is used extensively as a common means of treating 
cancer either in combination with surgery and radiotherapy or as a single treatment 
(Clingen et al. 2008). Most chemotherapeutic drugs target DNA of cancer cells; 
causing irreversible damage and ultimately leading to cell death. However 
chemotherapeutic cytotoxic drugs are not normally selective in killing cancer cells 
and the destruction of normal cells leads to the manifestation of side effects. 
Serious and unpleasant side effects are a fundamental limitation of chemotherapy 
and can vary dramatically between individuals. Subsequently, the utilisation of DNA 
damage and repair proteins is being increasingly being investigated in order to 
gauge the ability to predict possible outcomes of patient chemotherapy (Clingen et 
al. 2008). The efficacy of DNA repair in individuals may govern the level of side 
effects experienced by the patient.  
 Whereas the appearance of γ-H2AX foci post-irradiation is indicative of DNA 
damage, γ-H2AX foci appearing post treatment with chemotherapy, particularly in 
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the case of agents that do not induce direct DSBs, may be reflective of both 
chemotherapy induced DNA damage or repair processes taking place (Huang et al. 
2004). There have been several studies examining the potential of γ-H2AX as a 
potential marker of cell sensitivity to chemotherapeutic agents such as Huang et al, 
(2004) who determined that the elevated expression of γ-H2AX post treatment 
seen in HL-60 (human promyelocytic leukaemic cells) with chemotherapeutic 
agents such as Pt could be arising due to collapsed replication forks. Replication 
forks refer to the region where daughter strands are synthesised during the 
replication process. It requires the unwinding of DNA parental double helix by 
specific DNA helicases in order to synthesise the complementary strand and this 
process can be halted by the presence of an ICL (i.e. such as those induced by Pt) 
which would prevent the unwinding of the parental DNA strands. There is no direct 
evidence supporting the formation of DSBs as an initial form of damage post 
treatment with the ICL-inducing agent Pt (Olive and Banath 2009).  Similarly Clingen 
et al, (2008) determined that DSBs were initiated in both Chinese hamster and 
human ovarian cancer calls in response to the formation of ICLs to mediate repair 
of these lesions which caused a concomitant increase in γ-H2AX foci.   
 This study investigated the cytotoxicity of three chemotherapeutic drugs, Pt, 
HN2 and Adr by measuring γ-H2AX foci induction. HN2 is a bifunctional alkylating 
agent which is capable of forming both intrastrand and interstand crosslinks (Rink 
and Hopkins 1995). Pt is a platinum based compound whose main form of 
cytotoxicity is exerted by covalently linking the two DNA strands; forming an 
interstrand crosslink (Siddik 2003). Adr is known to exert its toxicity through 
multiple mechanisms such as inhibition of Topoisomerase II and intercalation with 
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DNA (Hawtin et al. 2010).  These agents also may induce other forms of DNA 
damage such as oxidative stress; however any such damage is considered 
secondary to the main mechanisms mentioned above. The three cell lines utilised in 
this study; MRC5-SV1, AT5BIVA and NB1-HTERT, were all seen to exhibit a different 
γ-H2AX induction and repair profile in response to each drug. These findings show 
that even in two cell lines with no known DNA repair defects, MRC5-SV1 and NB1-
HTERT, the level of resistance varied greatly in response to treatment with the 
same drug. These findings further emphasizes the need for development of 
individualised therapies based on personal responses to treatment regimens 
(Schwaiger and Peschel 2006).  
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5.2 Results  
 HN2 Dose Response 5.2.1
 Induction of γ-H2AX associated fluorescence was measured in each of the 
cell lines post treatment with 0.5, 1.5 and 2.5 μg/mL HN2 for 1 hr.  A nuclear 
morphology mask applied to the cells to determine the intensity of AF488 
(indicative of γ-H2AX) in the nucleus. The resulting dose response curve seen in 
Figure 5.1 shows that the level of relative fluorescence increases in all three cell 
lines as the dose of HN2 is increased.  
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Figure 5.1: Relative fluorescence levels of cells post exposure to increasing doses 
of HN2  
 
The relative levels of nuclear fluorescence exhibited in the three cell lines post treatment with 
increasing doses of HN2 ranging from 0.5 - 2.5 μg/mL. Relative fluorescence was calculated by 
dividing actual fluorescence levels seen at each time point by the fluorescence exhibited in the 
control cells for each cell line. All cells were fixed 24 hrs post treatment and it can be seen that 
there is an increase in relative florescence as the dose of HN was increased.   
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 γ-H2AX Foci quantification post treatment with HN2 5.2.2
 The average number of foci per cell in each of the three cell lines post 1 
hour treatment with HN2 was analysed and quantified using the ImagestreamX. γ-
H2AX foci were enumerated by applying a Morphology (nuclear region of cell) and 
Peak (AF488 staining representing γ-H2AX foci) mask to each of the cell images 
produced for each time point as described elsewhere in Section 2.4.7. The results 
are shown in Figure 5.2. The total nuclear fluorescence was also determined for 
each of the cell lines and is shown in Figure 5.3.  
 In untreated cells, the mean number of foci per nucleus is 2.24 for the 
MRC5-SV1 fibroblasts and 5 for the NB1-HTERT cells while a mean number of 3.58 
foci were seen in the AT5BIVA cell line. Following a 1 hr treatment with HN2, the 
induction of γ-H2AX was observed at 5 different times over a 48 hour period. There 
was a variance in the behaviour of these cell lines with each cell line showing a 
different time scale for the peak of γ-H2AX foci induction. By 5 hrs post treatment 
with 0.2 μg/mL HN2, the AT5BIVA cell line exhibited the peak of γ-H2AX foci 
formation with a mean number of 4.17 foci per cell. The NB1-HTERT cell line 
showed a peak of γ-H2AX foci formation at 24 hrs after treatment with 0.3 μg/mL 
HN2; exhibiting an average of 7.55 foci per cell. The most dramatic increase in γ-
H2AX foci induction was seen in the MRC5-SV1 cell line with an average of 13.51 
foci noted at 30 hrs post treatment with 0.5 μg/mL HN2. However by 48 hrs, all cell 
lines showed that the majority of these γ-H2AX foci have disappeared; exhibiting 
similar levels to their respective control samples. This was presumed to be 
indicative that the damage exerted by HN2 has now been repaired.      
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 The total nuclear fluorescence was also determined for each of the cell lines. 
It was seen the patterns of fluorescence appear to closely correlate to the number 
of γ-H2AX foci calculated in each cell line; i.e. a dramatic increase in foci seen at 
24 hrs (calculated as approximately 6 times higher than the control sample) in the 
MRC5-SV1 cell line was mimicked by a 7 fold increase in the level of fluorescence 
seen at the same time point.  
 Analysis of variance (ANOVA) was used to determine whether there was a 
significant difference in the distribution of foci over the 48 hour time period. 
Comparison of the three cell lines showed that the behaviour of each cell line was 
significantly different (p<0.001), refer to Table 5.1 below.  
Table 5.1: ANOVA Statistical Analysis of foci distribution in cell lines treated with 
HN2 
Cell line F P-value 
AT5BIVA v NB1-HTERT 1970.942 <0.001 
AT5BIVA v MRC5-SV1 5005.1 <0.001 
NB1-HTERT v MRC5-SV1 5415.05 <0.001 
The F value is obtained by dividng the variance of the group 
means by the mean of within group variances. It allows for 
testing of the hypthoesis that variance due to treatment is 
significantly larger than the variance due to experimental 
error.  
The relative fold increases in γ-H2AX foci induction were also calculated and are 
shown in Figure 5.4. The AT5BIVA and NB1-HTERT showed modest fold changes at 
24 hrs in comparison to the MRC5-SV1 cell line which indicated a 6 fold increase 
when compared to the untreated control sample. At 48 hrs, majority of foci 
induction seen in all cell lines at 24 hrs has disappeared.    
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Figure 5.2: Average foci numbers over a 48 hour period post treatment with HN2 
 
The mean number of γ-H2AX foci seen in MRC5-SV1, NB1-HTERT and AT5BIVA cell lines over a 48 
hour period post treatment with 0.5, 0.3 and 0.2 µg/mL to HN2. Error bars represent the standard 
error of the mean derived from three independent experiments. Standard error was calculated by 
dividing the standard deviation of the mean by the square root of the number of cells counted for 
each sample. There is a vast increase in the number of γ-H2AX foci at 24 hrs and 30 hrs for the 
MRC5-SV1 cell line. Although not as dramatic, there is an increase in the number of γ-H2AX foci 
seen at 24 hrs for the NB1-HTERT cell line in comparison to the control. The AT5BIVA cell line 
showed a modest increase in γ-H2AX foci across the 48 hour period. The number of γ-H2AX foci 
seen at 48 hrs in all cell lines has returned to similar levels to that seen in the control samples of 
these cell lines. *** ANOVA analysis of the foci distribution indicates a significant difference 
between the three cell lines (p value = <0.001) 
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The relative levels of nuclear fluorescence exhibited in the cell lines post treatment HN2 
treatment. Relative fluorescence was calculated by dividing actual fluorescence levels seen at each 
time point by the fluorescence exhibited in the control cells for each cell line. A dramatic increase 
in fluorescence was exhibited by the MRC5-SV1 cell line at 30 hrs post treatment with 0.5 µg/mL 
HN2, indicating the presence of γ-H2AX foci in the cell nuclei. AT5BIVA cells showed the peak of 
fluorescence at 5 hrs post treatment with 0.2 µg/mL HN2 whilst this was seen at 24 hrs post 
treatment with 0.3 µg/mL HN2 in NB1-HTERT cells. At 48 hrs post treatment, relative fluorescence 
levels of NB1-HTERT cells and AT5BIVA cells have returned to similar levels exhibited by the 
control samples while the MRC5-SV1 cell line still displayed fluorescence levels at approximately 
2.4 fold of the control sample. Error bars represent the standard error of the mean where 
approximately 10000 cells were collected from three independent experiments. Standard error 
was calculated by dividing the standard deviation of the mean by the square root of the number 
of cells counted for each sample   
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Figure 5.4: Relative fold changes in cell lines post treatment with HN2 
 
The fold increase in foci numbers were calculated for each of the cell lines by dividing the foci 
counts seen at 24 hrs and 48 hrs by the foci counts calculated for each of the control samples. The 
foci counts of the control samples were normalised to 1. The AT5BIVA cell line shows a 1.2 fold 
increase at 24 hrs while the MRC5-SV1 cell line shows a 6 fold increase at the same time point. The 
NB1-HTERT cell line shows a 1.5 fold increase at 24 hrs and this has decreased to -0.5 fold of the 
control at 48 hrs. The AT5BIVA cell line also shows a decrease below the control at 48 hrs. 
However the MRC5-SV1 cell line shows a 1.6 fold increase in comparison to the untreated control 
at 48 hrs.  
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 γ-H2AX Foci quantification post treatment with Pt 5.2.3
 The average number of foci per cell in each of the three cell lines post 1 hr 
treatment with Pt was analysed and quantified using the ImagestreamX as depicted 
in Figure 5.5. γ-H2AX foci were enumerated as described in section 2.4.7.   
 In untreated cells, the mean number of foci per nucleus is 3.59 for the 
MRC5-SV1 fibroblasts and 3.93 for the NB1-HTERT cells while a mean number of 
2.88 foci were seen in the AT5BIVA cell line. The three cell lines exhibited different 
DNA repair profiles in response to the Pt treatment. The MRC5-SV1 cell line showed 
a peak of γ-H2AX foci induction at 48 hrs post treatment with 12 μg/mL Pt. In 
contrast, the NB1-HTERT cell line indicated that the peak of γ-H2AX foci induction 
was at 24 hrs post treatment with 6 μg/mL Pt and most of the γ-H2AX foci have 
disappeared at 48 hrs. The AT5BIVA cell line also showed peak of γ-H2AX foci at 24 
hrs post treatment with 7 μg/mL Pt.  
 The fold increases in foci induction are higher for the AT5BIVA cell line at 6 
hrs and 24 hrs in comparison to the NB1-HTERT cell line, which is shown in Figure 
5.7. However at 48 hrs and 72 hrs, both cell lines show similar fold changes which is 
corroborated by similar relative nuclear fluorescence seen at these times points, 
seen in Figure 5.6. 
 By 72 hrs, both the AT5BIVA cell line and NB1-HTERT cell lines show γ-H2AX 
foci have returned to levels similar to that exhibited by their control samples whilst 
the MRC5-SV1 cell line still exhibits foci levels at a 1.6 fold increase in comparison 
to the untreated control.  Relative fluorescence levels measured for the cell lines 
showed similar increments in relation to the foci counts and is shown in Figure 5.5. 
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ANOVA statistical analysis showed a significant difference in the distribution of foci 
over the 72 hour time period in all cell lines (Refer to Table 5.2).  
Table 5.2: ANOVA Statistical Analysis of foci distribution in cell lines treated with 
Pt 
Cell line F P-value 
AT5BIVA v NB1-HTERT 1424.84 <0.001 
AT5BIVA v MRC5-SV1 1876.061 <0.001 
NB1-HTERT v MRC5-SV1 1673.32 <0.001 
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Figure 5.5: Average foci numbers over a 72 hour period post treatment with Pt 
 
The average foci numbers seen in the three cell lines over a 72 hr period. A similar pattern of 
repair is seen in the AT5BIVA and NB1-HTERT cell lines with a peak of foci induction seen at 24 hrs 
post treatment with 7 and 6 µg/mL Pt respectively and complete repair being seen at 72 hrs. The 
MRC5-SV1 cell line shows a peak of foci induction at 48 hrs post treatment with 12 µg/mL  Pt and 
still shows foci retention at 72 hrs with a 2 fold increase seen in comparison to its control sample. 
Error bars represent the standard error of the mean where approximately 10000 cells were 
collected from three independent experiments. Standard error was calculated by dividing the 
standard deviation of the mean by the square root of the number of cells counted for each 
sample. *** ANOVA analysis showed significant differences between each of the three cell line (p 
value = <0.001)  
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Figure 5.6: Relative fluorescence levels of cells post 1 hour treatment with Pt 
 
The relative levels of nuclear fluorescence exhibited in the three cell lines. Relative fluorescence 
was calculated by dividing actual fluorescence levels seen at each time point by the fluorescence 
exhibited in the control cells for each cell line. The NB1-HTERT cell line shows a peak of 
fluorescence at 24 hrs while the AT5BIVA cell line peaks at 30 hrs. The MRC5-SV1 samples show a 
peak of fluorescence being achieved at 48 hrs.  At 48 hrs post treatment, the NB1-HTERT cells and 
AT5BIVA cells show a drop in fluorescence and at 72 hrs, levels of fluorescence have returned to 
similar levels exhibited by the control samples while the MRC5-SV1 cell line still showed 
fluorescence levels at over 2.5 fold of the control sample. Error bars represent the standard error 
of the mean where approximately 10000 cells were collected from three independent 
experiments. Standard error was calculated by dividing the standard deviation by the square root 
of the number of cells counted for each sample   
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Figure 5.7: Relative fold changes of γ-H2AX foci in cell lines post treatment with Pt 
 
The fold increase in foci numbers were calculated for each of the cell lines by dividing the foci 
counts seen at 6, 24, 48 and 72 hrs by the foci counts derived for each of the control samples. The 
foci counts of the untreated controls were normalised to 1. At 6 hrs and 24 hrs, the cell lines all 
showed a similar pattern of an increase in foci induction although actual fold increases in foci 
differed between the three cell lines. However it can be seen that at 48 hrs, the AT5BIVA and NB1-
HTERT both started to show a reduction in foci numbers while the MRC5-SV1 cell line foci 
induction increased in comparison to the 24 hour time point. By 72 hrs, AT5BIVA and NB1-HTERT 
indicate that foci counts had dropped below levels observed in their untreated controls. The 
MRC5-SV1 cell line also showed a decrease in foci induction at this time point although it was still 
at a 1.6 fold increase in comparison to the untreated control.  
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 γ-H2AX Foci quantification post treatment with Adr 5.2.4
 The average number of foci per cell in each of the three cell lines post 1 hr 
treatment with Adr was analysed and quantified using the ImagestreamX as 
depicted in Figure 5.8. γ-H2AX foci were enumerated by the masking strategy 
described in Section 2.4.7.   
 In response to treatment with Adr, all cell lines exhibited peaks of γ-H2AX 
foci at 24 hrs. In the NB1-HTERT and MRC5-SV1 cell line, levels of γ-H2AX foci then 
proceeded to decline at the subsequent times points examined after 24 hrs. 
However the AT5BIVA cell line which averaged 9.42 foci at 24 hrs showed a 
decreased foci count at 30 hrs but showed an increased foci count of 9.09 at 48 hrs. 
Nevertheless, all cell lines had decreased to levels similar or below their untreated 
controls at 72 hrs. Relative nuclear fluorescence was also calculated for these cell 
lines (Refer to Figure 5.9) and appeared to correlate with the pattern of foci 
induction seen in the AT5BIVA cell line. However with respect to the NB1-HTERT cell 
line, the peak of fluorescence was seen at 12 hrs post treatment with 1.6 fold 
increase. At 24 hrs, the fluorescence levels have decreased to a 1.38 fold increase in 
comparison to the untreated control. Similarly the MRC5-SV1 cell line exhibited a 
peak of foci induction at 24 hrs but the peak of relative fluorescence was observed 
at 30 hrs. 
 Increases in foci induction were also calculated as fold changes at the 
following time points; 6 hr, 24 hr, 48 hr and 72 hr and expressed in relation to the 
individual control samples for each cell line (Refer to Figure 5.10). The AT5BIVA cell 
appeared to show the highest induction of γ-H2AX foci with a 1.7 fold increase seen 
at the 24 hr time point. At 24 hrs, the MRC5-SV1 cell line showed a 1.3 fold increase 
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in γ-H2AX foci induction and by 48 hrs, results indicated DNA repair is already 
complete with foci induction below the level seen in the untreated control. This was 
further correlated by the relative nuclear fluorescence data which showed a steep 
drop from the 30 hr time point to the 48 hour time point. The NB1-HTERT cell also 
showed a 1.3 fold increase in γ-H2AX foci at 24 hrs and at 72 hrs, foci induction has 
dropped below the level observed in the untreated control. Application of the 
ANOVA statistics revealed significant differences in foci distribution between each 
of the cell lines (p = <0.001). 
 
Table 5.3 ANOVA Statistical Analysis of foci distribution in cell lines treated with 
Adr 
Cell line F P-value 
AT5BIVA v NB1-HTERT 439.49 <0.001 
AT5BIVA v MRC5-SV1 361.87 <0.001 
NB1-HTERT v MRC5-SV1 320.63 <0.001 
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Figure 5.8: Average foci numbers over a 72 hour period post treatment with Adr 
 
The average foci numbers seen in the three cell lines over a 72 hour period post 1 hour treatment 
with Adr. All three cell lines show the peak of foci induction at 24 hrs post treatment, NB1-HTERT 
being treated with 93 ng/mL Adr, AT5BIVA with 84 ng/mL Adr and MRC5-SV1 with 56 ng/mL. By 
48 hrs, the MRC5-SV1 cell line has dropped to levels below that of its untreated control and the 
NB1-HTERT exhibits a similar characteristic at 72 hrs. The AT5BIVA cell line shows some foci 
retention at 72 hrs with a 1.2 fold increase seen in comparison to its control sample. Error bars 
represent the standard error of the mean where approximately 10000 cells were collected from 
three independent experiments. Standard error was calculated by dividing the standard deviation 
by the square root of the number of cells counted for each sample. *** ANOVA analysis showed 
significant differences between each of the three cell line (p value = <0.001)     
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Figure 5.9: Relative fluorescence levels of cells post 1 hour treatment with Adr 
 
The above shows relative fluorescence levels of cell lines post 1 hour treatment with their relative 
IC50 doses (93ng/mL NB1-HTERT, 84ng/mL AT5BIVA, 56 ng/mL MRC5-SV1). It was seen that the 
AT5BIVA cell line showed the highest induction of fluorescence with a 2 fold increase seen at the 
peak of foci formation at 24 hrs. In the MRC5-SV1 cell line, it can be seen that the peak of 
fluorescence is seen at 30 hrs and there is a steep decline in fluorescence in the next sample 
collected at 48 hrs. Standard error was calculated by dividing the standard deviation by the square 
root of the number of cells counted for each sample   
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Figure 5.10: Relative fold changes of γ-H2AX foci in cell lines post treatment with 
Adr 
 
The fold increase in foci numbers were calculated for each of the cell lines by dividing the foci 
counts seen at 24 hrs and 48 hrs by the foci counts calculated for each of the control samples. The 
foci counts of the control samples were normalised to 1. The AT5BIVA cell line shows 
approximately 1.8 fold increase at 24 hrs while the MRC5-SV1 and NB1-HTERT cell lines show a 1.3 
fold increase at the same time point. At 48 hrs, the AT5BIVA cell line still shows a similar increase 
while the NB1-HTERT cell shows a 1.2 fold increase. The MRC5-SV1 cell line has decreased to levels 
below that observed in its untreated control. At 72 hrs, the AT5BIVA cell line still indicates some 
foci retention with a fold increase of approximately 1.2 in comparison to its untreated control 
while the other two cell lines exhibit foci levels below their untreated controls.   
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Figure 5.11: Typical distributions of γ-H2AX foci in cell nuclei post 1 hour 
treatment with HN2 
 
The above shows typical distributions of γ-H2AX foci in MRC5-SV1 cells post 1 hour treatment with 
HN2. Figure 5.11A depicts the distribution seen in the control cells and as expected, the peak of 
the histogram is seen closer to the left of the graph, representing that a higher proportion of the 
cells had 0 -10 foci and no cells had more than 25 foci. The peak gradually shifts over the next 24 
hrs, (5.11B and 5.11C) and at 24 hrs represented in 5.11D, the peak of the histogram is seen to 
have shifted towards the centre of the graph, an indication that a higher proportion of the cells 
now had between 10 and 25 foci and the maximum number of foci had increased to 40 foci. By 48 
hrs (5.11F), the distribution of γ-H2AX foci had returned to similar levels seen in the control 
sample; thereby indicating that damage induced by the HN2 treatment had now been repaired.  
 
 Figure 5.11 above depicts an example of the histograms that were 
generated with the IDEASTM software when the Spot Mask (described in Section 
5.26) was applied to the images collected by the Inspire software. These histograms 
depict the distribution of γ-H2AX foci for the samples collected at different time 
points. It was noted that the distribution gradually started shifting to the right in 
the samples collected at 3 and 5 hrs with a more symmetrical appearance seen at 
24 and 30 hrs. At 48 hrs, the distribution of foci looks similar to the untreated 
control.  
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Figure 5.12: Comparison of foci numbers seen in the MRC5-SV1 cell line post 
treatment with chemotherapeutic drugs 
 
The average foci numbers seen in the MRC5-SV1 cell lines over a 72hr period post 1 hour 
treatment with different chemotherapeutic drugs. It was seen that the highest induction of foci 
was seen post treatment with 0.5 µg/mL HN2 at 24 hrs. By 48hrs, γ-H2AX foci levels had returned 
to similar levels to the untreated control. Interestingly, treatment with 12 µg/mL Pt led to the 
peak of γ-H2AX foci formation at 48hrs. However by 72 hrs, it can be seen that γ-H2AX foci levels 
have returned to similar levels as the untreated control. Post treatment with 56 ng/mL ADR, the 
peak of γ-H2AX foci formation was seen at 24 hours but foci induction was not as high as seen 
post treatment with HN2.  
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Figure 5.13: Comparison of foci numbers seen in the NB1-HTERT cell line post 
treatment with chemotherapeutic drugs 
 
 
The average foci numbers seen in the NB1-HTERT cell lines over a 72hr period post 1 hr treatment 
with different chemotherapeutic drugs. It was seen that the highest induction of foci was seen 
post treatment with 93 ng/mL ADR at 24 hrs. A similar level of induction of γ-H2AX foci was seen 
in response to treatment with both cross-linking agents, HN2 ( treated with 0.3 µg/mL) and Pt 
(treated with 6 µg/mL).   
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Figure 5.14: Comparison of foci numbers seen in the AT5BIVA cell line post 
treatment with chemotherapeutic drugs 
 The average foci numbers seen in the AT5BIVA cell lines over a 72hr period post 1 hr treatment 
with different chemotherapeutic drugs. Little change was seen across the 48 hr period post 
treatment with HN2. Post treatment with 7 µg/mL Pt and 84 ng/mL Adr, there was a clear peak of 
γ-H2AX foci formation seen at 24 hrs. With all drugs, γ-H2AX levels returned to similar levels to 
the untreated control by the end of the 2 or 3 day period.     
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5.3 Discussion 
 This study looked at the response of three cell lines to three different 
chemotherapeutic agents; Pt, HN2 and Adr by analysing γ-H2AX foci induction. Two 
of the cell lines, MRC5-SV1 and NB1-HTERT are repair normal cell lines with no 
known DNA repair defects. The AT5BIVA cell line which was derived from an Ataxia 
Telangiectasia patient is known to have a defect in the ATM gene which is involved 
in the initial stages of repairing DSBs (Friesner et al. 2005) and exhibits sensitivity to 
IR (Bourton et al. 2012). However the results obtained for this cell line did not seem 
to exhibit an increased sensitivity to the chemotherapeutic agents used. ATM is 
known to be involved in the signalling cascade for DSBs but it is known that ATR 
rather than ATM becomes phosphorylated in response to other types of DNA 
damage such as the formation of cross-links to initiate repair (Harper and Elledge 
2007). Furthermore it has been shown that inhibition of ATR in a human cancer cell 
line, DLD-ATR-Seckel was seen to enhance the effects of a range of anti-cancer 
agents such as 5-FU, Pt and Adriamycin (Wilsker and Bunz 2007). Therefore it may 
be likely that that the DNA repair mechanisms and responses of ATM-deficient cells 
such as the AT5BIVA cell line may not be sensitive to agents that do not form 
double strand breaks as their primary mechanism of exerting cytotoxicity. There is 
limited literature regarding chemosensitivity in A-T patients but a case study carried 
out by Tamminga et al (2002)  on a 14 year old A-T patient revealed limited 
sensitivity to the anticancer agents, Vincristine, Predisnone and Adriamycin. 
However this was only seen after doses was adjusted to a third of normal dosage 
levels found. This again emphasises the need for a bigger cohort of cell lines in 
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order to fully understand the DNA repair mechanisms involved in the repair of 
chemotherapy-induced damage. 
 With all drugs, the peak of γ-H2AX foci induction was seen 24 to 48 hrs after 
the 1 hr treatment in both the MRC5-SV1 and NB1-HTERT cell line. This was also 
seen in the AT5BIVA cell line post treatment with Pt and Adr. However post 
treatment with HN2 in the AT5BIVA cell line, the peak of H2AX foci formation was 
seen at 5 hrs with modest changes seen in the ensuing period. These findings are in 
line with other studies which suggest γ-H2AX foci induction in response to 
chemotherapeutic agents which do not form direct DSBS; primarily cross-linking 
agents such as Pt, is indicative of DSBs being formed during the course of DNA 
repair (Clingen et al. 2008),(Olive and Banath 2009). Based on this assumption, it 
was observed that 48 hrs after treatment with HN2, complete DNA repair was 
observed in the AT5BIVA and NB1-HTERT cell line due to the disappearance of the 
majority of the γ-H2AX foci. The MRC5-SV1 cell line still indicated foci retention but 
as the induction of H2AX foci at 24 hrs was so dramatic, it was assumed that DNA 
repair was nearing completion at 48 hrs as there was an approximately 70% 
decrease in foci in comparison to the foci count observed at 24 hrs. HR is required 
for the repair of the lesions formed and this repair pathway functions during the 
S/G2 phase of the cell cycle. This may provide an explanation for the peak of γ-
H2AX foci being seen at either 24 or 48 hrs after treatment and further supports the 
theory that γ-H2AX foci is indicative of DNA repair taking place. 
 When treated with Pt, it was observed that the repair process took 72 hrs to 
complete in the MRC5-SV1 cell line but only 48 hrs in the other two cell lines. As the 
other two cell lines exhibited increased sensitivity to Pt as seen from the results of 
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the clonogenic assays; these results may be indicative that the Pt administered 
during treatment was becoming inactivated through cellular defence mechanisms 
(Godwin et al. 1992).  Pt is a highly reactive compound once it undergoes hydrolysis 
(Siddik 2003) but this also makes it vulnerable to endogenous nucleophiles such as 
glutathione and metallathionein. Cellular levels of glutathione have been shown to 
be increased in the presence of DNA damaging agents and attempts to protect the 
DNA are made by binding to the drug and thereby reducing its rate of reaction 
(Godwin et al. 1992). In response to Adr, peak formation of γ-H2AX foci was also 
seen at 24 hrs in all cell lines post 1 hour treatments with their relevant IC50 doses 
and repair was completed by the end of the 72 hour time period in the NB1-HTERT 
and AT5BIVA cell lines. However in the MRC5-SV1 cell line, repair had completed by 
the end of the 48 hour time period.  
 Each of these cell lines were treated with the individual IC50 doses derived 
from the clonogenic assays. This allowed for a comparable assay where each drug 
exerted the same level of cytotoxicity on all the cell lines. Significantly different 
DNA repair profiles were identified for each of the cell lines examined. There is a 
trend that has emerged from this data in that the cell line exhibiting the highest 
level of resistance to each individual drug was also seen to exhibit the highest 
number of foci at each time point sampled. The MRC5-SV1 cell line exhibited the 
highest level of resistance to Pt and HN2 as determined by the clonogenic assays 
(detailed in Chapter 4) and it also showed the highest induction of γ-H2AX foci in 
response to treatment with both of these cross-linking agents. The NB1-HTERT cell 
line exhibited the highest resistance to Adr and this also showed the highest 
induction of γ-H2AX foci in response to treatment with this drug. There are a 
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number of reasons that this could be occurring; however it is most likely to be 
indicative of increased rate of DNA repair in these cell lines. Studies such as Clingen 
et al, (2007) and Niedernhofer et al, (2004) have shown the accumulation of γ-H2AX 
foci in response to treatment with chemotherapeutic agents such as Pt and 
Mitomycin C and furthermore Clingen et al, (2008) revealed a persistence of γ-H2AX 
foci in chemo-sensitive cell lines. It has been established that γ-H2AX foci forms in a 
1:1 ratio with DSBs (Sedelnikova et al. 2002) and H2AX phosphorylation in response 
to treatment with agents such as Pt is indicative of strand breaks being formed 
during the repair process (Dickey et al. 2009) . Therefore it could be theorised that a 
higher number of γ-H2AX foci being seen in response to treatment with 
chemotherapeutic agents could represent an increased rate of DNA repair. 
 A smaller cohort of cell lines was initially selected in order to develop this 
assay in a manageable way and it has revealed some interesting data. However 
there is a clear need to increase the cohort size in order to elucidate firm trends in 
γ-H2AX foci expression levels in response to treatment with chemotherapeutic 
drugs.  
To gain further understanding into the induction of γ-H2AX foci in response to anti-
cancer agents, resistant cell lines will be developed using two of the parental cell 
line employed in this chapter; MRC5-SV1 and NB1-HTERT. This is detailed and 
discussed further in the following chapters.  
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Chapter 6  
Analysis of DNA repair in human cell 
lines made resistant to the ICL agent 
HN2  
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6.1 Introduction 
 Development of resistance to chemotherapeutic drugs poses a serious 
limitation to the effectiveness of this form of treatment (Boehm et al. 1997; 
Carvalho et al. 2010) This was highlighted by Agarwal and Kaye 2003 (Agarwal and 
Kaye 2003) who noted that that acquiring resistance to Pt accounted for treatment 
failure and deaths in up to 90% of patients with ovarian cancer. They found that 
70% of patients responded well to initial Pt-based therapies but this figure declined 
to only 15- 20% survival rates at the end of a 5 year period. Similar statistics were 
established by Coley, (2008) who reviewed the prognosis of patients with 
metastatic breast cancer. Initial response rates to chemotherapy were seen in 30 - 
70 % of patients but this declined to 20 - 30% of patients with disease progression 
who entered into a second round of chemotherapy. Ultimately 90% of deaths were 
accountable to the development of resistance to chemotherapy in metastatic 
breast cancer patients.  
 Resistance can develop in many ways. To some extent, genetic instability 
and increased mutational rates of tumour cells attributes to this (Boehm et al. 
1997). However there are numerous other mechanisms that have been proposed 
that lead to the development of drug resistance. Repeated exposures to a single 
neoplastic agent often can lead to the development of cross-resistance to drugs 
which have similar mechanisms of action; i.e. it has been seen that patients that 
acquire resistance to Pt often develop cross-resistance to other cross-linking agents 
(Siddik 2003). Tumours which exhibit this are known as having a multi-drug 
resistant phenotype. The development of cross-resistance indicates that similar 
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pathways may be activated in response to these drugs to protect the cellular DNA 
from damage and undergoing apoptosis.   
 Increased drug efflux may serve as another mechanism of drug resistance as 
this prevents the cell from intracellular accumulation of anticancer agents. P-
glycoprotein (P-gp), a membrane transporter protein encoded by the MDR1 gene, 
normally functions as a barrier to the uptake of xenobiotics but has the capacity to 
export anticancer agents from cells (Fojo and Coley 2007). The majority of 
chemotherapeutic agents widely used have compounds which serve as a substrate 
for P-gp and the overexpression of the MDR1 gene has been found to lead to P-gp 
preventing the intracellular accumulation of the drug (Lorico et al. 1996).  
 The multi-drug resistant protein 1 (MRP1) belongs to a family of 11 
membrane transporters and there is increasing evidence that these transporters 
can also contribute to the development of drug resistance (Fojo and Coley 2007). 
Lorico et al, (1996) demonstrated that a double knockout of the MRP gene lead to 
an increased sensitivity to chemotherapeutic agents whilst Rudas et al, (2003) 
established an increase in the level of MRP1 after the administration of 
chemotherapy. Taken together, these findings very likely mean that over-
expression of the MRP gene could lead to the development of drug resistance. This 
was established by Cui et al, (1999) who demonstrated that over-expression of 
MRP2 lead to the development of resistance towards Pt and Adr amongst other 
drugs  
Cellular mechanisms such as increased drug inactivation by cellular 
metabolites such as Glutathione, increased levels of DNA repair or evasion of 
apoptosis may also lead to the development of acquired resistance (Banath and 
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Olive 2003; Siddik 2003). This inherent resistance can then be transferred to 
daughter cells during mitosis (Goldie and Coldman 1983).  
 This study will be focussing on the repair kinetics of resistant, sensitive and 
normal cell lines in response to treatment with ICL-inducing agents. Table 6.1 below 
shows different types of ICL inducing agents. ICL formation only accounts for a small 
proportion of the total number of DNA adducts with intrastrand cross-link 
formation being the primary form of DNA adduct formed; in the case of Pt, this 
accounts for approximately 90% of adduct formation (Crul et al. 2003). 
Nevertheless, the formation of ICLs is the main mechanism of cytotoxicity in these 
drugs due to the impairment of strand separation which in turn inhibits key cellular 
processes such as transcription and replication (Deans and West 2011). 
 
Table 6.1: Different classes of ICL-inducing agents (adapted from (de Jager et al. 
2001)) 
ICL Agent 
Primary 
Target 
% of DNA 
adducts in 
cell 
Distortion of 
DNA helix 
Cisplatin G - G 5 – 8 Major 
Nitrogen Mustard G - G 1 – 5 Major 
Psolaren T - T 30 - 40 Minor 
Mitomycin C G-G 5 – 13 Minor 
Carmustin G-C <8 Unknown 
  
 The main mode of repair for ICLs is mediated through the association of two 
different DNA repair pathways, NER and HR. ERCC1-XPF is a structure specific 
endonuclease involved in the excision process in NER and has been shown to be the 
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only two NER proteins to have key roles in the repair of ICLs. This has been 
determined by numerous studies such as De Silva et al, (2002) and Clingen et al, 
(2008). ERCC1-XPF plays a role in the repair of ICLs via the HR pathway. It is thought 
that the ERCC1-XPF complex is recruited to the site of damage by XPA (Al-Minawi et 
al. 2009). It incises one side 5’ of the DNA lesion and the other side is incised by 
XPG, thereby creating a DSB (Al-Minawi et al. 2009). This is supported by findings by 
Niedernhofer et al, (2004) who demonstrated that in mouse embryonic fibroblasts, 
ERCC1-XPF is not required to form DSBs after ICL damage but are crucial in resolving 
this damage. 
 A study by Clingen et al, (2008) examined the mechanisms of action involved 
in γ-H2AX expression after exposure to ICL agents. They found γ-H2AX foci were 
retained in DNA repair defective Chinese hamster cells in comparison to wild type. 
Furthermore they also showed a persistence of foci in chemo-sensitive human 
ovarian cancer cells in comparison to chemo-resistant cells. Therefore it highlighted 
the potential use of γ-H2AX as a marker of DNA damage induced by 
chemotherapeutic agents and concluded that the ability of cells to repair DNA ICLS 
could determine the level of sensitivity to anti-cancer agents such as Pt. The 
formation of DSBs can be detected by quantifying nuclear γ-H2AX foci and has been 
demonstrated to identify radiosensitivity in individuals (Bourton et al. 2011).   
 Understanding the mechanisms of actions that lead to resistance may 
provide useful knowledge in the development of new therapies with alternate 
mechanisms of action. As indicated above, there are diverse factors that could 
attribute towards the development of resistance. Furthermore the development of 
drug resistance accounts for a vast proportion of treatment failure and it can lead 
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to patients experiencing all the deleterious side effects of chemotherapy with no 
improvement in prognosis of the disease. This study focused on the use of multi-
spectral imaging flow cytometry to identify the expression of γ-H2AX in response to 
cross-linking agents such as HN2 and how this may differ between normal, resistant 
and sensitive patients. The development of biomarkers to monitor patient response 
to chemotherapy could lead to marked improvements in overall survival rates and 
help to isolate mechanisms of resistance in individual patients.  
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6.2 Results  
6.2.1 Clonogenic Assays 
 Colony counting and calculation of survival rates was carried out as detailed 
in Chapter 4 (refer to section 4.2.1 and 4.2.2). 
6.2.1.1 Determining IC50 values of HN2 
 The parental and resistant cell lines were exposed to a range of 
concentrations of HN2 from 0.5 μg/mL to 2.5 μg/mL. The GM08437B cell line 
(deficient in XPF) was exposed to a range of concentrations of HN2 from 0.1 μg/mL 
to 0.5 μg/mL. Figure 6.1 depicts the survival rates of all cell lines at their respective 
concentration ranges.  
 It was observed that the MRC5-SV1R cell line showed a 3 fold increase in 
resistance to HN2 in comparison to the parental cell line. Similarly the NB1-HTERTR 
cell line showed a 2.7 fold increase in resistance to HN2 in comparison to the 
parental cell line. As expected, the GM08437B cell line showed an increased 
sensitivity to the drug in comparison to all other cell lines observed with survival 
levels dropping below 5% at 0.5 μg/mL.  The IC50 was graphically determined for 
each of the cell lines and shown below in Table 6.2. The fold increase in resistance 
is shown in Table 6.3. 
Table 6.2: IC50 values for all cell lines post treatment with HN2 
Cell Line IC50 Value 
MRC5-SV1 Parental 0.5 μg/mL 
MRC5-SV1R 1.4 μg/mL 
NB1-HTERT 
Parental 
0.3 μg/mL 
NB1-HTERTR 0.82 μg/mL 
GM08437B 0.2 μg/mL 
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Figure 6.1: Comparing resistance of cell lines post 1 hour treatment with HN2 
 
The above shows the survival rates of all cell lines post treatment with HN2. It can be seen that 
the two resistant cell lines (indicated by the dotted lines) have an increased level of resistance to 
HN2 at all doses of the drug. The XPF deficient cell line (shown in purple) shows an increased 
sensitivity to the drug with a steep decline in survival seen as the dose of HN2 is increased. 
Standard error was calculated by dividing the standard deviation of the mean by the square root 
of the number of repeats.  
Table 6.3: Fold increase in resistance in resistant cell lines to HN2 in comparison 
to parental cell lines 
Cell line Fold increase in 
resistance 
MRC5-SV1R 2.8 
NB1-HTERTR 2.7 
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6.3.1.1 Determining IC50 values of Pt 
 The parental and resistant cell lines were exposed to a range of 
concentrations of Pt from 15 g/mL to 35 g/mL. The GM08437B cell line (deficient 
in XPF) was exposed to a range of concentrations of Pt from 4 g/mL to 20 g/mL. 
Figure 6.2 depicts the survival rates of all cell lines at their respective concentration 
ranges.  
 It was observed that the MRC5-SV1R cell line showed a 1.9 fold increase in 
resistance to HN2 in comparison to the parental cell line. The NB1-HTERTR cell line 
showed a 3.2 fold increase in resistance to HN2 in comparison to the parental cell 
line. The GM08437B cell line showed an increased sensitivity to Pt in comparison to 
the MRC5-SV1 parental cell line but showed that its resistance was higher to Pt than 
the NB1-HTERT parental cell line. The IC50 was graphically determined for each of 
the cell lines and shown below in Table 6.4. The fold increase in resistance is shown 
in Table 6.5. 
Table 6.4: IC50 values for all cell lines post treatment with Pt 
Cell line IC50 for Pt 
MRC5-SV1 Parental 12 μg/mL 
MRC5-SV1R 23 μg/mL 
NB1-HTERT Parental 6 μg/mL 
NB1-HTERTR 19 μg/mL 
GM08437B 7.8 μg/mL 
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Figure 6.2: Comparison of resistance in cell lines post 1 hour treatment with Pt 
 
The above shows the survival rates of all cell lines post treatment with Pt. It can be seen that the 
two resistant cell lines (represented by the dotted lines) have an increased level of resistance to Pt 
at all doses of the drug. The Gm08437B cell line shows an increased sensitivity to this cell line in 
comparison to one of the repair normal cell line MRC5-SV1 but not the other repair normal cell 
line NB1-HTERT. Standard error was calculated by dividing the standard deviation of the mean by 
the square root of the number of repeats. 
Table 6.5: Fold increase in resistance in resistant cell lines to Pt in comparison to 
parental cell lines 
Cell line Fold increase in 
resistance 
MRC5-SV1R 1.9 
NB1-HTERTR 3.2 
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6.3.1 γ-H2AX Foci quantification post treatment with HN2 in the NB1-HTERT, NB1-
HTERTR and GM08437B cell lines 
 The average number of foci per cell in each of the cell lines post 1 hr 
treatment with 0.3μg/mL HN2 was analysed and quantified using the Imagestream
X. 
γ-H2AX foci were enumerated by applying a Morphology and Peak mask as 
previously described. The results for the average foci numbers calculated for the 
NB1-HTERT, NB1-HTERTR and GM08437B cell lines are shown in Figure 6.3. The 
total nuclear fluorescence was also determined for each of the cell lines and is 
shown in Figure 6.4. 
 The NB1-HTERT parental cell line showed a lower number of γ-H2AX foci 
across the whole time period that was sampled in comparison to the NB1-HTERTR 
cell line. In the parental cell line, there is a sharp increase in foci number from 3 hrs 
to 5 hrs with an approximate 2 fold increase seen. In contrast, the resistant cell line 
shows little differences at the same time points.  
 In comparison to the untreated control, the NB1-HTERT parental cell line 
shows a 1.5 fold increase in foci induction at 24 hrs whilst the NB1-HTERT resistant 
cell line only shows a 1.1 fold increase in foci induction (Refer to Figure 6.5). At 48 
hrs, foci numbers in the parental cell line have decreased well below levels seen in 
the untreated control. However in the resistant cell line, foci numbers stay at a 1.2 
fold increase of the untreated control. 
 The GM08437B cell line exhibits the most dramatic induction of foci, 
showing a 2.4 fold increase in comparison to its untreated control. At 48 hrs, this is 
still 1.5 fold higher than the untreated control.    
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 Analysis of the total nuclear fluorescence for these three cell lines (Refer to 
Figure 6.4) showed that the repair normal NB1-HTERT and repair defective 
GM08437B cell lines resembled similar patterns of a peak of fluorescence at 24 hrs 
and by 48 hrs, this was seen to be declining. However the NB1-HTERTR cell line did 
not form any type of obvious peak when examined at the different time points and 
appeared to still be increasing at 48 hrs.  
 Analysis of variance (ANOVA) was used to determine whether there was a 
significant difference in the distribution of foci over the 48 hour time period. 
Comparison of the three cell lines showed that the distribution of γ-H2AX foci 
between the three cell lines were significantly different (p<0.001), refer to Table 6.6 
below.  
 
Table 6.6: ANOVA Statistics for foci distribution in the NB1-HTERT, NB1-HTERTR 
and GM08437B cell lines 
 F P-value F criteria 
NB1-HTERT 
parental v 
resistant 
1277.009 <0.001 2.214845 
Interaction 2.442791 0.03203 2.214845 
NB1-HTERT 
parental v 
GM08437B 
408.4305 <0.001 2.214845 
Interaction 304.5921 <0.001 2.214845 
NB1-HTERTR 
V 
GM08437B 
214.4096 <0.001 2.214845 
Interaction 93.4434 <0.001 2.214845 
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Figure 6.3: Average foci numbers over a 48 hour period in NB1-HTERT parental, 
resistant and GM0837B (XPF deficient) cell lines post treatment with HN2 
 
The mean number of γ-H2AX foci seen in NB1-HTERT, NB1-HTERT
R
 and GM08437B cell lines over a 
48 hr period post exposure to 0.3μg/mL HN2. Error bars represent the standard error of the mean 
derived from three independent experiments in which approximately 10000 cells were analysed at 
each time point for each cell line. Standard error was calculated by dividing the standard deviation 
of the mean by the square root of the number of cells counted for each sample There is a vast 
increase in the number of γ-H2AX foci at 24 hrs seen in the GM08437B cell line. Foci numbers for 
the NB1-HTERTR remain relatively similar over the 48 hr period while the NB1-HTERT parental cell 
line shows a clear pattern of induction and disappearance of γ-H2AX foci over the same time 
period. At 48 hrs, there is still a clear retention of foci seen in the GM08437B cell line. Standard 
error was calculated by dividing the standard deviation by the square root of the number of cells 
counted for each sample   
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Figure 6.4: Relative fluorescence levels of NB1-HTERT parental, resistant and 
GM0837B (XPF deficient) cell lines post 1 hour treatment with HN2 
 
The relative levels of nuclear fluorescence exhibited in NB1-HTERT, NB1-HTERT
R
 and GM08437B 
cell lines post treatment with 0.3μg/mL HN2 treatment. Relative fluorescence was calculated by 
dividing actual fluorescence levels seen at each time point by the fluorescence exhibited in the 
control cells for each cell line. A dramatic increase in fluorescence was exhibited by the GM08437B 
cell line at 24 hrs post treatment. The NB1-HTERT parental and resistant cell line also peaked at 24 
hrs post treatment but at much lower levels. At 48 hrs post treatment, relative fluorescence levels 
of NB1-HTERT parental and resistant cell lines had returned to similar levels exhibited by the 
control samples. However the GM08437B cell line still showed a 2.5 fold increase in comparison to 
its control. Standard error was calculated by dividing the standard deviation by the square root of 
the number of cells counted for each sample. 
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Figure 6.5: Comparison of fold increases in NB1-HTERT parental, resistant and 
GM0837B (XPF deficient) cell lines cell lines at 24 hrs and 48 hrs   
 
The fold increase in foci numbers were calculated for each of the cell lines by dividing the foci 
counts seen at 24 hrs and 48 hrs by the foci counts calculated for each of the control samples. The 
foci counts of the control samples were normalised to 1. The NB1-HTERT parental cell line shows a 
1.5 fold increase at 24 hrs and this has decreased to -0.5 fold of the control at 48 hrs. The NB1-
HTERT
R
 cell line shows a modest induction of foci at 24 hrs and at 48 hrs, this remains at 1.2 fold 
compared to the control. In contrast, the GM08437B cell line shows a more substantial fold 
change at 24 hrs with the foci count more than doubled the count seen in its control sample and at 
48 hrs, this still remains at 1.54 fold increase in comparison to the control sample.  
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6.3.2 γ-H2AX Foci quantification post treatment with HN2 in the MRC5-SV1 and 
MRC5-SV1R cell lines 
 The average number of foci per cell in the MRC5-SV1 parental and resistant 
cell lines post 1 hr treatment with 0.5μg/mL HN2 was analysed and quantified using 
the ImagestreamX. γ-H2AX foci were enumerated by applying a Morphology and 
Peak mask as previously described. The average foci numbers are shown in Figure 
6.6. The total nuclear fluorescence was also determined for each of the cell lines 
and is shown in Figure 6.7. 
 The MRC5-SV1 parental cell line showed less than half the number of γ-
H2AX foci exhibited in the resistant cell line at the untreated control, 3 hrs, 5 hrs 
and 48 hrs. At 24 hrs, there is a clear increase in foci induction in the parental cell 
line and this is slightly higher than the resistant cell line. However the MRC5-SV1 
foci induction does not appear to exhibit any dramatic increases or decreases over 
the same time period. Analysis of relative fold changes over the 48 hour period 
indicated minor to little changes in the MRC5-SV1R cell line in comparison to the 
parental cell line (Refer to Figure 6.8) 
 Analysis of the total nuclear fluorescence showed that there was a large 
induction in fluorescence at 30 hrs post treatment in the MRC5-SV1 parental cell 
line and a sharp decrease between 30 hrs and 48 hrs. In comparison, the MRC5-
SV1R cell line depicted a largely straight line with a much smaller incline at the peak 
of fluorescence. These results exhibit a similar trend to that seen with the NB1-
HTERTR cell line.  
 Analysis of variance (ANOVA) was used to determine whether there was a 
significant difference in the distribution of foci over the 48 hour time period. The 
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results showed that the behaviour of the two cell lines were significantly different 
(p<0.001), refer to Table 6.7 below.  
Table 6.7: ANOVA Statistics of foci distribution on the MRC5-SV1 and MRC5-SV1R 
cell lines  
 
F 
P-
value 
F criteria 
MRC5-SV1 
parental v 
resistant 
200.0467 <0.001 2.214846 
Interaction 72.10537 <0.001 2.214846 
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Figure 6.6: Average foci numbers in the MRC5-SV1 parental and resistant cell lines 
over a 48 hour period post 1 hour treatment with HN2 
 
The mean number of γ-H2AX foci seen in MRC5-SV1 parental and resistant cell lines over a 48 hour 
period post exposure to 0.5 μg/mL HN2. In the MRC5-SV1 cell line, there is a clear peak of H2AX 
foci formation at 24 hrs which has largely disappeared by 48 hrs. However the MRC5-SV1
R
 does 
not exhibit a clear trend with foci numbers fluctuating across the time period examined. Error bars 
represent the standard error of the mean derived from three independent experiments in which 
approximately 10000 cells were analysed at each time point for each cell line. Standard error was 
calculated by dividing the standard deviation of the mean by the square root of the number of 
cells counted for each sample. 
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Figure 6.7: Relative fluorescence levels of the MRC5-SV1 parental and resistant 
cells post 1 hour treatment with HN2 
 
The relative levels of nuclear fluorescence exhibited in the MRC5-SV1 parental and resistant cell 
lines over a 48 hour period post exposure to 0.5 μg/mL HN2. Relative fluorescence was calculated 
by dividing actual fluorescence levels seen at each time point by the fluorescence exhibited in the 
control cells for each cell line. A dramatic increase in fluorescence was exhibited by the MRC5-SV1 
parental cell line at 30 hrs post treatment. A slight increase in fluorescence was also seen for the 
MRC5-SV1
R
 cell line at the same time point. A sharp decline in fluorescence was seen at 48 hrs for 
the MRC5-SV1 parental cell line. In comparison, the resistance cell line only exhibits a minor 
decrease in fluorescence. Standard error was calculated by dividing the standard deviation of the 
mean by the square root of the number of cells counted for each sample. 
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Figure 6.8: Comparison of fold increases in the MRC5-SV1 parental and resistant 
cell lines at 24 hrs and 48 hrs   
 
The fold increase in foci numbers were calculated for each of the cell lines by dividing the foci 
counts seen at 24 hrs and 48 hrs by the foci counts calculated for each of the control samples. The 
foci counts of the control samples were normalised to 1. The MRC5-SV1 cell line showed a 6-fold 
increase at 24 hrs and at 48 hrs, this has decreased to a 1.5 fold increase in comparison to the 
control cell line. The MRC5-SV1
R
 cell line does not show much change in foci induction across the 
same time period; showing a 1.1 fold increase at 24 hrs and 1.2 fold increase in comparison to the 
control at 48 hrs. 
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6.3.3 ERCC1 Foci quantification post treatment with HN2 in the NB1-HTERT, NB1-
HTERTR and GM08437B cell lines 
 ERCC1 expression levels were examined to determine whether changes seen 
in excision levels detected by γ-H2AX were due to an upregulation of the 
endonuclease ERCC1-XPF. ERCC1 foci were analysed and quantified using a Spot 
mask (set to visualise AF488 staining on Ch02) combined with a nuclear morphology 
mask (Created on Ch05 to visualise nuclear staining) as previously described in 
Chapter 2. 
 
Figure 6.9: Increasing numbers of ERCC1 Foci with increasing numbers of foci 
 
The above figure shows example images of ERCC1 shown in grey scale. Ch01 shown in the first 
column depicts the BF image of these cells with the morphology mask shown in blue which 
highlights the nuclei of the cells. Ch02 shown in the second column (representing AF488 staining of 
the ERCC1 foci) depicts the unmasked cells whilst the third column depicts the same images 
masked with the ERCC1 foci spot mask. Ch05 shows the morphology of the nucleus of these cells. 
 
 ERCC1 foci counts remained unchanged throughout the 48 hr time period in 
the NB1-HTERT parental cell line. There was an approximate 2 fold increase in 
ERCC1 foci seen in the untreated control sample of the NB1-HTERTR cell line in 
comparison to the untreated control of the parental cell line. ERCC1 foci counts 
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continually decreased in the NB1-HTERTR cell line over the 48 hr time period. The 
untreated control sample for the GM08437B cell line showed the lowest levels of 
ERCC1 foci in comparison to the other two cell lines. However at 24 hrs, there is a 
dramatic increase in ERCC1 foci levels seen in the GM08437B cell line with a 3.5 fold 
increase seen. These levels are seen to decrease at 48 hrs to levels similar to the 
untreated control. The overall nuclear fluorescence data shows a similar trend to 
the foci counts calculated for these cell lines.   
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Figure 6.10: Average ERCC1 foci counts over a 48 hour period post treatment with 
HN2 
 
The above shows the average ERRC1 foci numbers in NB1-HTERT, NB1-HTERT
R
 and GM08437B cell 
lines post 1 hour treatment with 0.3μg/mL HN2. ERCC1 foci levels are higher in the NB1-HTERT
R 
control cell line in comparison to the parental and resistant cell lines. Over the 48 hour time 
period, the foci count is seen to decrease in the resistant cell line. The NB1-HTERT parental cell line 
shows that ERCC1 expression stays relatively similar over the 48 hour period. In the GM08437B 
cell line, there is a 3.5 fold increase at 24 hrs in ERCC1 foci levels which is seen to decrease to a 1.5 
fold increase of the untreated control at 48 hrs.    
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Figure 6.11: Relative nuclear intensity of ERCC1 post treatment with HN2 
 
Relative ERCC1 nuclear fluorescence in NB1-HTERT, NB1-HTERT
R
 and GM08437B cell lines post 1 
hour treatment with 0.3μg/mL HN2. It was observed that fluorescence levels of the NB1-HTERT 
and NB1-HTERT
R
 parental cell line did not differ significantly over the 48 hour period. However in 
the GM08437B cell line, there was a nearly 10-fold increase in florescence observed at 24hrs which 
then decreased at levels similar to the untreated control at 48 hrs.  
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6.3.4 ERCC1 Foci quantification post treatment with HN2 in the MRC5-SV1 and 
MRC5-SV1R cell lines 
 ERCC1 foci were quantified by creating a Spot Mask using the Spot Wizard as 
detailed in Chapter 2.  
 ERCC1 foci counts remained unchanged between the untreated control and 
24 hour samples for the MRC5-SV1 parental cell line with a 1.2 fold increment in 
foci counts seen at the 48 hr time point. The MRC5-SV1R cell line showed a 2 fold 
increase in ERCC1 foci in its untreated control in comparison to the untreated 
control of the parental cell line. The level of ERCC1 foci decrease throughout the 48 
hour time period in the MRC5-SV1R cell line.  
 The overall nuclear fluorescence was calculated for these cell lines through 
the application of an Intensity feature created in the same manner as detailed in 
Chapter 5 (Section 5.26). The fluorescence data obtained for the MRC5-SV1 cell line 
showed a continuous increment with a 3.3 fold increase seen at 48 hrs.  The 
converse was seen in the MRC5-SV1R cell line with fluorescence levels dropping well 
below the untreated control at 48 hrs.  
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Figure 6.12: Average ERCC1 foci counts over a 48 hour period post treatment with 
HN2 in MRC5-SV1 and MRC5-SV1
R cell lines 
 
The above shows average ERCC1 foci numbers in the MRC5-SV1 and MRC5-SV1
R
 cell lines post 
treatment with 0.5μg/mL HN2. ERCC1 foci levels are higher in the MRC5-SV1
R 
control cell line in 
comparison to the parental cell line. Over the 48 hour time period, the foci count is seen to 
decrease in the resistant cell line. However the contrary is seen in the MRC5-SV1 parental cell line 
with foci counts increasing over the 48 hr period. Standard error was calculated by dividing the 
standard deviation of the mean by the square root of the number of cells counted for each sample 
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Figure 6.13: Relative nuclear intensity of ERCC1 post treatment with HN2 
 
Relative ERCC1 nuclear fluorescence calculated for the MRC5-SV1 parental and MRC5-SV1
R
 cell 
lines post 1 hour treatment with 0.5μg/mL HN2.. Increases in fluorescence are seen over the 48 
hour time period for the MRC5-SV1 parental cell line whilst the fluorescence was seen to decrease 
in the resistant cell line over the same time period. Standard error was calculated by dividing the 
standard deviation of the mean by the square root of the number of cells counted for each sample 
 
 
 
0
0.5
1
1.5
2
2.5
3
3.5
4
0 10 20 30 40
R
e
la
ti
ve
 F
lu
o
re
sc
e
n
ce
 
Time (hours) 
Relative ERCC1 expression levels post 
treatment with HN2   
MRC5-SV1
MRC5-SV1R
 169   
 
6.3 Discussion 
 This study looked at the response of five different cell lines to the cross-
linking chemotherapeutic agent; HN2 by analysing γ-H2AX foci induction over a 48 
hr period. Two of the cell lines, MRC5-SV1 and NB1-HTERT are repair normal cell 
lines with no known DNA repair defects. These were used to create resistant cell 
lines; MRC5-SV1R and NB1-HTERTR through continuous exposure to HN2. 
Clonogenic assays confirmed that the MRC5-SV1R cell line showed a 3 fold increase 
in resistance to HN2 in comparison to the MRC5-SV1 parental cell line. Similarly the 
NB1-HTERTR cell line showed a 2.7 fold increase in resistance to HN2.  The fifth cell 
line, GM08437B has a known defect in the XPF gene and therefore was expected to 
show increased sensitivity to cross-linking agents.  
 γ-H2AX induction post treatment with ICL agents can be indicative of DSB 
formation during the initiation of DNA repair (Kuraoka et al. 2000). Studies have 
shown that tumours often exhibit enhanced DNA repair in response to 
chemotherapeutic agents (Salles et al. 2006). Masuda et al,  (1988) demonstrated 
that DNA repair capacity did contribute to the resistant phenotype exhibited by the 
2780 human ovarian carcinoma cell line. Although there are multiple other 
mechanisms by which resistance may arise; Masuda et al, (1988) postulated that 
once the DNA adduct has been formed, this causes irreversible damage to the DNA 
and one of the primary cellular mechanisms to survive would be through efficient 
repair of the lesion. Their findings were in line with other numerous other studies 
such as those conducted by Ferry et al, (2000) and Johnson et al, (1997). Similarly 
Koberle et al, (1997) demonstrated that diminished DNA repair of Pt-induced 
 170   
 
damage played a role in rendering testis tumour cells hypersensitive to DNA 
damaging agents. 
 Comparison of γ-H2AX induction in the NB1-HTERT parental and NB1-
HTERTR revealed the resistant cell line had increased foci induction at every time 
point sampled in comparison to the parental cell line. Therefore it is likely that the 
NB1-HTERTR cell line could have acquired resistance through upregulation of DNA 
repair pathways by increasing the rate of incisions of the cross-linked DNA possibly 
by the ERCC1-XPF endonuclease.    
 Another route of acquiring resistance could be through increased tolerance 
of DNA damage as suggested by Lanzi et al, (1998). Comparison of the MRC5-SV1 
parental and MRC5-SV1R resistant cell lines also showed increased numbers of γ-
H2AX induction in the resistant cell line. However unlike the NB1-HTERT parental 
and resistant cell lines, there were much higher background levels of γ-H2AX seen 
in the untreated control of the MRC5-SV1R cell line in comparison to the parental 
cell line. There was a 4.9 fold difference between the untreated controls. This data 
indicates that the mechanism of resistance for the MRC5-SV1R cell line could be due 
to an enhanced ability to tolerate DNA DSBs.  
 Numerous studies have shown that cells deficient in either ERCC1 or XPF 
render them highly sensitive to ICL agents (Kuraoka et al. 2000; De Silva et al. 2002; 
Niedernhofer et al. 2004; Clingen et al. 2008; Al-Minawi et al. 2009). ERCC1-XPF 
have been shown to “unhook” ICLs by making dual cuts on one strand of the cross-
linked DNA (Clingen et al. 2008) and Kuraoka et al, (2000) determined that this 
initiates the repair process of ICLs. However there are other studies which dispute 
this fact (Bhagwat et al, 2009). Findings by Niedernhofer et al, (2004) revealed 
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ERCC1-deficient cells still induced γ-H2AX formation and determined that ICL-
induced DSB formation was independent of the ERCC1-XPF endonuclease. This 
correlates with findings in this study which showed the GM08437B cell line, 
deficient in XPF, also induced γ-H2AX formation. Much higher induction of γ-H2AX 
foci was seen in this cell line in comparison to the NB1-HTERT parental and NB1-
HTERTR cell lines and there was also persistence of foci exhibited at 48 hrs. This is in 
line with findings by Clingen et al, (2008) who demonstrated a persistence of foci in 
ERCC1 deficient cells in comparison to resistance cells post treatment with Pt. 
Recent developments have been made into the role that the FA pathway plays in 
the repair of cross-linked DNA (Crossan and Patel, 2012). Bhagwat et al, 2009 
indicates that MUS81-EME1, recruited by various FA proteins makes the initial 
incision at the site of the cross-link; thereby creating a DSB. ERCC1-XPF then makes 
the second incision, resulting in the “un-hooking” of the cross-link. This theory 
provides an explanation for the induction of γ-H2AX foci in the XPF-deficient cell 
line but still does not provide a firm conclusion about the increased induction of γ-
H2AX foci seen in this cell line. It could be postulated that the persistence of the γ-
H2AX foci is linked to the inability of the cells to complete repair of the cross-linked 
DNA. However, this study would need to be extended to include FA patient cell 
lines in order to draw more informed conclusions about the expression levels of γ-
H2AX in chemo-sensitive cells. 
 Findings by Britten et al (2000) indicated that analysis of ERCC1 mRNA levels 
elicited an insight into determining resistance to Pt in human cervival tumour cells. 
Based on these findings, ERCC1 protein expression levels were also determined for 
each of the five cell lines in response to a 1 hour treatment with HN2. This was 
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done to determine whether an increased rate of “unhooking” of the ICLs was 
attributing to the resistance seen in the two resistant cell lines. There was an 
increased expression of ERCC1 seen in the two resistant cell lines in comparison to 
their respective parental cell lines in the control samples. However ERCC1 
expression decreased over the 48 hour time period in the resistant cell lines and 
furthermore the GM08437B cell line showed a vast induction in ERCC1 foci at 24 
hrs. Analysis of total nuclear fluorescence mimicked the same trends seen with 
total foci counts and it was not possible to relate the findings of the ERCC1 
experiments to the H2AX data obtained to identify a trend in expression levels. 
Therefore it was not possible to draw firm conclusions on the rate of “unhooking” 
of ICLs in these cell lines using the ERCC1 marker. 
 Recent evidence has implicated genes from the FA pathway in initiating the 
excisions to remove ICLs (Crossan and Patel 2012). These genes may likely be more 
sensitive markers of DNA damage and repair capacities post treatment with cross-
linking agents and they form the basis of future work I would undertake in further 
exploring the mechanisms behind resistant and sensitive cellular phenotypes.  
 Using γ-H2AX to predict chemosensitivity in patients may not be the most 
robust marker due to the conflicting data obtained for the XPF cell line. However 
both the resistant cell lines exhibited increases in H2AX foci in comparison with the 
parental cell lines. This mimics the trend identified in Chapter 5 where the cell line 
exhibiting the highest resistance to each of the chemotherapeutic agents also 
showed the highest induction of γ-H2AX foci.  Therefore it may be possible to 
identify chemoresistance in patients using this marker. However, a much larger 
sample set would be required in order to ascertain the true validity of γ-H2AX as a 
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diagnostic tool in identifying sensitive and resistant patients. Another important 
factor to consider is that γ-H2AX is a general marker of DNA damage rather than 
indicative of a particular repair pathway activation. Additionally the full repair 
kinetics post exposure to chemotherapeutic agents has yet to be elucidated in 
order to fully understand the γ-H2AX formation in cell lines such as the XPF 
deficient cell line GM08437B employed in this study. Most studies confirm that the 
ERCC1-XPF endonuclease is involved in the “un-hooking” mechanism of the cross 
linked DNA and produces a suitable substrate for the HR pathway to complete DNA 
repair (Ferry et al. 2000; McHugh et al. 2001; Clingen et al. 2007).  However the 
ERCC1 deficient embryonic stem cells employed in the study by Niedernhofer et al 
(2004) also showed H2AX formation post treatment with Pt and De Silva et al 
(2002) established that ERCC1 and XPF deficient cell lines were not hypersentive to 
cross-linking agents due to defective “unhooking” of ICLs.  
As the use of γ-H2AX has produced conflicting data, the potential of using a 
biomarker specific to a DNA repair pathway to identify chemosensitivity in patients 
was explored in the following chapter.   
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Chapter 7                          
Evaluation of the RAD51 protein as a 
DNA repair biomarker for 
chemotherapeutic response 
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7.1 Introduction 
HR is one of two DNA repair pathways that are responsible for the repair of DSBs. 
This pathway is also involved in other functions (Plo et al. 2008) such as 
 Gene diversification 
 Molecular evolution 
 Chromosome segregation in meiosis 
 Repair of DNA ICLs  
 Recovery of stalled replication forks 
The formation of ICLs poses a serious threat to the genomic stability due to the 
inhibition of essential cellular processes such as transcription and DNA synthesis 
(Wang et al. 2011). Due to the complex nature of ICL formation, the repair of ICLs is 
a significant challenge for cells and requires the coordinated interaction of multiple 
independent DNA pathways (Al-Minawi et al. 2009).  
 The preferred route taken for repair of ICL induced DNA damage is through 
the combination of components of the NER pathway and HR (Clingen et al. 2008). 
Kuraoka et al, (2000)  first demonstrated that the ERCC1-XPF endonuclease is 
involved in initiating repair of ICLs. There are several possible mechanisms for 
ERCC1-XPF; one of which involves the “unhooking” of the ICL through dual incisions 
either side of one arm of the ICL (Kuraoka et al. 2000). This then breaks the 
covalent bond between the two DNA strands (Clingen et al. 2008), providing a 
suitable substrate for the initiation of HR through the initiation of a DSB. RAD51 is 
involved in searching for an intact homologous duplex and binds to the ssDNA 
forming a presynaptic filament. RAD51 then mediates strand invasion and exchange 
of genetic information once the homologous strand has been located.  
 176   
 
 Studies have been carried out using the RAD51 as a biomarker of DNA 
damage in response to various DNA damaging agent. Haaf et al, (1995) showed an 
induction of nuclear RAD51 foci in human fibroblast cells in response to treatment 
with IR, UV irradiation and methyl methanesulfonate. They also demonstrated a 
role for RAD51 in the repair of DNA damage during meiosis. Findings by Raderschall 
et al, (1999) revealed that nuclear RAD51 foci showed preferential formation at 
sites of damaged ssDNA and theorised that the foci were indicating sites of filament 
formation on ssDNA.  Hannay et al, (2007) demonstrated that RAD51 was being 
overexpressed in a number of human soft tissue sarcoma cell lines. They further 
demonstrated that treating the human SKLMS1 leiomyosarcoma cell line with Adr 
increased the expression of the RAD51 protein in comparison to the untreated 
control cells which was determined by western blotting. They concluded that the 
overexpression of RAD51 was leading to the development of chemoresistance and 
this was further validated by showing that inhibiting Rad51 expression markedly 
increased cell sensitivity to Adr.  
 This study investigated the use of RAD51 as a potential biomarker in 
identifying chemosensitivity or resistance to the ICL-inducing agent, HN2. RAD51 
plays an integral role in HR which has been shown to be centrally involved in the 
repair of ICLS and furthermore having defective components of the HR pathway has 
been shown to contribute to the development of cancers such as breast and 
ovarian (Clingen et al. 2008; Li and Heyer 2008). Therefore it was hypothesised that 
analysis of RAD51 expression levels could elucidate information such as whether 
DNA repair of ICLs is up-regulated in cell lines made resistant to HN2.   
 
 177   
 
7.2 Results  
Figure 7.1: Multispectral images of Rad51 foci with increasing numbers of foci 
The above figure shows example images of cells with increasing numbers of Rad51 foci. Ch01 
shown in the first column depicts the BF image of these cells with the morphology mask shown in 
blue which highlights the nuclei of the cells. Ch02 shown in the second column (representing 
AF488 staining) depicts the unmasked cells whilst the third column depicts the same images 
masked with the RAD51 foci spot mask. Ch05 shows the morphology of the nucleus of these cells. 
 
 Figure 7.1 above shows example images of the RAD51 foci visualised in the 
cell lines post treatment with HN2. A spot mask was created using the Spot Wizard 
function for each cell line as detailed in Chapter 5. This was then combined with a 
nuclear morphology mask to enumerate the RAD51 foci present in the nucleus of 
each cell.   
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7.2.1 Quantification of RAD51 foci post treatment with HN2 in the MRC5-SV1 and 
MRC5-SV1R cell lines 
 The average number of RAD51 foci per cell in the MRC5-SV1 parental and 
resistant cell lines post 1 hr treatment with 0.5μg/mL HN2 was analysed and 
quantified using the ImagestreamX. RAD51 foci were enumerated by applying a 
Morphology and Peak mask to each of the cell images produced for each time point 
as detailed in previous chapters. The average foci numbers are shown in Figure 7.2. 
The total nuclear fluorescence was also determined for each of the cell lines and is 
shown in Figure 7.3. 
 At all time points examined, the MRC5-SV1 parental cell line showed fewer 
RAD51 foci than the MRC5-SV1R cell line. There was a 3.7 fold difference seen 
between the untreated controls of the two cell lines. There was little change seen 
between samples collected at 6 hrs and 24 hrs in the MRC5-SV1 parental cell line. 
This then increased by 1.2 fold at 30 hrs. A similar fold change was observed 
between the 6 hour and 24 hour samples for the MRC5-SV1R cell line. Foci counts at 
24 hrs and 30 hrs for the resistant cell line were similar.  A further increase in 
RAD51 foci was seen at 48 hrs for the MRC5-SV1R cell line; leaving it at a 1.5 fold 
increase of the untreated control. In the MRC5-SV1 parental cell line, there was a 
decrease in foci seen at 48 hrs in comparison to the 30 hour sample.  However this 
remained at a 2 fold increase of the untreated control. 
 The relative nuclear fluorescence data for the parental cell line showed that 
at 30 hrs, there was a peak of relative fluorescence and this was shown to decrease 
at 48 hrs; although it remained at a 1.5 fold increase of the untreated control. In 
contrast, the nuclear fluorescence exhibited by the MRC5-SV1R cell line continued 
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to increase over the same hour time period. The relative fluorescence data appears 
to correlate with the foci counts in these cell lines.  
 Statistical analysis of the data using ANOVA revealed significant differences 
(p value <0.001) in the distribution of foci between the MRC5-SV1 parental and 
resistant cell lines (See Table 7.1 below)  
Table 7.1: ANOVA Statistical analysis of foci distribution in the MRC5-SV1 parental 
and resistant cell lines 
 
F 
P-
value 
F criteria 
MRC5-SV1 
parental v 
resistant 
33.542 <0.001 2.374078 
Interaction 33.823 <0.001 2.374078 
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Figure 7.2: Average RAD51 Foci numbers over a 48 hour period post treatment 
with HN2 
 
The above shows nuclear RAD51 foci counts for the MRC5-SV1 and MRC5-SV1
R
 cell lines. There is a 
3.7 fold difference between the MRC5-SV1 parental and resistant cell lines in the untreated 
controls. Although the foci counts are seen to increase in the parental cell line, there is little 
difference seen between the time points. In contrast, the RAD51 foci counts in the MRC5-SV1
R
 cell 
line are seen to continually increase over the 48 hour time period. Standard error was calculated 
by dividing the standard deviation of the mean by the square root of the number of cells counted 
for each sample. 
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Figure 7.3: Relative Fluorescence of cells post 1 hour treatment with HN2 
 
The above shows the relative nuclear fluorescence levels of the MRC5-SV1 parental and MRC5-
SV1
R 
cell lines. There is a 1.8 fold increase in fluorescence seen at 6 hrs in the MRC5-SV1 parental 
cell line. Fluorescence levels remain unchanged between 6 hrs and 24 hrs and appear to peak at 30 
hrs before starting to decline. However in the MRC5-SV1
R
 cell line, relative fluorescence levels are 
continually increasing over the 48 hour time period. Standard error was calculated by dividing the 
standard deviation of the mean by the square root of the number of cells counted for each 
sample. 
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7.3.1 Quantification of RAD51 foci post treatment with HN2 in the NB1-HTERT, 
NB1-HTERTR and GM08437B cell lines 
 The average number of RAD51 foci per cell in the NB1-HTERT, NB1-HTERTR 
and GM08437B cell lines was analysed and quantified using the ImagestreamX post 
treatment with 0.3 μg/mL HN2. RAD51 foci were enumerated by applying a 
Morphology and Peak mask to each of the cell images produced for each time point 
as previously described. The average foci numbers are shown in Figure 7.4. The 
total nuclear fluorescence was also determined for each of the cell lines and is 
shown in Figure 7.5. 
 The NB1-HTERTR cell line showed little change in RAD51 foci counts over the 
48 hour period post treatment with HN2. It also showed lower levels of RAD51 in 
comparison to both the NB1-HTERT parental cell line and the GM08437B cell line. 
There was a 1.5 fold increase in RAD51 foci seen between 6 hrs and 24 hrs in the 
NB1-HTERT parental cell line. The peak of RAD51 formation was seen at 24 hrs 
which then was seen to slowly decrease at 30 and 48 hrs although it was not a 
dramatic decrease. 
 The GM08437B cell line shows an increase in RAD51 across the 48 hour time 
period with a 1.2 fold increment at each time point. At 48 hrs, RAD51 foci counts 
remain at a 1.9 fold increase in comparison to the untreated control.   
 Relative fluorescence data for the cell lines appear to show a similar trend to 
the foci counts obtained for the NB1-HTERT parental and GM08437B cell lines. 
However the NB1-HTERTR had much higher levels of fluorescence than the other 
two cell lines even though the foci counts were much lower in this cell line. 
Statistical analysis of the data using ANOVA revealed that the three cell lines all 
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showed significantly different RAD51 foci distributions across the 48 hour time 
period (Refer to Table 7.2 below). 
Table 7.2: ANOVA Statistical analysis of foci distribution in the NB1-HTERT, 
NB1-HTERTR and GM08437B cell lines 
 
F P-value 
F 
criteria 
NB1-HTERT parental v 
resistant 369.9995 <0.001 2.372509 
Interaction 115.9683 <0.001 2.372509 
NB1-HTERT parental v 
GM08437B 
469.9547 <0.001 2.372509 
Interaction 403.3087 <0.001 2.372509 
NB1-HTERTR V GM08437B 694.5374 <0.001 2.372509 
Interaction 271.1347 <0.001 2.372509 
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Figure 7.4: Average RAD51 Foci numbers over a 48 hour period post treatment 
with HN2 
 
The average RAD51 foci counts for the NB1-HTERT, NB1-HTERT
R
 and GM08437B cell lines post 1 
hour treatment with 0.3μg/mL HN2. The NB1-HTERT
R
 cell line showed little change in RAD51 foci 
counts over the 48 hour time period. The NB1-HTERT parental cell line showed an increased 
expression of RAD51 foci in comparison with the NB1-HTERT
R
 resistant cell line at all time points 
examined. The GM08437B cell line showed the highest expression of RAD51 foci of all 3 cell lines 
examined and this was seen to continually increase over the 48 hour time period. Standard error 
was calculated by dividing the standard deviation of the mean by the square root of the number 
of cells counted for each sample. 
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Figure 7.5: Relative Fluorescence of cells post 1 hour treatment with HN2 
 
Relative nuclear fluorescence levels for NB1-HTERT parental, NB1-HTERT
R
 and GM08437B cell 
lines. The NB1-HTERT parental cell line shows an increase in fluorescence between 6 hrs and 24 
hrs and this is seen to peak at 30 hrs before starting to decrease at the 48 hour time point. 
However it still maintains fluorescence levels at a 1.7 fold increase in comparison to the untreated 
control. The GM08437B cell line shows a steady increment in fluorescence levels across the 48 
hour time period. The NB1-HTERT
R
 cell line shows a steep increase in fluorescence at 6 hrs and this 
is seen to continually increase up to 30 hrs with a slight decrease seen at 48 hrs. Standard error 
was calculated by dividing the standard deviation of the mean by the square root of the number 
of cells counted for each sample. 
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7.3 Discussion 
 This study compared the expression levels of RAD51 in five different cell 
lines over a 48 hour time period in response to a 1 hour treatment with HN2. 
MRC5-SV1 and MRC5-SV1R cell lines were treated with a higher dose of HN2 
(0.5μg/mL) as the parental cell line exhibited higher resistance to this drug in 
comparison with the NB1-HTERT cell line (See Chapter 4). Increased levels of RAD51 
foci were seen in the MRC5-SV1R cell line across the 48 hour time period examined 
in comparison to the MRC5-SV1 parental cell line. A comparison of the untreated 
controls revealed a 3.7 fold increase in RAD51 foci in the MRC5-SV1R cell line. At 48 
hrs, there was a 2.7 fold increase in RAD51 foci in the MRC5-SV1R cell line.  
 This line of evidence suggests that there is an upregulation in the 
homologous recombination DNA repair pathway in the MRC5-SV1R cell line. This is 
supported by observations that the level of RAD51 foci increased 1.2 fold between 
6 hrs and 24 hrs in the MRC5-SV1R cell line while a similar increase was exhibited by 
the MRC5-SV1 parental cell line between 24 hrs and 30 hrs; suggesting an earlier 
onset of HR in the resistant cell line. These findings are in line with that of Al-
Minawi et al, (2009) who reported that HR proteins play a crucial role in the repair 
of ICLs. Thereby it is proposed that the MRC5-SV1R cell line acquired resistance to 
HN2 by up-regulating HR which would allow it to resolve damage incurred by the 
formation of ICLs more rapidly than its parental cell line.   
 However the NB1-HTERTR cell line did not exhibit a similar increase in RAD51 
foci in comparison to the parental cell line. Instead it showed lower levels of RAD51 
foci across the entire 48 hour time period examined which suggests that there is no 
up-regulation of HR seen in this cell line. Clonogenic data from Chapter 6 confirmed 
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that the resistant cell line exhibited a 2.7 fold increase in resistance to HN2. 
Therefore it is possible that the NB1-HTERTR cell line acquired resistance to HN2 
through increased efflux of the drug out of the cell or by increased inactivation of 
HN2 through interactions with intracellular metabolites such as Glutathione. 
Alternatively it could have become more tolerant to the induction of DNA DSBs.    
 The GM08437B cell line exhibited a steady increment in RAD51 foci at every 
time point observed over the 48 hour time period. Findings by Al-Minawi et al, 
(2009) indicated that ERCC1-XPF is not required for the formation of RAD51 foci 
which supports the findings in this chapter. Findings from the previous chapter 
have indicated the presence of DSBs in the GM08437B cell line in response to 
treatment with HN2. Therefore it is possible that RAD51 is still being recruited to 
the site of damage but DNA repair is not reaching completion as numerous findings 
support the theory that the ERCC1-XPF endonuclease is critical in the latter stages 
of ICL-induced DNA damage repair (De Silva et al. 2002; Niedernhofer et al. 2004; 
Clingen et al. 2008; Wang et al. 2011). In order to determine whether RAD51 is 
functional, expression levels of HR proteins downstream of RAD51 could be 
examined.  
The increased expression in RAD51 seen in the MRC5-SV1R cell line post 
treatment with HN2 in comparison to the parental cell line correlates with the 
findings that expression of γ-H2AX was also increased in this cell line. This provides 
a firm indication that there was an upregulation in DNA repair capacities of the 
MRC5-SV1R cell line. However contradictory findings were seen in the NB1-HTERTR 
cell line as this showed an increase in γ-H2AX expression post treatment with HN2 
in comparison to the parental cell line but did not show an increase in RAD51 
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protein levels. Therefore further work needs to be done with a bigger cohort of 
DNA repair normal and defective cell lines and also perhaps a wider array of 
chemotherapeutic drugs.  
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Chapter 8                        
General Discussion 
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This project examined the efficacy of two DNA biomarkers γ-H2AX and 
RAD51 in predicting patient response to chemotherapy and identifying sensitive 
and resistant cellular phenotypes. The novel technique of imaging flow cytometry 
was employed in the detection of these two biomarkers post treatment with 
different chemotherapeutic agents. Six different cell lines were utilised in this 
project: 
 MRC5-SV1 (derived from DNA repair normal) 
 NB1-HTERT (derived from DNA repair normal) 
 AT5BIVA (derived from classical A-T patient) 
 MRC5-SV1R (HN2 resistant) 
 NB1-HTERTR (HN2 resistant) 
 GM08437B (derived from an XP-F patient) 
 γ-H2AX and RAD51 expression levels were first evaluated in DNA repair 
normal cell lines and compared with resistant and sensitive cell lines to investigate 
whether distinguishable trends of increased foci formation or foci persistence could 
be linked to chemo-sensitivity or chemo-resistance.   
Side effects are a fundamental limitation of chemotherapy. The extent of 
normal cell damage governs the level of side effects experienced by the patient and 
can be extremely variable between individuals. Additionally the development of 
resistance to chemotherapeutic agents accounts for treatment failure in more than 
90% of breast and ovarian cancers (Ferry et al. 2000; Agarwal and Kaye 2003). 
Therefore the development of an assay that could identify these patients prior to 
undergoing therapy would aid in improving patient outcome and ultimately their 
quality of life.  
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 As the formation of γ-H2AX foci has been well-established post treatment 
with IR, the initial study looked at whether it was possible to detect differences in 
the induction and repair of DNA DSB post exposure to IR in three cell lines with 
different DNA repair capacities using the Imagestream. The data derived from the 
Imagestream was compared with classic methods such as in situ 
immunofluorescence and conventional flow cytometry. Similar patterns of foci 
induction in the different cell lines were seen using all three methods.  This then 
initiated the development of a chemotherapy γ-H2AX assay to examine whether 
distinct DNA damage and repair profiles could be established in a similar manner to 
those established in response to IR.  
 The chemotherapy γ-H2AX assay measured the response of cell lines to 
different chemotherapeutic agents by analysing γ-H2AX foci induction. In response 
to treatment with chemotherapeutic agents such as cross-linking agents, γ-H2AX 
formation is thought to be indicative of incisions being made during DNA repair.  A 
clear trend has emerged from this data in that cell lines exhibiting higher levels of 
resistance to each individual drug were also seen to exhibit the highest number of 
foci at each time point sampled. Therefore it is possible that the explanation for the 
increased foci numbers is due to an increased rate of DNA repair, likely through an 
increase in the number of incisions being made. This reasoning is supported by 
studies such as Clingen et al, (2007) and Niedernhofer et al, (2004) who have shown 
the accumulation of γ-H2AX foci in response to treatment with chemotherapeutic 
agents such as Pt and Mitomycin C. 
 The RAD51 assay revealed increased RAD51 expression levels in one of the 
resistant cell lines, MRC5-SV1R in comparison with its parental cell line. AS HR is 
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known to have a critical role in completing repair of ICLs, this increase in RAD51 
levels could indicate an upregulation of the HR pathway in this cell line. 
Interestingly, the NB1-HTERTR cell line did not show increases in RAD51 foci with 
much lower levels of RAD51 expression seen over the 48 hour time period. This 
may be indicating that this cell line may have acquired resistance through other 
mechanisms such as an increased tolerance to the formation of DNA DSBs as the 
results of the γ-H2AX assay revealed increases in foci formation in the NB1-HTERTR 
resistant cell line.  
 The kinetics of γ-H2AX formation in response to chemotherapeutic agents 
that do not form direct strand breaks has yet to be fully elucidated and it is not fully 
understood how DSB formation occurs during the course of DNA repair of these 
lesions. However the γ-H2AX biomarker has been successful in identifying different 
DNA damage and repair profiles in normal cell lines as well as chemo-resistant cell 
lines. However, it did not elicit a clear difference in foci formation between chemo-
sensitive and chemo-resistant cell lines as both cellular phenotypes revealed 
increased   γ-H2AX foci formation in comparison to the two DNA repair normal cell 
lines examined in this investigation. However a much larger sample set 
encompassing more control cell lines as well as cell lines with defects in different 
DNA repair pathways would be needed to ascertain the true validity of γ-H2AX as a 
diagnostic tool in identifying sensitive and resistant patients. The RAD51 biomarker 
has also successfully identified a potential upregulation of the HR pathway in the 
MRC5-SV1R cell line. The information discerned from the expression levels of this 
marker may provide more insight into the overall patient response to treatment 
with ICL agents as it is indicative of a specific DNA repair pathway.  However foci 
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formation seen with the RAD51 marker was not as clear cut and reliable as the 
formation of γ-H2AX foci.  
 Overall both markers have high potential in identifying chemo-sensitive and 
resistant patients but there is a lot of scope for further work in this area. As 
previously mentioned, a bigger cohort of cell lines encompassing a wider range of 
DNA repair defects should now be used to further investigate the trends in RAD51 
and γ-H2AX foci induction and resolution in response to chemotherapeutic drugs. 
The cohort should also include more control cell lines as there were some 
contradictory results seen between the two DNA repair normal cell lines used here. 
The differences in sensitivity seen between the two cell lines in response to the 
different chemotherapeutics could be highlighting that responses can vary greatly 
between individuals but this can only be determined by examining more DNA repair 
normal cell lines.  By examining a bigger cohort, I believe it would enable us to 
determine if there is a true trend in γ-H2AX and RAD51 foci induction emerging that 
can readily identify hypersensitivity and resistance in individuals.  
Recent studies have revealed that 15 genes belonging to the FA pathway 
play a vital role in the maintenance of genomic stability (Crossan and Patel 2012) 
and have a central role in ICL repair. They are involved in the coordination of 
multiple repair processes; particularly nucleases that are vital for incising the ICLS. 
Enhancing knowledge of the mechanisms of DNA repair in response to 
chemotherapy would allow for improved therapies that could circumvent the 
development of resistance and undoubtedly vastly improve patient response and 
overall survival rates especially in cancers such as ovarian or breast cancer where 
treatment failure accounts for nearly 90% of patient deaths.   
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Therefore it is concluded that both γ-H2AX and RAD51 have shown potential 
in being useful markers of DNA repair in response to chemotherapeutic drugs. 
However to further validate the work carried out here, my future work would 
involve 
 Increasing the number of DNA repair normal cell lines 
 Expanding the scope of DNA repair deficiencies 
 Include cell lines that have been made resistant to other chemotherapeutic 
drugs such as Pt 
 Examine other biomarkers representing the FA pathway 
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